<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" id="ctm270239" xml:lang="en" article-type="review-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Clin Transl Med</journal-id><journal-id journal-id-type="iso-abbrev">Clin Transl Med</journal-id><journal-id journal-id-type="doi">10.1002/(ISSN)2001-1326</journal-id><journal-id journal-id-type="publisher-id">CTM2</journal-id><journal-title-group><journal-title>Clinical and Translational Medicine</journal-title></journal-title-group><issn pub-type="epub">2001-1326</issn><publisher><publisher-name>John Wiley and Sons Inc.</publisher-name><publisher-loc>Hoboken</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">40008496</article-id><article-id pub-id-type="pmc">PMC11862898</article-id><article-id pub-id-type="doi">10.1002/ctm2.70239</article-id><article-id pub-id-type="publisher-id">CTM270239</article-id><article-categories><subj-group subj-group-type="overline"><subject>Review</subject></subj-group><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Detection, molecular function and mechanisms of m5C in cancer</article-title><alt-title alt-title-type="left-running-head">ZHANG <sc>et&#x000a0;al.</sc>
</alt-title></title-group><contrib-group><contrib id="ctm270239-cr-0001" contrib-type="author"><name><surname>Zhang</surname><given-names>Linhui</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-4672-8350</contrib-id><xref rid="ctm270239-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="ctm270239-aff-0002" ref-type="aff">
<sup>2</sup>
</xref><xref rid="ctm270239-aff-0003" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib id="ctm270239-cr-0002" contrib-type="author"><name><surname>Li</surname><given-names>Yuelong</given-names></name><xref rid="ctm270239-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="ctm270239-cr-0003" contrib-type="author"><name><surname>Li</surname><given-names>Liqing</given-names></name><xref rid="ctm270239-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="ctm270239-aff-0002" ref-type="aff">
<sup>2</sup>
</xref><xref rid="ctm270239-aff-0003" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib id="ctm270239-cr-0004" contrib-type="author"><name><surname>Yao</surname><given-names>Fei</given-names></name><xref rid="ctm270239-aff-0004" ref-type="aff">
<sup>4</sup>
</xref></contrib><contrib id="ctm270239-cr-0005" contrib-type="author" corresp="yes"><name><surname>Cai</surname><given-names>Maoping</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0009-0009-2242-2582</contrib-id><xref rid="ctm270239-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="ctm270239-aff-0002" ref-type="aff">
<sup>2</sup>
</xref><xref rid="ctm270239-aff-0003" ref-type="aff">
<sup>3</sup>
</xref><address><email>mpcai24@m.fudan.edu.cn</email></address></contrib><contrib id="ctm270239-cr-0006" contrib-type="author" corresp="yes"><name><surname>Ye</surname><given-names>Dingwei</given-names></name><xref rid="ctm270239-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="ctm270239-aff-0002" ref-type="aff">
<sup>2</sup>
</xref><xref rid="ctm270239-aff-0003" ref-type="aff">
<sup>3</sup>
</xref><address><email>dwyeli@163.com</email></address></contrib><contrib id="ctm270239-cr-0007" contrib-type="author" corresp="yes"><name><surname>Qu</surname><given-names>Yuanyuan</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-1179-2800</contrib-id><xref rid="ctm270239-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="ctm270239-aff-0002" ref-type="aff">
<sup>2</sup>
</xref><xref rid="ctm270239-aff-0003" ref-type="aff">
<sup>3</sup>
</xref><address><email>quyy1987@163.com</email></address></contrib></contrib-group><aff id="ctm270239-aff-0001">
<label>
<sup>1</sup>
</label>
<named-content content-type="organisation-division">Department of Urology</named-content>
<institution>Fudan University Shanghai Cancer Center</institution>
<city>Shanghai</city>
<country country="CN">China</country>
</aff><aff id="ctm270239-aff-0002">
<label>
<sup>2</sup>
</label>
<named-content content-type="organisation-division">Department of Oncology</named-content>
<named-content content-type="organisation-division">Shanghai Medical College</named-content>
<institution>Fudan University</institution>
<city>Shanghai</city>
<country country="CN">China</country>
</aff><aff id="ctm270239-aff-0003">
<label>
<sup>3</sup>
</label>
<institution>Shanghai Genitourinary Cancer Institute</institution>
<city>Shanghai</city>
<country country="CN">China</country>
</aff><aff id="ctm270239-aff-0004">
<label>
<sup>4</sup>
</label>
<named-content content-type="organisation-division">Department of Nursing</named-content>
<institution>Fudan University Shanghai Cancer Center</institution>
<city>Shanghai</city>
<country country="CN">China</country>
</aff><author-notes><corresp id="correspondenceTo">
<label>*</label>
<bold>Correspondence</bold>
<break/>Yuanyuan Qu, Dingwei Ye and Maoping Cai, Department of Urology, Fudan University Shanghai Cancer Center, Shanghai 200032, China.<break/> Email: <email>quyy1987@163.com</email>, <email>dwyeli@163.com</email> and <email>mpcai24@m.fudan.edu.cn</email>
<break/>
</corresp></author-notes><pub-date pub-type="epub"><day>26</day><month>2</month><year>2025</year></pub-date><pub-date pub-type="collection"><month>3</month><year>2025</year></pub-date><volume>15</volume><issue seq="110">3</issue><issue-id pub-id-type="doi">10.1002/ctm2.v15.3</issue-id><elocation-id>e70239</elocation-id><history>
<date date-type="rev-recd"><day>31</day><month>1</month><year>2025</year></date>
<date date-type="received"><day>24</day><month>9</month><year>2024</year></date>
<date date-type="accepted"><day>11</day><month>2</month><year>2025</year></date>
</history><permissions><!--&#x000a9; 2025 Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.--><copyright-statement content-type="article-copyright">&#x000a9; 2025 The Author(s). <italic toggle="yes">Clinical and Translational Medicine</italic> published by John Wiley &#x00026; Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.</copyright-statement><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="file:CTM2-15-e70239.pdf"/><abstract><title>Abstract</title><p>Interest in RNA posttranscriptional modifications, particularly 5&#x02010;methylcytosine (m5C), has surged in recent years. Studies have shown that m5C plays a key role in cellular processes and is closely linked to tumourigenesis. This growing focus emphasises the importance of understanding the diverse impacts of m5C modifications in both normal cellular functions and cancer development. Moreover, strides in methodologies for discerning m5C have facilitated intricate transcriptome cartography of RNA methylation at the solitary nucleotide echelon. This technical progress has fueled a surge in m5C&#x02010;centric investigations, facilitating further exploration of this RNA modification. This review provides a comprehensive analysis of the oncogenic potential of m5C RNA modification, elucidating the precise molecular mechanisms driving its role in cancer development. It consolidates current knowledge regarding the biological consequences of m5C RNA modification in tumour cells. Understanding the role of methylation&#x02010;related processes in tumourigenesis shows promise for advancing cancer diagnosis and therapeutic strategies.</p><sec id="ctm270239-sec-0020"><title>Highlights</title><p>
<list list-type="bullet" id="ctm270239-list-0001"><list-item><p>m5C modifications are dynamically regulated by writers, readers, and erasers, influencing cancer progression, metastasis, and immune evasion.</p></list-item><list-item><p>Distinct m5C regulatory networks exist across cancers, modulating oncogenic pathways and therapy responses.</p></list-item><list-item><p>m5C signatures serve as biomarkers for cancer prognosis and treatment stratification, highlighting their role in precision oncology.</p></list-item></list>
</p></sec></abstract><abstract id="ctm270239-abs-0001" abstract-type="graphical"><p>
<bold>The role of m5C in cancers</bold>. The role of m5C regulators&#x02010; writers, erasers, and readers&#x02010; in various cancer types, including NSCLC, PCa, GC, AML, BCa, and HCC.
<boxed-text position="anchor" content-type="graphic"><graphic xlink:href="CTM2-15-e70239-g001.jpg" position="anchor" id="jats-graphic-1"/></boxed-text>
</p></abstract><kwd-group kwd-group-type="author-generated"><kwd id="ctm270239-kwd-0004">5&#x02010;methylcytosine</kwd><kwd id="ctm270239-kwd-0001">biologic functions</kwd><kwd id="ctm270239-kwd-0002">cancer</kwd><kwd id="ctm270239-kwd-0003">detection techniques</kwd><kwd id="ctm270239-kwd-0005">RNA modification</kwd></kwd-group><funding-group><award-group id="funding-0001"><funding-source>National Ten Thousand Plan Young Top Talents</funding-source></award-group><award-group id="funding-0002"><funding-source>Shanghai &#x02018;Rising Stars of Medical Talent&#x02019; Outstanding Youth Medical Talents</funding-source></award-group><award-group id="funding-0003"><funding-source><institution-wrap><institution>Shanghai Rising&#x02010;Star Program
</institution><institution-id institution-id-type="doi">10.13039/501100013105</institution-id></institution-wrap></funding-source><award-id>23QA1408900</award-id></award-group><award-group id="funding-0004"><funding-source>Shanghai &#x02018;Science and Technology Innovation Action Plan&#x02019; Medical Innovation Research Project</funding-source><award-id>22Y11905100</award-id></award-group><award-group id="funding-0005"><funding-source>Shanghai Municipal Health Bureau Project</funding-source><award-id>2020CXJQ03</award-id></award-group><award-group id="funding-0006"><funding-source>Fund of Fudan University and Cao'ejiang Basic Research</funding-source><award-id>24FCA13</award-id></award-group><award-group id="funding-0007"><funding-source><institution-wrap><institution>National Natural Science Foundation of China
</institution><institution-id institution-id-type="doi">10.13039/501100001809</institution-id></institution-wrap></funding-source><award-id>82172817</award-id><award-id>82172741</award-id><award-id>82473192</award-id></award-group></funding-group><counts><fig-count count="4"/><table-count count="2"/><page-count count="26"/><word-count count="14775"/></counts><custom-meta-group><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>March 2025</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:6.5.4 mode:remove_FC converted:26.02.2025</meta-value></custom-meta></custom-meta-group></article-meta><notes><p content-type="self-citation">
<mixed-citation publication-type="journal" id="ctm270239-cite-0001">
<string-name>
<surname>Zhang</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>L</given-names>
</string-name>, et&#x000a0;al. <article-title>Detection, molecular function and mechanisms of m5C in cancer</article-title>. <source>Clin Transl Med</source>. <year>2025</year>;<volume>15</volume>:<elocation-id>e70239</elocation-id>. <pub-id pub-id-type="doi">10.1002/ctm2.70239</pub-id>
</mixed-citation>
</p><fn-group><fn id="ctm270239-note-0001" fn-type="equal"><p>Linhui Zhang, Yuelong Li and Liqing Li contributed equally to this work.</p></fn></fn-group></notes></front><body><sec id="ctm270239-sec-0030"><label>1</label><title>INTRODUCTION</title><p>RNA modifications represent a vital layer of gene expression regulation, shaping RNA stability, translation and interactions.<xref rid="ctm270239-bib-0001" ref-type="bibr">
<sup>1</sup>
</xref> Since pseudouridine was first identified in 1951 as the earliest known post&#x02010;transcriptional RNA modification,<xref rid="ctm270239-bib-0002" ref-type="bibr">
<sup>2</sup>
</xref> over 170 chemical modifications have been discovered across various RNA types, including messenger RNA (mRNA), transfer RNA (tRNA), ribosomal RNA (rRNA) and long non&#x02010;coding RNA (lncRNA).<xref rid="ctm270239-bib-0003" ref-type="bibr">
<sup>3</sup>
</xref> Among these, N6&#x02010;methyladenosine (m6A) and 5&#x02010;methylcytosine (m5C) have garnered particular attention for their dynamic and reversible nature, allowing precise regulation of RNA function. These modifications play critical roles in processes such as RNA stability, translation efficiency and splicing, underscoring their importance in maintaining cellular homeostasis and driving disease progression.<xref rid="ctm270239-bib-0004" ref-type="bibr">
<sup>4</sup>
</xref>, <xref rid="ctm270239-bib-0005" ref-type="bibr">
<sup>5</sup>
</xref>
</p><p>m5C, defined by the methylation of the fifth carbon in cytosine residues, plays a role in numerous physiological and pathological processes, including tumourigenesis. This modification occurs across different RNA species, and is mediated by specific &#x02018;writer&#x02019; enzymes such as NSUN2 and DNMT2, &#x02018;eraser&#x02019; enzymes such as TET and &#x02018;reader&#x02019; proteins such as ALYREF.<xref rid="ctm270239-bib-0006" ref-type="bibr">
<sup>6</sup>
</xref>, <xref rid="ctm270239-bib-0007" ref-type="bibr">
<sup>7</sup>
</xref>, <xref rid="ctm270239-bib-0008" ref-type="bibr">
<sup>8</sup>
</xref>, <xref rid="ctm270239-bib-0009" ref-type="bibr">
<sup>9</sup>
</xref> Dysregulation of these components can significantly impact RNA metabolism and cellular processes, contributing to cancer initiation and progression.</p><p>Despite its emerging significance, the precise mechanisms and biological implications of m5C remain underexplored. Recent technological advancements, such as bisulphite sequencing and liquid chromatography&#x02012;tandem mass spectrometry (LC&#x02012;MS/MS), have enabled high&#x02010;resolution mapping of m5C modifications, providing novel insights into its functional roles.<xref rid="ctm270239-bib-0010" ref-type="bibr">
<sup>10</sup>
</xref>, <xref rid="ctm270239-bib-0011" ref-type="bibr">
<sup>11</sup>
</xref> However, many questions remain unanswered, particularly regarding the interplay between m5C and other RNA modifications and its contributions to oncogenic pathways.</p><p>This review provides a comprehensive overview of m5C RNA modification, delving into its specific molecular mechanisms and contributions to cancer progression. By synthesising current research, it highlights the biological effects of m5C in tumour cells, shedding light on its regulatory functions in key processes such as RNA stability, translation and gene expression. Additionally, the review emphasises the significance of m5C&#x02010;related methylation in tumourigenesis, offering valuable insights into its potential as a biomarker for cancer diagnosis and a target for therapeutic intervention. This expanded understanding aims to bridge knowledge gaps and inspire future studies to advance precision medicine in oncology.</p></sec><sec id="ctm270239-sec-0040"><label>2</label><title>RNA METHYLATION</title><p>RNA methylation stands as a meticulously scrutinised alteration in the realm of RNA modifications, with recent advancements in RNA methylation research due to the development of high&#x02010;throughput sequencing technology.<xref rid="ctm270239-bib-0012" ref-type="bibr">
<sup>12</sup>
</xref> It has been established that RNA methylation is associated with various human physiologies and diseases, particularly tumour immunity.<xref rid="ctm270239-bib-0013" ref-type="bibr">
<sup>13</sup>
</xref> The regulation of normal physiological processes relies on the important role of RNA methylation, while abnormal methylation can lead to diseases and cancers. RNA methylation can be categorised into various forms based on the locus of methylation, including N1&#x02010;methyladenosine (m1A), m5C, m6A, N7&#x02010;methylguanosine (m7G) and N6,2&#x02032;&#x02010;O&#x02010;dimethyladenosine (m6Am). RNA modification proteins (RMPs) exert a pivotal influence in facilitating the dynamic and reversible methylation of RNA.<xref rid="ctm270239-bib-0014" ref-type="bibr">
<sup>14</sup>
</xref>
</p><p>Methylcytosine methylation, also known as m5C, is a common modification that occurs on the fifth carbon atom of cytosine. This modification is found in various types of RNAs, involving mRNA, tRNA, rRNA, viral RNA, vault RNA and lncRNA. These diverse RNAs play important roles in maintaining RNA constancy and augmenting translational efficacy.<xref rid="ctm270239-bib-0015" ref-type="bibr">
<sup>15</sup>
</xref> The induction of m5C methylation is orchestrated by methyltransferases, which are referred to as &#x02018;writer&#x02019; enzymes. Examples of these enzymes include NSUN and members of the DNMT family. On the other hand, demethylases such as the TET families and binding proteins such as YBX1 function as &#x02018;eraser&#x02019; and &#x02018;reader&#x02019; proteins, respectively, dynamically regulating the m5C methylation process<xref rid="ctm270239-bib-0016" ref-type="bibr">
<sup>16</sup>
</xref> (Figure&#x000a0;<xref rid="ctm270239-fig-0001" ref-type="fig">1</xref>). The significance of m5C in modulating gene expression, metabolism and diseases has been extensively documented.<xref rid="ctm270239-bib-0017" ref-type="bibr">
<sup>17</sup>
</xref>, <xref rid="ctm270239-bib-0018" ref-type="bibr">
<sup>18</sup>
</xref> In the realm of oncology, the post&#x02010;transcriptional alteration of RNA has long been acknowledged for its pivotal roles in the progression and pathological mechanisms across diverse cancer types,<xref rid="ctm270239-bib-0019" ref-type="bibr">
<sup>19</sup>
</xref> offering innovative pathways for mechanistic exploration and therapeutic progress. Variations in m5C modifications within both coding and non&#x02010;coding RNA molecules exhibit intimate correlations with cellular proliferation, metabolic dynamics, tumour dissemination and are evident in various malignancies,<xref rid="ctm270239-bib-0020" ref-type="bibr">
<sup>20</sup>
</xref> including hepatocellular carcinoma (HCC),<xref rid="ctm270239-bib-0021" ref-type="bibr">
<sup>21</sup>
</xref> breast cancer (BC)<xref rid="ctm270239-bib-0022" ref-type="bibr">
<sup>22</sup>
</xref> and bladder cancer (BCa).<xref rid="ctm270239-bib-0023" ref-type="bibr">
<sup>23</sup>
</xref> Additionally, m5C exerts a substantial impact on a myriad of immune cell populations, encompassing B cells, T cells, NK cells, granulocytes, macrophages and others.<xref rid="ctm270239-bib-0024" ref-type="bibr">
<sup>24</sup>
</xref>
</p><fig position="float" fig-type="FIGURE" id="ctm270239-fig-0001"><label>FIGURE 1</label><caption><p>Overview of 5&#x02010;methylcytosine (m5C). Dynamic regulation of m5C RNA modification. The &#x02018;writers&#x02019; (e.g., NSUN family, NSUN1&#x02010;7) catalyse the methylation of cytosine residues, while &#x02018;erasers&#x02019; (e.g., TET1/2/3, ALKBH1) demethylate m5C, allowing for reversibility. &#x02018;Readers&#x02019; (e.g., ALYREF, YBX1, LIN28B, RAD52, FMRP, YTHDF2) bind to m5C&#x02010;modified RNAs and mediate downstream processes. These include RNA export, transcript stabilisation, homologous recombination and pre&#x02010;rRNA processing. Dysregulation of these pathways contributes to various cancers through effects on gene expression, RNA metabolism and tumour microenvironment interactions.</p></caption><graphic xlink:href="CTM2-15-e70239-g003" position="anchor" id="jats-graphic-3"/></fig></sec><sec id="ctm270239-sec-0050"><label>3</label><title>DETECTION METHODS OF M5C</title><p>Delving into modified target genes is imperative for thoroughly probing the biological ramifications of mRNA m5C alterations, particularly in the field of cancer research. Recent advancements in sequencing technologies and experimental methodologies have enabled the qualitative and quantitative analysis of mRNA methylation at the individual nucleoside tier, furnishing unparalleled elucidations into its functional capacities.<xref rid="ctm270239-bib-0025" ref-type="bibr">
<sup>25</sup>
</xref> In recent times, various robust detection approaches are utilised to identify m5C modifications, including: (1) physicochemical techniques embracing chromatography, mass spectrometry (MS),<xref rid="ctm270239-bib-0026" ref-type="bibr">
<sup>26</sup>
</xref> high&#x02010;performance liquid chromatography (HPLC)<xref rid="ctm270239-bib-0027" ref-type="bibr">
<sup>27</sup>
</xref> and LC&#x02012;MS/MS<xref rid="ctm270239-bib-0028" ref-type="bibr">
<sup>28</sup>
</xref>; (2) chemical conversion approaches merging next&#x02010;generation sequencing (NGS) methodologies such as RNA bisulphite sequencing (RNA&#x02010;BisSeq),<xref rid="ctm270239-bib-0029" ref-type="bibr">
<sup>29</sup>
</xref> ten&#x02012;eleven translocation (TET)&#x02010;assisted peroxotungstate oxidation sequencing (TAWO&#x02010;seq)<xref rid="ctm270239-bib-0030" ref-type="bibr">
<sup>30</sup>
</xref> and ultrafast bisulphite sequencing (UBS&#x02010;seq)<xref rid="ctm270239-bib-0031" ref-type="bibr">
<sup>31</sup>
</xref>; (3) immunoprecipitation coupled with NGS, including 5&#x02010;aza&#x02010;immunoprecipitation (5&#x02010;Aza&#x02010;seq)<xref rid="ctm270239-bib-0032" ref-type="bibr">
<sup>32</sup>
</xref> in conjunction with m5C individual&#x02010;nucleotide&#x02010;resolution cross&#x02010;linking and immunoprecipitation (miCLIP)<xref rid="ctm270239-bib-0033" ref-type="bibr">
<sup>33</sup>
</xref>; (4) third&#x02010;generation sequencing (TGS), leveraging differences in electrical signals, as seen in Nanopore&#x02010;seq<xref rid="ctm270239-bib-0034" ref-type="bibr">
<sup>34</sup>
</xref>; (5) predictive models powered by machine learning, such as PEAm5C, m5C&#x02010;PseDNC (5&#x02010;methylcytosine site prediction using pseudo&#x02010;nucleotide compositions),<xref rid="ctm270239-bib-0035" ref-type="bibr">
<sup>35</sup>
</xref> Pm5CS&#x02010;Comp&#x02010;mRMR (minimum redundancy maximum relevance), identifying RNA m5C sites via pseudo&#x02010;nucleotide compositions (iRNA&#x02010;m5C&#x02010;PseDNC)<xref rid="ctm270239-bib-0036" ref-type="bibr">
<sup>36</sup>
</xref> and m5CHPCR (heuristic reduction of nucleotide physicochemical properties) (Table&#x000a0;<xref rid="ctm270239-tbl-0001" ref-type="table">1</xref>).<xref rid="ctm270239-bib-0037" ref-type="bibr">
<sup>37</sup>
</xref> These methodologies collectively constitute an extensive arsenal frequently utilised for the systematic identification of m5C modifications within designated genetic loci. This integrative approach allows for a nuanced understanding of the complex landscape of mRNA modifications and their functional consequences. Such insights are instrumental in advancing our knowledge of cancer&#x02010;related epigenetic alterations, offering novel breakthroughs and potential strategies for targeted therapies.</p><p>This section categorises these methodologies into distinct groups, starting from traditional physicochemical techniques to cutting&#x02010;edge sequencing methods and computational tools. By systematically examining their relevance to m5C detection, sample preparation requirements, mechanisms and practical applications, this section aims to provide a comprehensive framework for understanding the current capabilities and limitations of m5C detection technologies.</p><sec id="ctm270239-sec-0060"><label>3.1</label><title>Physicochemical methods</title><p>Physicochemical methods are critical tools for identifying and characterising m5C modifications in RNA. These techniques are renowned for their high sensitivity, specificity and quantitative capabilities, making them ideal for the precise detection of RNA modifications.</p><sec id="ctm270239-sec-0070"><label>3.1.1</label><title>High&#x02010;performance liquid chromatography</title><p>HPLC is a highly sensitive analytical technique capable of detecting substances at nanogram levels. In this method, RNA samples are enzymatically digested into nucleosides using nucleases such as RNase T2 or nuclease P1. The resulting nucleosides are separated based on their hydrophobicity using a chromatographic column under optimised conditions, such as gradient elution with buffers of varying ionic strength. m5C is specifically detected by its unique retention time, which is compared against standard references to confirm its identity. Quantification is achieved by integrating the peak areas corresponding to m5C, often calibrated against synthetic standards. This technique has been extensively used for studying RNA modifications, particularly in small RNA species like tRNA and rRNA. For example, researchers used HPLC to determine the major and minor DNA base composition of 17 thermophilic bacteria.<xref rid="ctm270239-bib-0038" ref-type="bibr">
<sup>38</sup>
</xref>
</p></sec><sec id="ctm270239-sec-0080"><label>3.1.2</label><title>Mass spectrometry</title><p>MS provides a direct and highly accurate method for detecting m5C modifications.<xref rid="ctm270239-bib-0039" ref-type="bibr">
<sup>39</sup>
</xref> RNA is first digested enzymatically into individual nucleosides, as purity is critical to minimise ion suppression during analysis. The nucleosides are ionised, typically using electrospray ionisation, and analysed in the mass spectrometer. m5C is identified by its distinct mass&#x02010;to&#x02010;charge ratio (m/z), with high&#x02010;resolution MS capable of distinguishing closely related methylated and unmethylated cytosines. Tandem MS (MS/MS) is employed to further fragment the molecule, confirming the modification by analysing its fragmentation pattern. This method is widely used due to its sensitivity and specificity, although it requires access to advanced instrumentation.</p><p>As a specialised form of MS, LC&#x02012;MS/MS integrates the separation efficiency of LC with the analytical precision of MS.<xref rid="ctm270239-bib-0040" ref-type="bibr">
<sup>40</sup>
</xref> This method uses enzymatic RNA digestion and stable isotope&#x02010;labelled nucleoside standards to enhance quantification accuracy. LC isolates m5C based on its physicochemical properties, effectively reducing background noise and enhancing the clarity of the MS signal. The MS/MS mode provides additional structural confirmation by analysing the fragmentation patterns of m5C.<xref rid="ctm270239-bib-0041" ref-type="bibr">
<sup>41</sup>
</xref>
</p><p>LC&#x02012;MS/MS is one of the most widely used MS techniques in epigenetic research due to its high sensitivity, strong resolution and broad applicability. It is extensively applied in studies involving DNA methylation, histone modifications and RNA modifications. This method offers both qualitative and quantitative insights, making it especially suitable for analysing complex RNA populations, such as transcriptome&#x02010;wide studies.<xref rid="ctm270239-bib-0042" ref-type="bibr">
<sup>42</sup>
</xref> For instance, LC&#x02012;MS/MS has been used to study the dynamic changes of m5C mRNA in different tissues and developmental stages of <italic toggle="yes">Arabidopsis thaliana</italic>.<xref rid="ctm270239-bib-0028" ref-type="bibr">
<sup>28</sup>
</xref>
</p></sec></sec><sec id="ctm270239-sec-0090"><label>3.2</label><title>Chemical conversion methods</title><p>Chemical conversion methods are specialised techniques that rely on chemical reactions to selectively modify nucleotides, enabling the detection and quantification of m5C in RNA. These techniques exploit the unique reactivity of m5C compared to unmodified cytosines, enabling precise analysis.</p><sec id="ctm270239-sec-0100"><label>3.2.1</label><title>RNA bisulphite sequencing</title><p>RNA&#x02010;BisSeq is the gold standard for single&#x02010;base m5C detection. The method involves treating RNA with bisulphite, a reagent that deaminates unmethylated cytosines into uracil, while leaving m5C unmodified. Following conversion, the RNA is reverse transcribed into cDNA and sequenced. By comparing the sequence of treated and untreated RNA, m5C sites are identified. The efficiency of bisulphite conversion is critical, and incomplete conversion can lead to false positives. Computational tools are often employed to correct for such artefacts. RNA&#x02010;BisSeq has been used extensively in transcriptome&#x02010;wide studies. For example, it identified target genes involved in Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor (EGFR&#x02010;TKI) resistance by NSUN2 in EGFR&#x02010;mutant non&#x02010;small&#x02010;cell lung cancer.<xref rid="ctm270239-bib-0043" ref-type="bibr">
<sup>43</sup>
</xref>
</p></sec><sec id="ctm270239-sec-0110"><label>3.2.2</label><title>TAWO&#x02010;seq</title><p>TAWO&#x02010;seq employs chemical oxidation to convert m5C into 5&#x02010;hydroxymethylcytosine (5&#x02010;hmC), which is then sequenced. RNA is treated with peroxotungstate, a specific oxidant, under conditions that preserve RNA integrity. Following oxidation, RNA is subjected to library preparation and high&#x02010;throughput sequencing. The chemical specificity of the oxidation step ensures accurate identification of m5C, while minimising RNA degradation compared to bisulphite treatment. Despite its advantages, the transformation efficiency of m5C in TAWO&#x02010;seq requires optimisation to enhance its applicability in mRNA studies.<xref rid="ctm270239-bib-0030" ref-type="bibr">
<sup>30</sup>
</xref> TAWO&#x02010;seq is a relatively new technique and is not yet widely adopted. However, its ability to identify three known m5C sites in human tRNA, thereby validating the applicability of the approach for analysing real RNA samples.<xref rid="ctm270239-bib-0030" ref-type="bibr">
<sup>30</sup>
</xref>
</p></sec></sec><sec id="ctm270239-sec-0120"><label>3.3</label><title>Immunoprecipitation&#x02010;based methods</title><p>Immunoprecipitation&#x02010;based methods are powerful tools for studying m5C modifications in RNA. These methods use specific antibodies or binding proteins to capture and enrich m5C&#x02010;modified RNA, allowing for downstream analyses. Immunoprecipitation&#x02010;based approaches are widely used due to their ability to identify m5C modifications across different RNA types and in various biological contexts.</p><sec id="ctm270239-sec-0130"><label>3.3.1</label><title>m5C&#x02010;RNA immunoprecipitation sequencing</title><p>m5C&#x02010;RNA immunoprecipitation sequencing (m5C&#x02010;RIP&#x02010;seq) combines immunoprecipitation with high&#x02010;throughput sequencing to identify m5C modifications. RNA is incubated with anti&#x02010;m5C antibodies, which specifically bind to m5C residues. The RNA&#x02012;antibody complexes are captured using protein A/G beads, and the enriched RNA is purified for sequencing. The success of this method depends on the specificity and affinity of the antibodies, as cross&#x02010;reactivity can lead to false positives. While the resolution is limited compared to chemical conversion methods, m5C&#x02010;RIP&#x02010;seq is highly scalable and has been used to profile m5C across transcriptomes. For example, transcriptome full spectrum analysis was performed on Eimeria tenella mRNA m5C by m5C&#x02010;RIP&#x02010;seq.<xref rid="ctm270239-bib-0044" ref-type="bibr">
<sup>44</sup>
</xref>
</p></sec><sec id="ctm270239-sec-0140"><label>3.3.2</label><title>miCLIP</title><p>miCLIP provides single&#x02010;nucleotide resolution for mapping m5C by utilising cross&#x02010;linking of RNA to m5C&#x02010;specific antibodies. The cross&#x02010;linked sites introduce truncations or mutations during reverse transcription, which are then identified in sequencing reads. This method requires stringent controls and specialised protocols to maintain cross&#x02010;link stability. Computational pipelines analyse the mutation patterns to precisely locate m5C sites. miCLIP was used to identify RNA substrates of human NOP2/NUN1.<xref rid="ctm270239-bib-0045" ref-type="bibr">
<sup>45</sup>
</xref>
</p></sec></sec><sec id="ctm270239-sec-0150"><label>3.4</label><title>Third&#x02010;generation sequencing</title><p>TGS technologies, such as nanopore sequencing and single&#x02010;molecule real&#x02010;time (SMRT) sequencing, enable direct detection of m5C modifications without the need for chemical conversion. Nanopore sequencing measures disruptions in electrical conductivity as RNA passes through a nanopore, with m5C causing characteristic changes in signal. SMRT sequencing detects m5C by analysing the altered kinetics of reverse transcription, as the enzyme hesitates or changes speed when encountering modifications. These methods allow for transcriptome&#x02010;wide analysis of m5C with minimal sample preparation, although they require advanced computational algorithms to interpret the data. For instance, researchers sequenced the complete genome and full&#x02010;length transcript of <italic toggle="yes">Saccharomyces cerevisiae</italic> CEN. PK113&#x02010;7D.<xref rid="ctm270239-bib-0046" ref-type="bibr">
<sup>46</sup>
</xref>
</p></sec><sec id="ctm270239-sec-0160"><label>3.5</label><title>Predictive models</title><p>In the post&#x02010;genome era, computational models have emerged as powerful tools for predicting RNA m5C modification sites, supplementing experimental approaches that are often costly, labour intensive and time consuming. These models leverage machine learning algorithms trained on sequence data to predict m5C sites based on sequence context, secondary structures and evolutionary conservation. They also address challenges such as optimising mixed datasets, eliminating false negatives and refining feature extraction methods to enhance prediction accuracy.</p><p>A lot of models have been constructed to date for predicting mRNA m5C modifications, including tools such as m5C&#x02010;PseDNC,<xref rid="ctm270239-bib-0036" ref-type="bibr">
<sup>36</sup>
</xref> DeepMRMP,<xref rid="ctm270239-bib-0047" ref-type="bibr">
<sup>47</sup>
</xref> iRNA&#x02010;m5C<xref rid="ctm270239-bib-0035" ref-type="bibr">
<sup>35</sup>
</xref> and RNA&#x02010;m5C&#x02010;finder.<xref rid="ctm270239-bib-0048" ref-type="bibr">
<sup>48</sup>
</xref> Most of these models target human m5C modifications, while a few, such as PEA&#x02010;m5C,<xref rid="ctm270239-bib-0004" ref-type="bibr">
<sup>4</sup>
</xref>, <xref rid="ctm270239-bib-0049" ref-type="bibr">
<sup>49</sup>
</xref> focus on specific species such as <italic toggle="yes">A. thaliana</italic>. Each tool has unique strengths: DeepMRMP<xref rid="ctm270239-bib-0047" ref-type="bibr">
<sup>47</sup>
</xref> employs deep learning to predict multiple RNA modifications (e.g., m1A, &#x003c8; and m5C) across species, offering higher sensitivity and specificity; m5C&#x02010;PseDNC<xref rid="ctm270239-bib-0036" ref-type="bibr">
<sup>36</sup>
</xref> excels in identifying m5C sites in human samples due to its high sensitivity but has limitations in specificity; RNA&#x02010;m5C&#x02010;finder<xref rid="ctm270239-bib-0048" ref-type="bibr">
<sup>48</sup>
</xref> identifies m5C modification sites in various tissues and cell types, including mouse heart cells and human HeLa cells, but lacks cross&#x02010;species functionality; iRNA&#x02010;m5C<xref rid="ctm270239-bib-0035" ref-type="bibr">
<sup>35</sup>
</xref> and m5C&#x02010;Pred&#x02010;SVM<xref rid="ctm270239-bib-0050" ref-type="bibr">
<sup>50</sup>
</xref> support multi&#x02010;species predictions, including <italic toggle="yes">Homo sapiens</italic>, <italic toggle="yes">Mus musculus</italic> and <italic toggle="yes">S. cerevisiae</italic>, while achieving superior accuracy.</p><p>Early models faced significant challenges, such as data redundancy and imbalanced datasets, where positive samples far outnumbered negative ones. For instance, iRNA&#x02010;m5C&#x02010;PseDNC, while offering high sensitivity, suffered from reduced generalizability due to redundant sequences in training data. Subsequent advancements, such as the m5C&#x02010;HPCR model,<xref rid="ctm270239-bib-0037" ref-type="bibr">
<sup>37</sup>
</xref> addressed these issues by using optimised encoding algorithms to enhance performance metrics such as the Matthews correlation coefficient.</p><p>More recent developments, such as RNA&#x02010;m5C&#x02010;Pred<xref rid="ctm270239-bib-0051" ref-type="bibr">
<sup>51</sup>
</xref> and iMRM,<xref rid="ctm270239-bib-0052" ref-type="bibr">
<sup>52</sup>
</xref> integrate diverse nucleotide composition features and advanced machine learning techniques such as extreme gradient boosting (XGBoost). These tools not only predict m5C but also incorporate other RNA modifications, providing a comprehensive platform for multi&#x02010;modification analysis. For example, iMRM predicts m5C, m6A, m1A, &#x003c8; and A&#x02010;to&#x02010;I modifications in RNA across species, making it cost&#x02010;effective and versatile for large&#x02010;scale studies.</p><p>Despite these advancements, computational models still face challenges, including the need for better species&#x02010;specific feature extraction and improved datasets to ensure robust predictions. Current approaches often rely on manually curated training datasets, which may not fully capture the complexity of RNA modifications across species. Species&#x02010;specific models remain essential, as m5C modifications exhibit high variability between organisms.</p><p>In summary, computational predictive models have become indispensable for identifying potential m5C modification sites. While traditional machine learning methods have been effective, deep learning and hybrid approaches are paving the way for more accurate and scalable predictions. Future efforts should focus on enhancing dataset quality, refining feature extraction methods and improving cross&#x02010;species applicability to address the limitations of existing tools. These developments will ultimately enable the analysis of increasingly complex biological samples and experimental conditions, advancing our understanding of RNA methylation mechanisms.</p></sec></sec><sec id="ctm270239-sec-0170"><label>4</label><title>UNDERLYING MECHANISMS AND BASIC BIOLOGICAL FUNCTIONS OF M5C RNA MODIFICATION</title><p>RNA m5C undergoes a dynamic and reversible regulation, governed by three key elements: &#x02018;writers&#x02019;, &#x02018;erasers&#x02019; and &#x02018;readers&#x02019; (Figure&#x000a0;<xref rid="ctm270239-fig-0002" ref-type="fig">2</xref>).<xref rid="ctm270239-bib-0053" ref-type="bibr">
<sup>53</sup>
</xref> Within this framework, &#x02018;writers&#x02019; denote proteins responsible for facilitating the establishment of methylation patterns. Among the enzymes associated with m5C (RNA Cytosine&#x02010;5 Methyltransferases, RCMTs), the NSUN subgroups and the DNMT2 homologue, a DNA methyltransferase, emerge as pivotal catalysts for cytosine&#x02010;5 methylation.<xref rid="ctm270239-bib-0018" ref-type="bibr">
<sup>18</sup>
</xref>&#x000a0;Conversely, &#x02018;readers&#x02019; represent recognition proteins tasked with binding to and identifying methylated sites. Examples of such proteins encompass the Y&#x02010;box&#x02010;binding protein 1 (YBX1) and the Aly/REF export factor (ALYREF).<xref rid="ctm270239-bib-0054" ref-type="bibr">
<sup>54</sup>
</xref> Despite &#x02018;readers&#x02019; themselves not participating in catalytic reactions, anomalies in their functions frequently correlate with metabolic abnormalities and diseases.<xref rid="ctm270239-bib-0055" ref-type="bibr">
<sup>55</sup>
</xref> In comparison, &#x02018;erasers&#x02019; play a role in eliminating methylated sites. Noteworthy examples of these erasers include the genes belonging to the TET family and ALKBH1, an ALKB homologue. This intricate interplay establishes a dynamic equilibrium between opposing biological processes (Table&#x000a0;<xref rid="ctm270239-tbl-0002" ref-type="table">2</xref>).<xref rid="ctm270239-bib-0056" ref-type="bibr">
<sup>56</sup>
</xref>
</p><fig position="float" fig-type="FIGURE" id="ctm270239-fig-0002"><label>FIGURE 2</label><caption><p>Underlying mechanisms of 5&#x02010;methylcytosine (m5C) modulating cancers. The dynamic regulation of m5C modifications in mRNA, mediated by writers (e.g., NSUN2), readers (e.g., YBX1 and ALYREF) and their downstream effects. m5C influences RNA stability, translation and degradation, impacting key cellular processes such as ferroptosis, glycolysis and oncogene expression. Dysregulation of m5C contributes to cancer proliferation, invasion and metastasis, offering potential therapeutic targets in oncology.</p></caption><graphic xlink:href="CTM2-15-e70239-g004" position="anchor" id="jats-graphic-5"/></fig><sec id="ctm270239-sec-0180"><label>4.1</label><title>Writers</title><p>The methyltransferase RCMTs utilises adenosylmethionine as a methyl group donor to generate m5C by transferring the methyl moiety onto cytosine.<xref rid="ctm270239-bib-0057" ref-type="bibr">
<sup>57</sup>
</xref> RCMTs are primarily accountable for catalysing the methylation of cytosine&#x02010;5, which includes the NSUN methyltransferases and DNMT2.<xref rid="ctm270239-bib-0058" ref-type="bibr">
<sup>58</sup>
</xref>
</p><p>DNMT2, also referred to as tRNA methyltransferase 1 (TRDMT1), chiefly oversees the methylation processes of tRNA molecules, specifically methylating cytosine at position C38 within the anticodon loop.<xref rid="ctm270239-bib-0059" ref-type="bibr">
<sup>59</sup>
</xref> Structurally, DNMT2 exhibits a Rossman&#x02010;fold enzymatic domain alongside a specific site for S&#x02010;adenosyl methionine binding, which is essential for its catalytic activity.<xref rid="ctm270239-bib-0060" ref-type="bibr">
<sup>60</sup>
</xref> Experimental inquiries have unveiled that the simultaneous deletion of DNMT2 and NSUN2 precipitates a decline in tRNA methylation, inducing hampered protein synthesis and cellular differentiation, ultimately resulting in the demise of experimental mice. Interestingly, deficiencies in either DNMT2 or NSUN2 in isolation failed to elicit discernible impacts. However, a significant decrease in the stable&#x02010;state abundance of non&#x02010;methylated tRNAs was observed, leading to a marked decrease in the pace of protein synthesis.<xref rid="ctm270239-bib-0061" ref-type="bibr">
<sup>61</sup>
</xref> Moreover, the involvement of DNMT2 in mRNA methylation and its influence on expression regulation have been extensively documented. DNMT2 deficiency correlates with modifications in mRNA expression and methylation patterns, alongside the hindrance of cell proliferation and migration.<xref rid="ctm270239-bib-0062" ref-type="bibr">
<sup>62</sup>
</xref> These collective observations underscore the significance of total depletion of cytosine&#x02010;5&#x02010;tRNA methylation, highlighting its profound influence on the stability of particular tRNAs and underscoring the critical role of tRNA methylation in the intricate process of protein translation.<xref rid="ctm270239-bib-0061" ref-type="bibr">
<sup>61</sup>
</xref>
</p><p>The NSUN family comprises seven members, denoted as NSUN1&#x02010;7, each with specificity towards distinct RNA types.<xref rid="ctm270239-bib-0063" ref-type="bibr">
<sup>63</sup>
</xref> Notably, NSUN2 stands out as the initial member discovered and extensively investigated among them.<xref rid="ctm270239-bib-0064" ref-type="bibr">
<sup>64</sup>
</xref> NSUN2 primarily methylates tRNAs, modifying cytosine residues at positions C48&#x02012;C50. It also targets mRNAs, especially in 3&#x02032;&#x02010;UTRs with the consensus motif CTCCA, influencing transcript stability and translation. The dynamic spatial distribution of NSUN2 has been linked to the cell cycle in human epidermal cells. It exhibits enrichment in the nucleolus during G1, transitions between nucleoli and nucleoplasm in S phase, localises to the cytoplasm during G2 and resides in centrioles during M phase.<xref rid="ctm270239-bib-0065" ref-type="bibr">
<sup>65</sup>
</xref> Newly findings have unveiled the methylation of cytosine at positions C48&#x02013;C50 (m5C) in mitochondrial transfer RNAs (mt&#x02010;tRNAs) within mammalian mitochondria. However, suppressing NSUN2 did not markedly impact the stability of mitochondrial tRNAs, suggesting a potentially dispensable role for NSUN2 in mitochondrial tRNA methylation.<xref rid="ctm270239-bib-0066" ref-type="bibr">
<sup>66</sup>
</xref>, <xref rid="ctm270239-bib-0067" ref-type="bibr">
<sup>67</sup>
</xref> Additionally, NSUN2 is implicated in biological processes such as cell proliferation and carcinogenesis.<xref rid="ctm270239-bib-0068" ref-type="bibr">
<sup>68</sup>
</xref> Increased levels of NSUN2 and NSUN2&#x02010;mediated m5C have been observed in various types of cancer, including gastric cancer (GC),<xref rid="ctm270239-bib-0069" ref-type="bibr">
<sup>69</sup>
</xref>, <xref rid="ctm270239-bib-0070" ref-type="bibr">
<sup>70</sup>
</xref> esophageal squamous cell carcinoma (ESCC),<xref rid="ctm270239-bib-0071" ref-type="bibr">
<sup>71</sup>
</xref> HCC,<xref rid="ctm270239-bib-0072" ref-type="bibr">
<sup>72</sup>
</xref> hypopharyngeal squamous cell carcinoma,<xref rid="ctm270239-bib-0073" ref-type="bibr">
<sup>73</sup>
</xref> prostate cancer (PCa),<xref rid="ctm270239-bib-0074" ref-type="bibr">
<sup>74</sup>
</xref> cervical cancer,<xref rid="ctm270239-bib-0075" ref-type="bibr">
<sup>75</sup>
</xref> nasopharyngeal carcinoma<xref rid="ctm270239-bib-0076" ref-type="bibr">
<sup>76</sup>
</xref> and uveal melanoma.<xref rid="ctm270239-bib-0077" ref-type="bibr">
<sup>77</sup>
</xref> Moreover, Rennai's research<xref rid="ctm270239-bib-0078" ref-type="bibr">
<sup>78</sup>
</xref> underscores NSUN2's involvement in regulating RNA methyltransferase activity during human neurocognitive development. In summary, NSUN2 assumes a multifaceted role, impacting plant root morphogenesis, mitochondrial oxidative phosphorylation, tumourigenesis, protein biosynthesis and cellular mitotic progression.<xref rid="ctm270239-bib-0079" ref-type="bibr">
<sup>79</sup>
</xref> Additionally, it has been documented to regulate HIV replication, Epstein&#x02012;Barr virus degradation and epidermal cell differentiation.<xref rid="ctm270239-bib-0080" ref-type="bibr">
<sup>80</sup>
</xref>, <xref rid="ctm270239-bib-0081" ref-type="bibr">
<sup>81</sup>
</xref>, <xref rid="ctm270239-bib-0082" ref-type="bibr">
<sup>82</sup>
</xref>
</p><p>NSUN3, recognised as a tRNA methyltransferase, exerts influence on various biological processes, encompassing tumour advancement,<xref rid="ctm270239-bib-0020" ref-type="bibr">
<sup>20</sup>
</xref>, <xref rid="ctm270239-bib-0083" ref-type="bibr">
<sup>83</sup>
</xref>, <xref rid="ctm270239-bib-0084" ref-type="bibr">
<sup>84</sup>
</xref> infiltration of immune cells<xref rid="ctm270239-bib-0084" ref-type="bibr">
<sup>84</sup>
</xref>, <xref rid="ctm270239-bib-0085" ref-type="bibr">
<sup>85</sup>
</xref> and disorders related to mitochondria.<xref rid="ctm270239-bib-0086" ref-type="bibr">
<sup>86</sup>
</xref> Its increased expression in low&#x02010;grade glioma and head and neck squamous cell carcinoma is associated with heightened metastasis, attributed to m5C modification of tRNA at C34 within the anticodon loop.<xref rid="ctm270239-bib-0087" ref-type="bibr">
<sup>87</sup>
</xref>, <xref rid="ctm270239-bib-0088" ref-type="bibr">
<sup>88</sup>
</xref>
</p><p>Regarding NSUN4, it operates in the assembly of mitoribosomes, serving as a methyltransferase acting upon 12S rRNA, tRNA and mRNA. This function influences adaptation to elevated temperatures and differentiation into chondrocytes.<xref rid="ctm270239-bib-0089" ref-type="bibr">
<sup>89</sup>
</xref>, <xref rid="ctm270239-bib-0090" ref-type="bibr">
<sup>90</sup>
</xref> Furthermore, NSUN4 facilitates the generation of HCC<xref rid="ctm270239-bib-0091" ref-type="bibr">
<sup>91</sup>
</xref>, <xref rid="ctm270239-bib-0092" ref-type="bibr">
<sup>92</sup>
</xref> and infiltration of neutrophils.<xref rid="ctm270239-bib-0085" ref-type="bibr">
<sup>85</sup>
</xref>
</p><p>NSUN5 participates in the methylation of rRNA, introducing m5C3782 in humans and m5C3438 in mice within the 28S rRNA.<xref rid="ctm270239-bib-0093" ref-type="bibr">
<sup>93</sup>
</xref>, <xref rid="ctm270239-bib-0094" ref-type="bibr">
<sup>94</sup>
</xref> Its overexpression is linked to tumourigenesis in HCC<xref rid="ctm270239-bib-0095" ref-type="bibr">
<sup>95</sup>
</xref> and colorectal cancer (CRC)<xref rid="ctm270239-bib-0096" ref-type="bibr">
<sup>96</sup>
</xref> patients, while deficiency in NSUN5 reduces overall protein synthesis, thus hindering cell proliferation. Notably, NSUN5 is significantly downregulated in patients with tetralogy of Fallot<xref rid="ctm270239-bib-0097" ref-type="bibr">
<sup>97</sup>
</xref> and Williams&#x02012;Beuren syndrome.<xref rid="ctm270239-bib-0098" ref-type="bibr">
<sup>98</sup>
</xref>
</p><p>Initially acknowledged as a tRNA methyltransferase targeting C72 in the tRNA acceptor stem, NSUN6 has been discovered to possess mRNA methylating activity.<xref rid="ctm270239-bib-0099" ref-type="bibr">
<sup>99</sup>
</xref>, <xref rid="ctm270239-bib-0100" ref-type="bibr">
<sup>100</sup>
</xref> It methylates mRNA, primarily focusing on the 3&#x02032;&#x02010;UTR with the consensus motif CTCCA, leading to heightened levels of transcripts and proteins.<xref rid="ctm270239-bib-0101" ref-type="bibr">
<sup>101</sup>
</xref> The role of NSUN6 in the progression of cancer is convoluted, with evidence suggesting its protective role against triple&#x02010;negative breast cancer (TNBC),<xref rid="ctm270239-bib-0102" ref-type="bibr">
<sup>102</sup>
</xref> pancreatic cancer,<xref rid="ctm270239-bib-0103" ref-type="bibr">
<sup>103</sup>
</xref> testis cancer,<xref rid="ctm270239-bib-0101" ref-type="bibr">
<sup>101</sup>
</xref> thyroid cancer<xref rid="ctm270239-bib-0101" ref-type="bibr">
<sup>101</sup>
</xref> and ovary cancer,<xref rid="ctm270239-bib-0101" ref-type="bibr">
<sup>101</sup>
</xref> while entailing a hazard factor for CRC.<xref rid="ctm270239-bib-0104" ref-type="bibr">
<sup>104</sup>
</xref>, <xref rid="ctm270239-bib-0105" ref-type="bibr">
<sup>105</sup>
</xref> The variability in the impact of NSUN6 across various cancers may arise from its differential expression in immune cells within the tumour microenvironment (TME). Remarkably, NSUN6 exhibits predominant expression in regulatory T cells (Tregs) within TNBC, whereas it is observed in exhausted CD8<sup>+</sup> T cells, proliferating T cells and myofibroblasts within CRC.<xref rid="ctm270239-bib-0104" ref-type="bibr">
<sup>104</sup>
</xref> Furthermore, NSUN6 impacts the cell cycle, immune cell infiltration, and the generation of antibody&#x02010;secreting plasma cells,<xref rid="ctm270239-bib-0106" ref-type="bibr">
<sup>106</sup>
</xref> highlighting its multifaceted impact on cancer biology and immune modulation.</p><p>NSUN7 carries out methylation of enhancer RNAs, thereby modulating transcription and augmenting the expression of specific mRNAs. This process potentially contributes to adaptive metabolic alterations during starvation in a PGC&#x02010;1a&#x02010;dependent manner.<xref rid="ctm270239-bib-0107" ref-type="bibr">
<sup>107</sup>
</xref>
</p></sec><sec id="ctm270239-sec-0190"><label>4.2</label><title>Erasers</title><p>Erasers dynamically regulate RNA modifications by reversing methylation, thus playing a critical role in modulating RNA function. In the demethylation of m5C, the TET protein family and ALKBH1 have emerged as pivotal enzymes. While the mechanisms of DNA demethylation by these enzymes are well characterised, their roles in RNA demethylation remain an area of active exploration.</p><p>The TET family proteins (TET1, TET2 and TET3) primarily catalyse the demethylation of m5C in DNA. This process requires Fe<sup>2</sup>&#x0207a; and &#x003b1;&#x02010;ketoglutarate as cofactors and produces intermediates such as 5&#x02010;hmC, 5&#x02010;formylcytosine and 5&#x02010;carboxycytosine.<xref rid="ctm270239-bib-0108" ref-type="bibr">
<sup>108</sup>
</xref> The demethylation activity of TET1 on mRNA m5C is vital for completing DNA repair and ensuring cell survival following DNA damage.<xref rid="ctm270239-bib-0109" ref-type="bibr">
<sup>109</sup>
</xref>
</p><p>In mouse embryonic stem cells, the deletion of TET2 significantly reduces the levels of 5&#x02010;hmC in tRNAs, while TET2 overexpression increases 5&#x02010;hmC levels and decreases m5C levels. These findings indicate that TET2 can oxidise m5C in tRNAs, contributing to dynamic regulation. Moreover, in vitro experiments suggest that this oxidative process may enhance translational efficiency, highlighting a potential link between TET2&#x02010;mediated RNA demethylation and protein synthesis. Despite these findings, the oxidation efficiency of RNA m5C by TET proteins is considerably lower than that of DNA, suggesting distinct catalytic mechanisms for RNA and DNA substrates.<xref rid="ctm270239-bib-0110" ref-type="bibr">
<sup>110</sup>
</xref>, <xref rid="ctm270239-bib-0111" ref-type="bibr">
<sup>111</sup>
</xref>
</p><p>TET3, in particular, has been implicated in increasing RNA 5&#x02010;hmC levels, but its efficiency in oxidising RNA m5C remains low.<xref rid="ctm270239-bib-0112" ref-type="bibr">
<sup>112</sup>
</xref> Furthermore, the structural basis of TET&#x02012;RNA complexes is still unclear, which limits the understanding of their substrate specificity and catalytic mechanisms. However, some studies suggest a potential correlation between elevated TET3 expression and poor prognosis in PCa patients.<xref rid="ctm270239-bib-0016" ref-type="bibr">
<sup>16</sup>
</xref> Cellularly, the constituents of the TET family demonstrate disparate spatial distributions; TET3 is present in both the nucleus and cytoplasm, whereas TET1 and TET2 are predominantly localised in the nucleus.<xref rid="ctm270239-bib-0113" ref-type="bibr">
<sup>113</sup>
</xref>
</p><p>ALKBH1 serves as a demethyltransferase for both RNA and DNA substrates.<xref rid="ctm270239-bib-0114" ref-type="bibr">
<sup>114</sup>
</xref> Studies suggest that ALKBH1 participates in converting m5C RNA modifications into either 5&#x02010;hmC or 5&#x02010;formylcytidine (f5C) RNA modifications.<xref rid="ctm270239-bib-0115" ref-type="bibr">
<sup>115</sup>
</xref> In HEK293T cells, ALKBH1 deletion results in a marked reduction of f5C modifications in mt&#x02010;tRNAs, leading to impaired mitochondrial translation and respiratory function. These findings underscore the essential role of ALKBH1&#x02010;mediated m5C demethylation in maintaining mitochondrial activity.<xref rid="ctm270239-bib-0115" ref-type="bibr">
<sup>115</sup>
</xref> Deficiency in ALKBH1 results in a significant impairment in mitochondrial translation and oxygen consumption, underscoring the substantial regulatory role of ALKBH1 in RNA m5C metabolism concerning mitochondrial function. Furthermore, ALKBH1 exhibits specificity in targeting a histone dioxygenase&#x02010;histone H2A.<xref rid="ctm270239-bib-0116" ref-type="bibr">
<sup>116</sup>
</xref> Beyond its impact on mt&#x02010;tRNAs, ALKBH1 may influence other RNA types by modulating their stability and translational efficiency.<xref rid="ctm270239-bib-0117" ref-type="bibr">
<sup>117</sup>
</xref> This broad functional spectrum highlights the importance of ALKBH1 in cellular metabolism and suggests a potential link to pathological states, including mitochondrial disorders and cancer progression. Future research should focus on elucidating ALKBH1's substrate range and its interplay with cellular metabolic pathways.</p></sec><sec id="ctm270239-sec-0200"><label>4.3</label><title>Readers</title><p>The biological roles of RNA modification are predominantly linked to the proteins with which it forms associations. Such proteins, termed &#x02018;readers&#x02019;, interpret the epigenetic code imparted by m5C modifications, mediating their downstream effects. Proteins binding to RNA &#x02012;m5C, such as ALYREF and YBX1, function as code interpreters, recognising and binding to &#x02012;m5C sites.<xref rid="ctm270239-bib-0114" ref-type="bibr">
<sup>114</sup>
</xref>
</p><p>ALYREF, identified as the primary mRNA&#x02010;reading protein in the nucleus, discerns m5C within the viral RNA transcript localised in the nucleus and facilitates its translocation to the cytoplasm.<xref rid="ctm270239-bib-0023" ref-type="bibr">
<sup>23</sup>
</xref> ALYREF binding to m5C facilitates the nuclear export of these transcripts to the cytoplasm, ensuring proper RNA trafficking and translation. This process has been shown to significantly influence cellular processes such as apoptosis, growth and energy metabolism, particularly in cancer cells. Across various cancer scenarios, the expression levels of ALYREF exhibit correlations with patient survival. Elevated ALYREF expression, particularly observed in BC, is linked to unfavourable survival outcomes. In BC cells, ALYREF exerts influence over cellular processes such as growth, apoptosis and mitochondrial energy metabolism, primarily through its interaction with the lncRNA NEAT1.<xref rid="ctm270239-bib-0118" ref-type="bibr">
<sup>118</sup>
</xref> This underscores the intricate interplay between RNA modifications, binding proteins and cellular functions in cancer contexts. Moreover, ALYREF has a pivotal role in the regulation of mRNA and lncRNA degradation within the nucleus. Research carried out in HeLa and HEK293 cells has demonstrated that this degradation process involves the nuclear exosome and is facilitated by the cofactor hMTR4, which recruits the exosome to its designated targets. Intriguingly, investigations by Fan et&#x000a0;al.<xref rid="ctm270239-bib-0119" ref-type="bibr">
<sup>119</sup>
</xref> and collaborators have unveiled a competitive interaction between hMTR4 and ALYREF in their binding to ARS2. This competitive dynamic significantly influences the destiny of an RNA molecule. When ARS2 binds with ALYREF, the latter is mobilised to the RNA. If the RNA is stabilised by ribonucleoprotein (RNP) factors, it undergoes translocation into the cytoplasm. Conversely, if ALYREF fails to engage with ARS2 or RNP factors, hMTR4 binds to ARS2 on the RNA, initiating the recruitment of the exosome for degradation.<xref rid="ctm270239-bib-0119" ref-type="bibr">
<sup>119</sup>
</xref> This intricate interplay underscores the regulatory intricacy orchestrated by ALYREF in RNA processing and cellular equilibrium.</p><p>YBX1 exhibits versatility by participating in various cellular processes, including translational repression, RNA stabilisation, mRNA splicing, DNA repair and transcriptional regulation.<xref rid="ctm270239-bib-0120" ref-type="bibr">
<sup>120</sup>
</xref> Through structural and thermal analyses, it has been determined that YBX1 can recognise m5C within its cold&#x02010;shock domain (CSD), particularly through the indole ring of W65.<xref rid="ctm270239-bib-0121" ref-type="bibr">
<sup>121</sup>
</xref> This protein selectively targets oncogenes that contain m5C, such as heparin&#x02010;binding growth factor (HDGF), thereby increasing their stability and promoting cancer progression by recruiting the well&#x02010;established mRNA stability maintenance factor ELAVL1.<xref rid="ctm270239-bib-0122" ref-type="bibr">
<sup>122</sup>
</xref> Recent investigations have revealed that YBX1 can identify approximately 87.8% of mRNAs modified by m5C. Depleting YBX1 during early zebrafish embryo development leads to a significant reduction in the expression of 397 maternal mRNAs bearing m5C. This observation implies a critical role for YBX1&#x02010;mediated m5C modifications in governing the clearance of maternal genes during the transition from maternal to zygotic control.<xref rid="ctm270239-bib-0123" ref-type="bibr">
<sup>123</sup>
</xref> In Drosophila, the YBX1 homologue, known as Ypsilon Schachtel (YPS), also serves as an RNA m5C reading protein.<xref rid="ctm270239-bib-0124" ref-type="bibr">
<sup>124</sup>
</xref> Within the Drosophila ovary, YPS contributes to the homeostasis, proliferation, and differentiation of germline stem cells (GSCs), relying on the binding of m5C&#x02010;containing RNAs. Intriguingly, like YBX1 in humans and zebrafish, the highly conserved CSD of YPS also harbours the m5C binding site. Mutations in this site can lead to defective development of GSCs, suggesting that RNA m5C modification plays a role in influencing the development of adult stem cells.<xref rid="ctm270239-bib-0125" ref-type="bibr">
<sup>125</sup>
</xref>
</p></sec></sec><sec id="ctm270239-sec-0210"><label>5</label><title>THE ROLE OF M5C RNA MODIFICATION IN CANCERS</title><p>RNA m5C modification has become a significant biological phenomenon in various pathological conditions, particularly in neoplastic disorders such as cancer.<xref rid="ctm270239-bib-0126" ref-type="bibr">
<sup>126</sup>
</xref> Changes in the expression profiles of m5C writers, readers and erasers have a noticeable impact on the development of tumours, progression of malignancy and metastasis by causing alterations in both mRNA and non&#x02010;coding RNAs at the levels of expression and transcription. This study aims to provide a comprehensive understanding of the molecular changes induced by m5C within cancer cells, as explored so far (Figure&#x000a0;<xref rid="ctm270239-fig-0003" ref-type="fig">3</xref>).</p><fig position="float" fig-type="FIGURE" id="ctm270239-fig-0003"><label>FIGURE 3</label><caption><p>Role of 5&#x02010;methylcytosine (m5C) in cancers. Role of m5C regulators, writers, erasers and readers in various cancer types, including non&#x02010;small&#x02010;cell lung cancer (NSCLC), prostate cancer (PCa), gastric cancer (GC), acute myeloid leukaemia (AML), bladder cancer (BCa) and hepatocellular carcinoma (HCC).</p></caption><graphic xlink:href="CTM2-15-e70239-g002" position="anchor" id="jats-graphic-7"/></fig><p>To present a detailed exploration, we have focused on cancers where m5C&#x02010;related mechanisms have been most extensively studied, such as BCa, HCC, leukaemia, GC, PCa, BCa and lung cancer. These cancers exemplify the diverse ways in which m5C influences tumour biology, providing critical insights into the regulatory roles of m5C modification. For other cancers, such as pancreatic cancer, CRC and cholangiocarcinoma, which have emerging but comparatively limited data, we have provided concise discussions to highlight significant findings while maintaining a balanced presentation across cancer types.</p><sec id="ctm270239-sec-0220"><label>5.1</label><title>BCa</title><p>The exploration of RNA m5C modification landscape offers valuable insights into comprehending BCa development. Within cancer tissues, the heightened expression of NSUN2 and YBX1, functioning as the &#x02018;writer&#x02019; and &#x02018;reader&#x02019; of m5C, respectively, contributes to tumour formation by upholding mRNA stability. This aberration strongly correlates with an unfavourable prognosis for BCa patients.<xref rid="ctm270239-bib-0023" ref-type="bibr">
<sup>23</sup>
</xref> To elaborate, NSUN2 methylates the mRNA of the oncogenic gene HDGF,<xref rid="ctm270239-bib-0127" ref-type="bibr">
<sup>127</sup>
</xref>, <xref rid="ctm270239-bib-0128" ref-type="bibr">
<sup>128</sup>
</xref> concentrating significantly in its 3&#x02032;&#x02010;UTR. Subsequently, the RNA&#x02010;binding protein YBX1 recognises these m5C&#x02010;methylated sites, facilitating the recruitment of ELAVL1, thereby ensuring the stability of HDGF mRNA. This intricate process assumes a central role in the oncogenic function of YBX1 in the advancement of BCa by triggering the activation of HDGF.<xref rid="ctm270239-bib-0053" ref-type="bibr">
<sup>53</sup>
</xref> During clinical scenarios, heightened co&#x02010;expression of NSUN2, YBX1 and HDGF signifies the poorest survival outcomes. Additionally, the presence of m5C&#x02010;modified mRNAs in tumour&#x02010;related pathways, including the Phosphoinositide 3&#x02010;Kinase&#x02010;Protein Kinase B Signaling Pathway (PI3K&#x02010;AKT) and Extracellular Signal&#x02010;Regulated Kinase&#x02010;Mitogen&#x02010;Activated Protein Kinase (ERK&#x02010;MAPK) signalling pathways, suggests that m5C hypermethylation may instigate tumourigenesis by activating oncogenic signalling pathways.<xref rid="ctm270239-bib-0129" ref-type="bibr">
<sup>129</sup>
</xref>
</p></sec><sec id="ctm270239-sec-0230"><label>5.2</label><title>HCC</title><p>Previous investigations have established a clear correlation between elevated m5C levels and the progression, migration and malignancy of HCC.<xref rid="ctm270239-bib-0130" ref-type="bibr">
<sup>130</sup>
</xref> Recent research has focused on lncRNAs in relation to HCC. For example, during the course of HCC, there is a significant increase in the expression of m5C&#x02010;associated genes, embracing NSUN2,<xref rid="ctm270239-bib-0072" ref-type="bibr">
<sup>72</sup>
</xref> NSUN4,<xref rid="ctm270239-bib-0091" ref-type="bibr">
<sup>91</sup>
</xref> NSUN5<xref rid="ctm270239-bib-0095" ref-type="bibr">
<sup>95</sup>
</xref> and ALYREF.<xref rid="ctm270239-bib-0131" ref-type="bibr">
<sup>131</sup>
</xref> NSUN2 promotes HCC cell growth by stabilising the mRNA of fizzy&#x02010;related&#x02010;1 (FZR1),<xref rid="ctm270239-bib-0132" ref-type="bibr">
<sup>132</sup>
</xref> a critical regulator of mitosis and the G1 phase of the cell cycle.<xref rid="ctm270239-bib-0133" ref-type="bibr">
<sup>133</sup>
</xref> Furthermore, NSUN2 introduces m5C modifications on H19 lncRNA, allowing it to compete with MYC mRNA for binding to G3BP1, resulting in MYC accumulation and driving HCC cell development.<xref rid="ctm270239-bib-0072" ref-type="bibr">
<sup>72</sup>
</xref> These mechanisms collectively drive HCC proliferation, migration and poor differentiation. The elevated expression of m5C regulators, specifically NSUN4 and ALYREF, is inversely associated with the survival outcomes of HCC patients, highlighting their importance as diagnostic and prognostic biomarkers for HCC.<xref rid="ctm270239-bib-0092" ref-type="bibr">
<sup>92</sup>
</xref> A comprehensive bioinformatics analysis has shown a positive correlation between NSUN5 overexpression and enhanced ribosomal activities and protein synthesis in HCC cells.<xref rid="ctm270239-bib-0095" ref-type="bibr">
<sup>95</sup>
</xref> Dysregulation of ALYREF is associated with the irregular control of the cellular division cycle and mitotic processes in HCC cells, potentially promoting HCC through the stimulation of eIF4A3 expression.<xref rid="ctm270239-bib-0092" ref-type="bibr">
<sup>92</sup>
</xref>, <xref rid="ctm270239-bib-0131" ref-type="bibr">
<sup>131</sup>
</xref> Therefore, antagonists directed towards ALYREF and eIF4A3, exemplified by miR&#x02010;4666a&#x02010;5p and miR&#x02010;6124, are burgeoning as auspicious contenders for therapeutic intervention. Additionally, the modulation of m5C in circular RNA has a vital role in the development about HCC.<xref rid="ctm270239-bib-0134" ref-type="bibr">
<sup>134</sup>
</xref> Furthermore, modifications in the TME and the infiltration of immune cells also play a role in m5C&#x02010;mediated HCC progression.<xref rid="ctm270239-bib-0135" ref-type="bibr">
<sup>135</sup>
</xref> Recently, researchers are actively exploring novel approaches to predict prognosis in HCC patients. Speculative models have been constructed based on m5C&#x02010;related modulators, including members of the NSUN family, TET1 and YBX1.<xref rid="ctm270239-bib-0136" ref-type="bibr">
<sup>136</sup>
</xref> These insightful findings have the potential for significant clinical implications in the understanding and management of HCC.</p></sec><sec id="ctm270239-sec-0240"><label>5.3</label><title>Leukaemia</title><p>RNA m5C alteration and the impact of RCMTs have been elucidated to exert an effect on the responsiveness to pharmacotherapeutics and resilience, not solely in neoplasms of a solid nature but also in the context of leukaemia. These molecules engage with various partners to control diverse chromatin configurations. Specifically, NSUN1 collaborates with BRD4 to establish a distinctive NSUN1/BRD4/RNA&#x02010;pol&#x02010;II CTD&#x02010;S2P complex in leukaemia cells resistant to 5&#x02010;AZA. This intricate formation directly engages with RNA&#x02010;pol&#x02010;II CTD&#x02010;S2P, fostering the creation of a chromatin framework resilient to 5&#x02010;AZA, thereby fostering resistance to this medication in leukaemia.<xref rid="ctm270239-bib-0137" ref-type="bibr">
<sup>137</sup>
</xref> Conversely, NSUN3 and DNMT2 exhibit antagonistic impacts on 5&#x02010;AZA&#x02010;responsive leukaemia cells. The RNA&#x02010;binding protein hnRNPK directly engages with RCMTs (NSUN3 and DNMT2), pivotal transcriptional regulators (GATA1 and SPI1/PU.1) and CDK9/P&#x02010;TEFb to enlist RNA polymerase II and establish a distinct assembly, thereby fostering the formation of a chromatin configuration susceptible to 5&#x02010;AZA.<xref rid="ctm270239-bib-0053" ref-type="bibr">
<sup>53</sup>
</xref> In a clinical trial utilising bone marrow (BM) samples from both 5&#x02010;AZA&#x02010;resistant and 5&#x02010;AZA&#x02010;sensitive leukaemia cases, elevated levels of m5C mRNA were observed in the 5&#x02010;AZA&#x02010;resistant specimens. The expression levels of hnRNPK, NSUN1 and BRD4 were also linked to leukaemia progression and implicated in both 5&#x02010;AZA resistance and cancer advancement. These observations underscore the significant roles of hnRNPK, NSUN1 and BRD4 in the mechanisms underlying 5&#x02010;AZA resistance and leukaemia progression. Separately, TET2 deficiency in acute myeloid leukaemia increases the expression of Tetraspanin 13 (TSPAN13) by enhancing m5C modification in its mRNA and stabilising it through YBX1, thereby activating the CXCR4/CXCL12 signalling pathway to promote leukaemia stem cell homing to the BM niche and enhance self&#x02010;renewal.<xref rid="ctm270239-bib-0138" ref-type="bibr">
<sup>138</sup>
</xref> Furthermore, TET2 depletion impairs m5C oxidation and antagonises the MBD6&#x02010;dependent deubiquitination of Lys119 of histone H2A (H2AK119ub), leading to open chromatin and increased transcription in stem cells. Targeting MBD6 may offer a therapeutic strategy for TET2&#x02010;mutant leukaemia.<xref rid="ctm270239-bib-0139" ref-type="bibr">
<sup>139</sup>
</xref> Consequently, targeting m5C could represent a promising therapeutic strategy for haematologic malignancies.<xref rid="ctm270239-bib-0137" ref-type="bibr">
<sup>137</sup>
</xref>
</p></sec><sec id="ctm270239-sec-0250"><label>5.4</label><title>GC</title><p>The involvement of m5CRNA modification in GC generally takes on an oncogenic role, as elevated m5C levels are indicative of an unfavourable prognosis and a diminished overall survival rate.<xref rid="ctm270239-bib-0140" ref-type="bibr">
<sup>140</sup>
</xref> Within this context, NSUN2 emerges as the principal oncogenic m5C methyltransferase associated with GC.<xref rid="ctm270239-bib-0130" ref-type="bibr">
<sup>130</sup>
</xref>, <xref rid="ctm270239-bib-0141" ref-type="bibr">
<sup>141</sup>
</xref> Its specific influence extends to the methylation status of mRNAs linked to pivotal genes, including phosphoinositide&#x02010;3&#x02010;kinase regulatory subunit 1 (PIK3R1), phosphate cytidylyltransferase 1 choline&#x02010;alpha (PCYT1A), Forkhead box protein C2 (FOXC2)<xref rid="ctm270239-bib-0142" ref-type="bibr">
<sup>142</sup>
</xref> and p57Kip2, a cyclin&#x02010;dependent kinase (CDK) inhibitor.<xref rid="ctm270239-bib-0141" ref-type="bibr">
<sup>141</sup>
</xref>, <xref rid="ctm270239-bib-0143" ref-type="bibr">
<sup>143</sup>
</xref>, <xref rid="ctm270239-bib-0144" ref-type="bibr">
<sup>144</sup>
</xref> Following m5C modification and subsequent binding to m5C readers, notably exemplified by YBX1, there is a noticeable augmentation in the transcriptional activity of PIK3R1, PCYT1A and FOXC2 mRNA. Conversely, the tumour&#x02010;suppressive p57Kip2 mRNA undergoes destabilisation due to m5C modification in the 3&#x02032;&#x02010;UTR.<xref rid="ctm270239-bib-0145" ref-type="bibr">
<sup>145</sup>
</xref> As a result, heightened levels of NSUN2 in GC patients contribute to increased proliferation, migration and invasion of cancerous cells. The activation of NSUN2, facilitated by the small ubiquitin&#x02010;like modifier (SUMO)&#x02010;2/3, involves a direct interaction that stabilises NSUN2 and facilitates nuclear transport. This activated state, in turn, propels the progression of GC. Furthermore, the oncogenic interplay between NSUN2 and FOXC2 mRNA can be facilitated by the lncRNA FOXC2&#x02010;AS1 (FOXC2 antisense RNA 1). This intricate network of molecular events underscores the oncogenic role of NSUN2 and its downstream targets in the pathogenesis of GC.<xref rid="ctm270239-bib-0141" ref-type="bibr">
<sup>141</sup>
</xref>
</p></sec><sec id="ctm270239-sec-0260"><label>5.5</label><title>PCa</title><p>Several prognostic models have been developed for PCa patients based on m5C modulators or m5C&#x02010;related lncRNAs.<xref rid="ctm270239-bib-0146" ref-type="bibr">
<sup>146</sup>
</xref> Experimental findings consistently demonstrate that elevated levels of NSUN2, YBX1 and TET3 are associated with an unfavourable prognosis. NSUN2, through its interaction with YBX1, post&#x02010;transcriptionally modifies androgen receptor (AR) mRNA with m5C, leading to increased stability and translation of AR mRNA. This molecular interplay highlights the collective influence of these regulatory elements on clinical outcomes, emphasising the critical role of NSUN2&#x02010;mediated m5C modification in AR regulation and its impact on disease prognosis.<xref rid="ctm270239-bib-0147" ref-type="bibr">
<sup>147</sup>
</xref> Notably, a reciprocal activation loop exists, as AR positively modulates NSUN2 at the transcriptional tier. This bidirectional regulation creates a feedback mechanism, suggesting a tightly interconnected relationship between AR and NSUN2 expression. Furthermore, elevated NSUN2 expression correlates with diminished responsiveness to chemotherapy and attenuated immune cell infiltration, highlighting the multifaceted impact of NSUN2 in cancer. This implicates NSUN2 not only in AR regulation but also in the modulation of therapeutic responsiveness and the TME.<xref rid="ctm270239-bib-0148" ref-type="bibr">
<sup>148</sup>
</xref> Additionally, the m5C reader, ALYREF, has been pinpointed as a prognostic biomarker and a plausible therapeutic target for PCa. The m5C signature exhibits potential as a novel instrument for prognosticating patient outcomes across various molecular subtypes and for steering personalised treatments contingent upon therapeutic responses.<xref rid="ctm270239-bib-0149" ref-type="bibr">
<sup>149</sup>
</xref>
</p></sec><sec id="ctm270239-sec-0270"><label>5.6</label><title>BC</title><p>The modification of m5C RNA exhibits both advantageous and detrimental impacts on the progression of BC. Recent investigations have pinpointed NSUN2, ALYREF and DNMT3B as factors posing risks.<xref rid="ctm270239-bib-0102" ref-type="bibr">
<sup>102</sup>
</xref>, <xref rid="ctm270239-bib-0150" ref-type="bibr">
<sup>150</sup>
</xref> Conversely, NSUN5, NSUN6, TET2 and DNMT2 have emerged as protective elements.<xref rid="ctm270239-bib-0151" ref-type="bibr">
<sup>151</sup>
</xref> Mechanistically, in TNBC, both NSUN2 and NSUN6 play critical roles in tumourigenicity and the tumour immune microenvironment. Additionally, the upregulation of NSUN2 and NOP2 is significantly associated with shorter disease&#x02010;free survival in BC patients.<xref rid="ctm270239-bib-0130" ref-type="bibr">
<sup>130</sup>
</xref> Interestingly, NSUN6 may promote bone metastasis. Specifically, HER3 is phosphorylated by the tyrosine kinase (RTK)&#x02010;like orphan receptor 1 (ROR1), which recruits NSUN6 to methylate MST1, thereby modulating its kinase activity and activating YAP. The nuclear accumulation of YAP subsequently stimulates the expression of genes associated with tumour proliferation and bone metastasis.<xref rid="ctm270239-bib-0152" ref-type="bibr">
<sup>152</sup>
</xref> The amplification of ALYREF, detected in both mRNA and protein expressions, has been linked to its interaction with the promoter region of the oncogenic NEAT1 lncRNA, thereby facilitating its transcriptional augmentation.<xref rid="ctm270239-bib-0118" ref-type="bibr">
<sup>118</sup>
</xref> Moreover, through thorough enrichment analysis, prospective targets of DNMT3B have been delineated, encompassing vascular endothelial growth factor A and enhancer of zeste homologue 2 (EZH2). Additionally, the modification activities of NSUN5, TET2 and DNMT2 have been discerned to exert influence over three specific lncRNAs, namely, AP005131.2, AL121832.2 and LINC01152, rendering them as defensive shields against BC.<xref rid="ctm270239-bib-0151" ref-type="bibr">
<sup>151</sup>
</xref> This comprehensive scrutiny illuminates the intricate molecular pathways involving ALYREF, DNMT3B, NSUN5, TET2 and DNMT2 in sculpting the regulatory framework of lncRNAs associated with BC.</p></sec><sec id="ctm270239-sec-0280"><label>5.7</label><title>Lung cancer</title><p>The heightened presence of m5C modification within RNA, particularly evident in circulating tumour cells extracted from lung cancer patients when contrasted with whole blood cells, underscores a unique signature linked with the onset of tumourigenesis.<xref rid="ctm270239-bib-0153" ref-type="bibr">
<sup>153</sup>
</xref> Various indications suggest the involvement of RNA cytosine methyltransferases NSUN2<xref rid="ctm270239-bib-0087" ref-type="bibr">
<sup>87</sup>
</xref>, <xref rid="ctm270239-bib-0154" ref-type="bibr">
<sup>154</sup>
</xref> and DNMT2<xref rid="ctm270239-bib-0155" ref-type="bibr">
<sup>155</sup>
</xref> in tumourigenesis, albeit their precise mechanisms remaining elusive. NSUN2, functioning as a writer for m5C, emerges as a direct target of MYC, a renowned modulator of tumour cell proliferation, initially identified for its upregulation in malignant skin tumours.<xref rid="ctm270239-bib-0156" ref-type="bibr">
<sup>156</sup>
</xref> Similar to MYC, NSUN2 was also highly expressed in various tumours.<xref rid="ctm270239-bib-0157" ref-type="bibr">
<sup>157</sup>
</xref>, <xref rid="ctm270239-bib-0158" ref-type="bibr">
<sup>158</sup>
</xref> Additional inquiries are warranted to unravel the plausible implications of m5C modification in the progression of lung cancer, particularly the potential contributions of NSUN2, potentially through interactions with lncRNAs. Notably, the heightened expression of H19 lncRNA, observed in numerous adult malignant lung cancer tumours, has been linked to NSUN2&#x02010;mediated m5C modification, resulting in H19 stabilisation and subsequent pro&#x02010;oncogenic effects.<xref rid="ctm270239-bib-0072" ref-type="bibr">
<sup>72</sup>
</xref> This association emphasizes the complex interplay between NSUN2, m5C modification and lncRNA regulation in the context of lung cancer, necessitating further exploration to uncover their precise mechanistic contributions.</p></sec><sec id="ctm270239-sec-0290"><label>5.8</label><title>Other cancers</title><p>Apart from the aforementioned cancer types, the oncogenic mechanisms of m5C in other malignancies remain poorly understood. In individuals diagnosed with pancreatic cancer, NSUN2 emerges as a pivotal controller influencing both the onset of pancreatic tumourigenesis and the differentiation of epithelial cells through its involvement in mRNA methylation.<xref rid="ctm270239-bib-0159" ref-type="bibr">
<sup>159</sup>
</xref> Conversely, NSUN6 and DNMT3A have exhibited inhibitory impacts on pancreatic cancer, effectively curbing the proliferation of malignant cells.<xref rid="ctm270239-bib-0103" ref-type="bibr">
<sup>103</sup>
</xref> NSUN6 may regulate pancreatic cancer tumour growth by modulating CDK10.<xref rid="ctm270239-bib-0130" ref-type="bibr">
<sup>130</sup>
</xref> However, further elucidation is warranted regarding the precise mechanisms orchestrating this inhibition.<xref rid="ctm270239-bib-0160" ref-type="bibr">
<sup>160</sup>
</xref>
</p><p>Among CRC patients, heightened levels of regulators associated with m5C, including NSUN5, NSUN6, ALYREF and YBX1, have been noted by researchers.<xref rid="ctm270239-bib-0096" ref-type="bibr">
<sup>96</sup>
</xref> Notably, the diagnostic potential of m5C levels in immune cells within peripheral blood surpasses that of conventional blood tumour biomarkers, suggesting a role for m5C modification in impeding the infiltration of immune cells into tumours.<xref rid="ctm270239-bib-0161" ref-type="bibr">
<sup>161</sup>
</xref>
</p><p>In individuals suffering from cholangiocarcinoma, the presence of m5C&#x02010;modified functional lncRNA NKILA (NF&#x02010;kappa B interacting lncRNA), recognised and stabilised by YBX1, correlates with an advanced TNM stage and unfavourable prognosis.<xref rid="ctm270239-bib-0162" ref-type="bibr">
<sup>162</sup>
</xref> Similarly, glioma patients manifest heightened expression of m5C&#x02010;related genes, including NSUN1&#x02010;5, NSUN7, DNMT1, DNMT3B and YBX&#x02010;1, excluding NSUN6.<xref rid="ctm270239-bib-0083" ref-type="bibr">
<sup>83</sup>
</xref> In the context of glioblastoma, a formidable subtype of diffuse glioma, the heightened expression of ALYREF undertakes an oncogenic function by triggering the Wnt/&#x003b2;&#x02010;catenin signalling pathway and enhancing the resilience of MYC mRNA.<xref rid="ctm270239-bib-0163" ref-type="bibr">
<sup>163</sup>
</xref>, <xref rid="ctm270239-bib-0164" ref-type="bibr">
<sup>164</sup>
</xref>
</p><p>Among neuroblastoma patients, the m5C reader ALYREF forms a nuclear coactivator complex alongside MYCN, thereby prompting USP3 transcription and fostering neuroblastoma tumourigenesis.<xref rid="ctm270239-bib-0165" ref-type="bibr">
<sup>165</sup>
</xref> Meanwhile, in cases of ESCC, NSUN2 fosters disease progression and chemoresistance by amplifying the expression of TIGAR (TP53&#x02010;induced glycolysis regulatory phosphatase)<xref rid="ctm270239-bib-0166" ref-type="bibr">
<sup>166</sup>
</xref> and growth factor receptor bound protein 2 (GRB2).<xref rid="ctm270239-bib-0071" ref-type="bibr">
<sup>71</sup>
</xref> The NSUN2&#x02010;dependent LIN28B pathway exerts a positive influence on GRB2, culminating in m5C modification of GRB2 mRNA, thereby indirectly stimulating the PI3K/AKT and ERK/MAPK signalling cascades.</p><p>NSUN2 and YBX1 play important roles in catalysing and recognising methylation sites, leading to the methylation of KRT13 mRNA and facilitating translational initiation.<xref rid="ctm270239-bib-0167" ref-type="bibr">
<sup>167</sup>
</xref> During ovarian cancer patients, YBX1 acts as a regulator that influences the expression of various downstream targets, including CD44, thereby increasing chemoresistance.<xref rid="ctm270239-bib-0168" ref-type="bibr">
<sup>168</sup>
</xref> On the other hand, NSUN6, a methyltransferase, is involved in RNA m5C modification and has a suppressive effect on testis, thyroid and ovary cancers.<xref rid="ctm270239-bib-0101" ref-type="bibr">
<sup>101</sup>
</xref> Additionally, the NSUN2&#x02010;driven RNA m5C modification is linked to the modulation of uveal melanoma cell proliferation and motility. However, the exact mechanisms underlying these effects are still unknown.<xref rid="ctm270239-bib-0077" ref-type="bibr">
<sup>77</sup>
</xref> This comprehensive explanation highlights the complex regulatory roles of m5C&#x02010;related factors in different types of cancer, providing valuable insights into the molecular mechanisms of tumourigenesis and progression.</p><p>Notably, recent research has uncovered a significant interaction between glucose and the amino acids of NSUN2, facilitating its oligomerisation and activation.<xref rid="ctm270239-bib-0169" ref-type="bibr">
<sup>169</sup>
</xref> Activated NSUN2 plays a crucial role in maintaining m5C RNA methylation, stabilising TREX2, and limiting the accumulation of membrane&#x02010;associated DNA while suppressing cGAS/STING activation. This, in turn, promotes tumourigenesis and contributes to resistance against PD&#x02010;L1 immunotherapy. The study elucidates the pivotal role of glucose in tumourigenesis and immune therapy resistance. Glucose, through the modulation of NSUN2 activity, exerts influence over global m5C RNA methylation and the accumulation of membrane&#x02010;associated DNA, ultimately fostering tumour development and immune therapy resistance. These findings provide a novel perspective on the molecular mechanisms underlying tumourigenesis, offering insights into the intricate interplay between glucose metabolism, NSUN2 activation and the modulation of anti&#x02010;tumour immune responses.</p><p>RNA m5C modification has emerged as a pivotal epigenetic mechanism influencing gene regulation across various cancer types. Its role extends beyond gene expression modulation to impacting tumourigenesis, progression, metastasis, immune evasion and therapeutic resistance. Further research is required to elucidate the molecular mechanisms underpinning m5C regulation in cancers and to harness its diagnostic and therapeutic potential. Understanding these processes can pave the way for innovative cancer treatments targeting RNA modifications.</p></sec></sec><sec id="ctm270239-sec-0300"><label>6</label><title>CONCLUSIONS AND PERSPECTIVES</title><p>Epigenetic modifications are increasingly recognised for their role in biological processes, with recent focus on nucleic acid methylation. This review specifically examines the relatively less explored RNA m5C modification in tumour cells. While m5C methylation has received less attention compared to its counterpart, m6A methylation, it remains an important aspect of epigenetic modification. Several writers and readers of RNA m5C have been discerned, exerting influence over a myriad of biological phenomena. DNMT2, concomitant with NSUN2, NSUN3 and NSUN6, focalise on tRNAs, contributing to their fragmentation and influencing energy metabolism.<xref rid="ctm270239-bib-0020" ref-type="bibr">
<sup>20</sup>
</xref>, <xref rid="ctm270239-bib-0061" ref-type="bibr">
<sup>61</sup>
</xref>, <xref rid="ctm270239-bib-0066" ref-type="bibr">
<sup>66</sup>
</xref>, <xref rid="ctm270239-bib-0067" ref-type="bibr">
<sup>67</sup>
</xref>, <xref rid="ctm270239-bib-0083" ref-type="bibr">
<sup>83</sup>
</xref>, <xref rid="ctm270239-bib-0084" ref-type="bibr">
<sup>84</sup>
</xref>, <xref rid="ctm270239-bib-0099" ref-type="bibr">
<sup>99</sup>
</xref>, <xref rid="ctm270239-bib-0100" ref-type="bibr">
<sup>100</sup>
</xref> NSUN1, NSUN4 and NSUN5 selectively engage with rRNA, shaping ribosomal metabolism.<xref rid="ctm270239-bib-0045" ref-type="bibr">
<sup>45</sup>
</xref>, <xref rid="ctm270239-bib-0089" ref-type="bibr">
<sup>89</sup>
</xref>, <xref rid="ctm270239-bib-0093" ref-type="bibr">
<sup>93</sup>
</xref> Regarding mRNA, DNMT2 and NSUN2 emerge as the principal artisans, with m5C modification in mRNA pivotal to cellular processes encompassing growth, differentiation, motility and RNA alteration.<xref rid="ctm270239-bib-0062" ref-type="bibr">
<sup>62</sup>
</xref>, <xref rid="ctm270239-bib-0065" ref-type="bibr">
<sup>65</sup>
</xref> Further exploration in this domain is merited. NSUN2 and NSUN7 collaborate with non&#x02010;coding RNAs to govern cellular metabolism.<xref rid="ctm270239-bib-0170" ref-type="bibr">
<sup>170</sup>
</xref> Writers of RNA m5C, such as NSUN enzymes, collaborate with readers like YBX1 and ALYREF to enhance mRNA transportation and stability.<xref rid="ctm270239-bib-0114" ref-type="bibr">
<sup>114</sup>
</xref> In contrast, YTHDF2 binds to m5C&#x02010;modified rRNA, similar to m6A modification.<xref rid="ctm270239-bib-0171" ref-type="bibr">
<sup>171</sup>
</xref> However, comprehensive erasers for RNA m5C are still elusive. DNA demethylases TETs are implicated in potential cascade oxidations, suggesting a mechanism for RNA demethylation in the m5C region. The co&#x02010;functionality of methylation components in DNA and RNA, observed in m6A, m5C, 5&#x02010;hmC and m1A modifications, warrants investigation into whether they induce methylation or demethylation and the associated mechanisms. Despite this gap, various types of RNA methylation collaborate to regulate disease development. For instance, the collaborative action of NSUN2&#x02010;mediated m5C with METTL&#x02010;mediated m6A serves to bolster p21 expression, thereby exemplifying their involvement in the onset and advancement of glioma.<xref rid="ctm270239-bib-0172" ref-type="bibr">
<sup>172</sup>
</xref>
</p><p>The pivotal involvement of RNA m5C has been recognised in diverse pathological conditions, encompassing disorders in energy metabolism,<xref rid="ctm270239-bib-0173" ref-type="bibr">
<sup>173</sup>
</xref> afflictions of the hematopoietic system,<xref rid="ctm270239-bib-0139" ref-type="bibr">
<sup>139</sup>
</xref> viral infections,<xref rid="ctm270239-bib-0174" ref-type="bibr">
<sup>174</sup>
</xref> and notably, the progression of malignancies.<xref rid="ctm270239-bib-0020" ref-type="bibr">
<sup>20</sup>
</xref> The expression of RNA m5C writers and readers has been found to be significantly associated with poor prognosis and TNM classification in neoplasms, particularly affecting tumourigenesis and metastasis in different tissues such as the brain, lung,<xref rid="ctm270239-bib-0154" ref-type="bibr">
<sup>154</sup>
</xref> breast<xref rid="ctm270239-bib-0130" ref-type="bibr">
<sup>130</sup>
</xref> and prostate.<xref rid="ctm270239-bib-0074" ref-type="bibr">
<sup>74</sup>
</xref> Cytokines such as HDGF, TGF&#x02010;&#x003b2;, FGF2 and G3BP1, which are recognised tumour promoters, contribute to cell migration and metastasis through m5C modification, highlighting the connection between RNA m5C levels and cancer cell mobility. The presence of elevated RNA m5C levels in circulating tumour cells further underscores its potential as a prognostic marker for cancer.<xref rid="ctm270239-bib-0153" ref-type="bibr">
<sup>153</sup>
</xref> The discovery of m5C in circulating DNA highlights its potential as a biomarker for cancer prognosis. While RNA m5C and DNA m5C modifications share common methyltransferases and may both play roles in tumour biology, the direct connection between these modifications requires further investigation to establish mechanistic links or clinical relevance.</p><p>RNA m5C modification is a potential therapeutic target, particularly in gene therapy for diseases induced by RNA m5C and cancer progression. Modifying key RNA m5C methylases, such as NSUN2, through gene sequence alterations can reduce RNA methylation, thereby preventing disease onset or reversing cancer development. While gene therapy lacks specificity, the development of well&#x02010;designed molecular inhibitors that target specific RNA m5C writers<xref rid="ctm270239-bib-0175" ref-type="bibr">
<sup>175</sup>
</xref> shows promise in countering disease progression, taking inspiration from the successful use of m6A component inhibitors in cancer therapy. Additionally, exploring upstream molecules that regulate the functional activity of RNA m5C provides an alternative treatment approach. For instance, the phosphorylation of NSUN2 at Ser&#x02010;139 by Aurora kinase B has been shown to result in reduced RNA methylation levels. This suggests that protein&#x02010;level regulation is feasible.<xref rid="ctm270239-bib-0176" ref-type="bibr">
<sup>176</sup>
</xref> To fully harness the potential of RNA m5C modification in clinical applications, further research into molecular structures and functional pathways is imperative. Tables&#x000a0;<xref rid="ctm270239-tbl-0001" ref-type="table">1</xref>, <xref rid="ctm270239-tbl-0002" ref-type="table">2</xref>
</p><table-wrap position="float" id="ctm270239-tbl-0001" content-type="TABLE"><label>TABLE 1</label><caption><p>Current techniques for 5&#x02010;methylcytosine (m5C) detection.</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><thead><tr style="border-bottom:solid 1px #000000"><th align="left" rowspan="1" colspan="1">Detection methods</th><th align="left" rowspan="1" colspan="1">Subdivision</th><th align="left" rowspan="1" colspan="1">Advantages</th><th align="left" rowspan="1" colspan="1">References</th></tr></thead><tbody><tr><td rowspan="7" align="left" colspan="1">Physicochemical methods</td><td align="left" rowspan="1" colspan="1">HPLC</td><td align="left" rowspan="1" colspan="1">Remarkable sensitivity, capable of detecting substances at the nanogram level.</td><td align="left" rowspan="1" colspan="1">
<xref rid="ctm270239-bib-0026" ref-type="bibr">
<sup>26</sup>
</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">MS</td><td align="left" rowspan="1" colspan="1">Useful for direct RNA sequencing and transcriptomic analysis, allowing for the detection of modification types.</td><td align="left" rowspan="1" colspan="1">
<xref rid="ctm270239-bib-0039" ref-type="bibr">
<sup>39</sup>
</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">LC&#x02012;MS/MS</td><td align="left" rowspan="1" colspan="1">Suitable for detecting low&#x02010;abundance modifications.</td><td align="left" rowspan="1" colspan="1">
<xref rid="ctm270239-bib-0041" ref-type="bibr">
<sup>41</sup>
</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Top&#x02010;down MS</td><td align="left" rowspan="1" colspan="1">Particularly effective in detecting, localising, and relatively quantifying RNA modifications.</td><td align="left" rowspan="1" colspan="1">
<xref rid="ctm270239-bib-0177" ref-type="bibr">
<sup>177</sup>
</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">NAIL&#x02010;MS</td><td align="left" rowspan="1" colspan="1">Available for the assessment of the external environment's influence on the apparent transcriptome.</td><td align="left" rowspan="1" colspan="1">
<xref rid="ctm270239-bib-0178" ref-type="bibr">
<sup>178</sup>
</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Nano&#x02010;LC&#x02012;MS/MS/MS</td><td align="left" rowspan="1" colspan="1">Heightened chemical specificity and superior sensitivity.</td><td align="left" rowspan="1" colspan="1">
<xref rid="ctm270239-bib-0011" ref-type="bibr">
<sup>11</sup>
</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">2D&#x02010;HELS MS Seq</td><td align="left" rowspan="1" colspan="1">Increased precision and versatility in the detection of various modifications.</td><td align="left" rowspan="1" colspan="1">
<xref rid="ctm270239-bib-0179" ref-type="bibr">
<sup>179</sup>
</xref>
</td></tr><tr><td rowspan="3" align="left" colspan="1">Chemical conversion methods</td><td align="left" rowspan="1" colspan="1">RNA&#x02010;BisSeq</td><td align="left" rowspan="1" colspan="1">Gold standard for detecting m5C modifications. Achieving single&#x02010;base resolution in recognising cytosine methylation sites.</td><td align="left" rowspan="1" colspan="1">
<xref rid="ctm270239-bib-0029" ref-type="bibr">
<sup>29</sup>
</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">TAWO&#x02010;seq</td><td align="left" rowspan="1" colspan="1">Minimising RNA damage compared to RNA&#x02010;BisSeq and avoiding false positives caused by incomplete transformation of unmodified cytosines.</td><td align="left" rowspan="1" colspan="1">
<xref rid="ctm270239-bib-0030" ref-type="bibr">
<sup>30</sup>
</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">UBS&#x02010;seq</td><td align="left" rowspan="1" colspan="1">Enabling the detection of numerous sites with low modification ratios.</td><td align="left" rowspan="1" colspan="1">
<xref rid="ctm270239-bib-0031" ref-type="bibr">
<sup>31</sup>
</xref>
</td></tr><tr><td rowspan="2" align="left" colspan="1">Immunoprecipitation</td><td align="left" rowspan="1" colspan="1">m5C&#x02010;RIP&#x02010;seq</td><td align="left" rowspan="1" colspan="1">Available for the detection of m5C modifications without altering the RNA sequence or requiring RNA&#x02010;modifying enzymes.</td><td align="left" rowspan="1" colspan="1">
<xref rid="ctm270239-bib-0032" ref-type="bibr">
<sup>32</sup>
</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">5&#x02010;AZA&#x02010;seq and miCLIP</td><td align="left" rowspan="1" colspan="1">Effectively addressing the non&#x02010;specific binding issues of MeRIP&#x02010;seq and accurately locates individual nucleosides.</td><td align="left" rowspan="1" colspan="1">
<xref rid="ctm270239-bib-0180" ref-type="bibr">
<sup>180</sup>
</xref>
</td></tr><tr><td rowspan="2" align="left" colspan="1">TGS</td><td align="left" rowspan="1" colspan="1">NGS</td><td align="left" rowspan="1" colspan="1">Accurately identifying modified nucleosides in the transcriptome.</td><td align="left" rowspan="1" colspan="1">
<xref rid="ctm270239-bib-0181" ref-type="bibr">
<sup>181</sup>
</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">SMRT</td><td align="left" rowspan="1" colspan="1">Eliminating the need for RNA recombination or qPCR amplification, enhancing continuity and integrity.</td><td align="left" rowspan="1" colspan="1">
<xref rid="ctm270239-bib-0034" ref-type="bibr">
<sup>34</sup>
</xref>
</td></tr><tr><td rowspan="12" align="left" colspan="1">Predictive models</td><td align="left" rowspan="1" colspan="1">PEA&#x02010;m5C</td><td align="left" rowspan="1" colspan="1">A hybrid model for quickly and accurately identifying m5C sites from non&#x02010;m5C sites in <italic toggle="yes">Homo sapiens</italic> RNA.</td><td align="left" rowspan="1" colspan="1">
<xref rid="ctm270239-bib-0049" ref-type="bibr">
<sup>49</sup>
</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Pm5CS&#x02010;Comp&#x02010;mRMR</td><td align="left" rowspan="1" colspan="1">Utilising an mRMR algorithm that offers heightened sensitivity compared to m5C&#x02010;PseDNC.</td><td align="left" rowspan="1" colspan="1">
<xref rid="ctm270239-bib-0182" ref-type="bibr">
<sup>182</sup>
</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">m5C&#x02010;PseDNC</td><td align="left" rowspan="1" colspan="1">Highly accurately predictive performance, effectively identifying the positions of m5C in DNA or RNA sequences.</td><td align="left" rowspan="1" colspan="1">
<xref rid="ctm270239-bib-0035" ref-type="bibr">
<sup>35</sup>
</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">iRNA&#x02010;m5CPseDNC</td><td align="left" rowspan="1" colspan="1">Highest overall accuracy, particularly in detecting m5C sites in human samples, with notable sensitivity.</td><td align="left" rowspan="1" colspan="1">
<xref rid="ctm270239-bib-0036" ref-type="bibr">
<sup>36</sup>
</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">m5C&#x02010;HPCR</td><td align="left" rowspan="1" colspan="1">Performance metrics and Matthews correlation coefficient, outperformed those of iRNA&#x02010;m5C&#x02010;PseDNC.</td><td align="left" rowspan="1" colspan="1">
<xref rid="ctm270239-bib-0037" ref-type="bibr">
<sup>37</sup>
</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">RNA&#x02010;m5C&#x02010;Pred</td><td align="left" rowspan="1" colspan="1">Improved specificity and sensitivity compared to models developed before 2019.</td><td align="left" rowspan="1" colspan="1">
<xref rid="ctm270239-bib-0051" ref-type="bibr">
<sup>51</sup>
</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">iRNA&#x02010;PseColl</td><td align="left" rowspan="1" colspan="1">Identifying methylation sites for three RNA modifications.</td><td align="left" rowspan="1" colspan="1">
<xref rid="ctm270239-bib-0183" ref-type="bibr">
<sup>183</sup>
</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">RNA&#x02010;m5C&#x02010;finder</td><td align="left" rowspan="1" colspan="1">Recognising m5C modification sites in various tissues.</td><td align="left" rowspan="1" colspan="1">
<xref rid="ctm270239-bib-0048" ref-type="bibr">
<sup>48</sup>
</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">iRNAm5C</td><td align="left" rowspan="1" colspan="1">Detection for m5C modification sites in four species.</td><td align="left" rowspan="1" colspan="1">
<xref rid="ctm270239-bib-0035" ref-type="bibr">
<sup>35</sup>
</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">m5CPred&#x02010;SVM</td><td align="left" rowspan="1" colspan="1">Outperforming existing methods in detecting m5C sites in specific species.</td><td align="left" rowspan="1" colspan="1">
<xref rid="ctm270239-bib-0050" ref-type="bibr">
<sup>50</sup>
</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">DeepMRMP</td><td align="left" rowspan="1" colspan="1">Efficiently predicting multiple modification types across different species.</td><td align="left" rowspan="1" colspan="1">
<xref rid="ctm270239-bib-0047" ref-type="bibr">
<sup>47</sup>
</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">iMRM</td><td align="left" rowspan="1" colspan="1">Predicting various RNA modifications in <italic toggle="yes">H. sapiens</italic>, <italic toggle="yes">Mus musculus</italic> and <italic toggle="yes">Saccharomyces cerevisiae</italic>.</td><td align="left" rowspan="1" colspan="1">
<xref rid="ctm270239-bib-0052" ref-type="bibr">
<sup>52</sup>
</xref>
</td></tr></tbody></table><table-wrap-foot><fn id="ctm270239-tbl1-note-0001"><p>Abbreviations: HPLC, high&#x02010;performance liquid chromatography; LC&#x02012;MS/MS, liquid chromatography&#x02012;tandem mass spectrometry; MS, mass spectrometry; NGS, next&#x02010;generation sequencing; SMRT, single&#x02010;molecule real&#x02010;time; TGS, third&#x02010;generation sequencing;</p></fn></table-wrap-foot><permissions><copyright-holder>John Wiley &#x00026; Sons, Ltd.</copyright-holder></permissions></table-wrap><table-wrap position="float" id="ctm270239-tbl-0002" content-type="TABLE"><label>TABLE 2</label><caption><p>Common writers, readers and erasers of 5&#x02010;methylcytosine (m5C) modification.</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><thead><tr style="border-bottom:solid 1px #000000"><th align="left" rowspan="1" colspan="1">Types</th><th align="left" rowspan="1" colspan="1">Proteins</th><th align="left" rowspan="1" colspan="1">Substrate</th><th align="left" rowspan="1" colspan="1">Target sites</th><th align="left" rowspan="1" colspan="1">Cellular functions</th><th align="left" rowspan="1" colspan="1">Mechanisms</th><th align="left" rowspan="1" colspan="1">References</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Writers</td><td align="left" rowspan="1" colspan="1">DNMT2</td><td align="left" rowspan="1" colspan="1">tRNA&#x02010;Asp</td><td align="left" rowspan="1" colspan="1">C38</td><td align="left" rowspan="1" colspan="1">Protein synthesis and cellular differentiation</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">
<xref rid="ctm270239-bib-0060" ref-type="bibr">
<sup>60</sup>
</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Cell proliferation and migration</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">
<xref rid="ctm270239-bib-0184" ref-type="bibr">
<sup>184</sup>
</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">NSUN1</td><td align="left" rowspan="1" colspan="1">28S rRNA</td><td align="left" rowspan="1" colspan="1">Conserved cytosines</td><td align="left" rowspan="1" colspan="1">Ribosome biogenesis</td><td align="left" rowspan="1" colspan="1">Modulates pre&#x02010;rRNA processing through interaction with the 5&#x02032;&#x02010;ETS region of the pre&#x02010;rRNA transcript, forming a non&#x02010;catalytic complex in conjunction with box C/D snoRNAs.</td><td align="left" rowspan="1" colspan="1">
<xref rid="ctm270239-bib-0045" ref-type="bibr">
<sup>45</sup>
</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">HIV&#x02010;1 viral latency</td><td align="left" rowspan="1" colspan="1">Competes with HIV&#x02010;1 Tat protein to interact with HIV&#x02010;1 TAR RNA.</td><td align="left" rowspan="1" colspan="1">
<xref rid="ctm270239-bib-0185" ref-type="bibr">
<sup>185</sup>
</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Cell growth</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">
<xref rid="ctm270239-bib-0186" ref-type="bibr">
<sup>186</sup>
</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">NSUN2</td><td align="left" rowspan="1" colspan="1">tRNA, mRNA</td><td align="left" rowspan="1" colspan="1">C34, C48 (tRNA); UTRs, CDS (mRNA)</td><td align="left" rowspan="1" colspan="1">Synaptic signalling at prefrontal cortex pyramidal neurons and contextual fear memory</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">
<xref rid="ctm270239-bib-0187" ref-type="bibr">
<sup>187</sup>
</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Cell proliferation and migration</td><td align="left" rowspan="1" colspan="1">m5C&#x02010;methylates GRB2 and CD44.</td><td align="left" rowspan="1" colspan="1">
<xref rid="ctm270239-bib-0068" ref-type="bibr">
<sup>68</sup>
</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Progression of GC</td><td align="left" rowspan="1" colspan="1">m5C&#x02010;methylates PIK3R1, PCYT1A and FOXC2 mRNAs; represses p57Kip2 by destabilising its mRNA in a m5C&#x02010;dependent manner.</td><td align="left" rowspan="1" colspan="1">
<xref rid="ctm270239-bib-0145" ref-type="bibr">
<sup>145</sup>
</xref>, <xref rid="ctm270239-bib-0188" ref-type="bibr">
<sup>188</sup>
</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Progression of ESCC</td><td align="left" rowspan="1" colspan="1">m5C&#x02010;methylates GRB2 via LIN28B&#x02010;dependent way, thus activating PI3K/AKT and ERK/MAPK signalling pathway.</td><td align="left" rowspan="1" colspan="1">
<xref rid="ctm270239-bib-0071" ref-type="bibr">
<sup>71</sup>
</xref>, <xref rid="ctm270239-bib-0166" ref-type="bibr">
<sup>166</sup>
</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Progression of HCC</td><td align="left" rowspan="1" colspan="1">m5C&#x02010;methylates H19 lncRNA, leading to MYC stimulation; modulates Ras signalling pathway and cell cycle.</td><td align="left" rowspan="1" colspan="1">
<xref rid="ctm270239-bib-0189" ref-type="bibr">
<sup>189</sup>
</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Progression of HPSCC</td><td align="left" rowspan="1" colspan="1">m5C&#x02010;methylates TEAD1 mRNA, thus upregulating its expression.</td><td align="left" rowspan="1" colspan="1">
<xref rid="ctm270239-bib-0190" ref-type="bibr">
<sup>190</sup>
</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Progression of PCa</td><td align="left" rowspan="1" colspan="1">m5C&#x02010;methylates and stabilises AR mRNA.</td><td align="left" rowspan="1" colspan="1">
<xref rid="ctm270239-bib-0147" ref-type="bibr">
<sup>147</sup>
</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Progression of cervical cancer</td><td align="left" rowspan="1" colspan="1">m5C&#x02010;methylates KRT13 mRNA, enhancing its binding with m5C reader YBX1.</td><td align="left" rowspan="1" colspan="1">
<xref rid="ctm270239-bib-0167" ref-type="bibr">
<sup>167</sup>
</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Progression of NPC</td><td align="left" rowspan="1" colspan="1">Negatively regulates immune cell infiltration in TME.</td><td align="left" rowspan="1" colspan="1">
<xref rid="ctm270239-bib-0191" ref-type="bibr">
<sup>191</sup>
</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Progression of uveal melanoma</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">
<xref rid="ctm270239-bib-0077" ref-type="bibr">
<sup>77</sup>
</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">IL&#x02010;17A secretion of T cells</td><td align="left" rowspan="1" colspan="1">m5C&#x02010;methylates IL&#x02010;17A mRNA in T cells.</td><td align="left" rowspan="1" colspan="1">
<xref rid="ctm270239-bib-0192" ref-type="bibr">
<sup>192</sup>
</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">p21 expression under conditions of oxidative stress&#x02010;induced cellular senescence</td><td align="left" rowspan="1" colspan="1">m5C&#x02010;methylates p21 mRNA at the 3&#x02032;&#x02010;UTR.</td><td align="left" rowspan="1" colspan="1">
<xref rid="ctm270239-bib-0172" ref-type="bibr">
<sup>172</sup>
</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">ALYREF's nuclear&#x02010;cytoplasmic shuttling, RNA&#x02010;binding affinity and associated mRNA export</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">
<xref rid="ctm270239-bib-0008" ref-type="bibr">
<sup>8</sup>
</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">NSUN3</td><td align="left" rowspan="1" colspan="1">mt&#x02010;tRNA</td><td align="left" rowspan="1" colspan="1">C34 in anticodon loop</td><td align="left" rowspan="1" colspan="1">Low&#x02010;grade glioma development</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">
<xref rid="ctm270239-bib-0083" ref-type="bibr">
<sup>83</sup>
</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Development of HNSCC</td><td align="left" rowspan="1" colspan="1">Promotes tumour progression by regulating immune cell infiltration.</td><td align="left" rowspan="1" colspan="1">
<xref rid="ctm270239-bib-0084" ref-type="bibr">
<sup>84</sup>
</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Mitochondrial mRNA translation, thus promoting metastasis</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">
<xref rid="ctm270239-bib-0087" ref-type="bibr">
<sup>87</sup>
</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">CD8+ T cells and M2 macrophages infiltration</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">
<xref rid="ctm270239-bib-0085" ref-type="bibr">
<sup>85</sup>
</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Mitochondrial regulation</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">
<xref rid="ctm270239-bib-0086" ref-type="bibr">
<sup>86</sup>
</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">NSUN4</td><td align="left" rowspan="1" colspan="1">12S rRNA, tRNA</td><td align="left" rowspan="1" colspan="1">Multiple</td><td align="left" rowspan="1" colspan="1">Facilitates mitoribosomal assembly</td><td align="left" rowspan="1" colspan="1">m5C&#x02010;methylates 12S rRNA and interacts with MTERF4.</td><td align="left" rowspan="1" colspan="1">
<xref rid="ctm270239-bib-0089" ref-type="bibr">
<sup>89</sup>
</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Facilitates adaptation to higher temperatures</td><td align="left" rowspan="1" colspan="1">Ensures translation efficiency of UUG&#x02010;rich transcripts and fertility.</td><td align="left" rowspan="1" colspan="1">
<xref rid="ctm270239-bib-0090" ref-type="bibr">
<sup>90</sup>
</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Chondrogenic differentiation</td><td align="left" rowspan="1" colspan="1">m5C&#x02010;methylates the 3&#x02032;&#x02010;UTR of Sox9 mRNA.</td><td align="left" rowspan="1" colspan="1">
<xref rid="ctm270239-bib-0193" ref-type="bibr">
<sup>193</sup>
</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Progression of HCC</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">
<xref rid="ctm270239-bib-0091" ref-type="bibr">
<sup>91</sup>
</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">NSUN5</td><td align="left" rowspan="1" colspan="1">28S rRNA</td><td align="left" rowspan="1" colspan="1">m5C3782 (humans)</td><td align="left" rowspan="1" colspan="1">Protein synthesis and cell proliferation</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">
<xref rid="ctm270239-bib-0093" ref-type="bibr">
<sup>93</sup>
</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Progression of HCC</td><td align="left" rowspan="1" colspan="1">Strengthens ribosome functions and global protein translation.</td><td align="left" rowspan="1" colspan="1">
<xref rid="ctm270239-bib-0095" ref-type="bibr">
<sup>95</sup>
</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Progression of CRC</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">
<xref rid="ctm270239-bib-0096" ref-type="bibr">
<sup>96</sup>
</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">NSUN6</td><td align="left" rowspan="1" colspan="1">tRNA, mRNA</td><td align="left" rowspan="1" colspan="1">C72 in tRNA, 3&#x02032;&#x02010;UTRs</td><td align="left" rowspan="1" colspan="1">Suppression of TNBC</td><td align="left" rowspan="1" colspan="1">Potentially regulates infiltration of CD4<sup>+</sup> T cells.</td><td align="left" rowspan="1" colspan="1">
<xref rid="ctm270239-bib-0102" ref-type="bibr">
<sup>102</sup>
</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Suppression of pancreatic cancer</td><td align="left" rowspan="1" colspan="1">Promotes tumour&#x02010;suppressive CDK10.</td><td align="left" rowspan="1" colspan="1">
<xref rid="ctm270239-bib-0103" ref-type="bibr">
<sup>103</sup>
</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Suppression of testis, thyroid and ovary cancers</td><td align="left" rowspan="1" colspan="1">Promotes higher expression and translation levels of m5C&#x02010;methylated mRNAs.</td><td align="left" rowspan="1" colspan="1">
<xref rid="ctm270239-bib-0101" ref-type="bibr">
<sup>101</sup>
</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Progression of CRC</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">
<xref rid="ctm270239-bib-0105" ref-type="bibr">
<sup>105</sup>
</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Cell cycle dysfunction</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">
<xref rid="ctm270239-bib-0194" ref-type="bibr">
<sup>194</sup>
</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Infiltration of B cells and CD8<sup>+</sup> T cells</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">
<xref rid="ctm270239-bib-0104" ref-type="bibr">
<sup>104</sup>
</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Formation of antibody&#x02010;secreting plasma cells</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">
<xref rid="ctm270239-bib-0106" ref-type="bibr">
<sup>106</sup>
</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">NSUN7</td><td align="left" rowspan="1" colspan="1">eRNA</td><td align="left" rowspan="1" colspan="1">Enhancer regions</td><td align="left" rowspan="1" colspan="1">transcriptional coactivator function of PGC&#x02010;1a</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">
<xref rid="ctm270239-bib-0107" ref-type="bibr">
<sup>107</sup>
</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Erasers</td><td align="left" rowspan="1" colspan="1">TET1</td><td align="left" rowspan="1" colspan="1">DNA, RNA (potential)</td><td align="left" rowspan="1" colspan="1">
<p>DNA: CpG sites</p>
<p>RNA: unclear, low efficiency</p>
</td><td align="left" rowspan="1" colspan="1">Proper completion of DNA repair and survival of cells after DNA damage</td><td align="left" rowspan="1" colspan="1">Mediates mRNA m5C&#x02010;demethylation, thus promoting mRNA&#x02010;dependent recombination.</td><td align="left" rowspan="1" colspan="1">
<xref rid="ctm270239-bib-0109" ref-type="bibr">
<sup>109</sup>
</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">TET2</td><td align="left" rowspan="1" colspan="1">DNA, RNA (tRNA)</td><td align="left" rowspan="1" colspan="1">
<p>DNA: CpG sites</p>
<p>RNA: tRNA, m5C sites</p>
</td><td align="left" rowspan="1" colspan="1">Conversion of m5C into 5&#x02010;hmC</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">
<xref rid="ctm270239-bib-0110" ref-type="bibr">
<sup>110</sup>
</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Promotion of low&#x02010;grade glioma</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">
<xref rid="ctm270239-bib-0083" ref-type="bibr">
<sup>83</sup>
</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Suppression of ccRCC</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">
<xref rid="ctm270239-bib-0195" ref-type="bibr">
<sup>195</sup>
</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Inhibition of ovarian cancer</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">
<xref rid="ctm270239-bib-0196" ref-type="bibr">
<sup>196</sup>
</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Inhibition of prostate adenocarcinoma</td><td align="left" rowspan="1" colspan="1">Potentially promotes immune cell infiltration.</td><td align="left" rowspan="1" colspan="1">
<xref rid="ctm270239-bib-0197" ref-type="bibr">
<sup>197</sup>
</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">TET3</td><td align="left" rowspan="1" colspan="1">DNA, RNA (potential)</td><td align="left" rowspan="1" colspan="1">
<p>DNA: CpG sites</p>
<p>RNA: possible mRNA targets</p>
</td><td align="left" rowspan="1" colspan="1">Promotion of PCa</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">
<xref rid="ctm270239-bib-0115" ref-type="bibr">
<sup>115</sup>
</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">ALKBH1</td><td align="left" rowspan="1" colspan="1">RNA (tRNA, mt&#x02010;tRNA), DNA</td><td align="left" rowspan="1" colspan="1">
<p>RNA: mt&#x02010;tRNA C34 (anticodon loop), m5C</p>
<p>DNA: n/a</p>
</td><td align="left" rowspan="1" colspan="1">Converting m5C RNA modifications into either 5&#x02010;hmC or 5&#x02010;formylcytidine RNA modifications</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">
<xref rid="ctm270239-bib-0115" ref-type="bibr">
<sup>115</sup>
</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Readers</td><td align="left" rowspan="1" colspan="1">ALYREF</td><td align="left" rowspan="1" colspan="1">mRNA; lncRNA</td><td align="left" rowspan="1" colspan="1">m5C&#x02010;modified sites in nuclear mRNA and viral RNA transcripts; NEAT1</td><td align="left" rowspan="1" colspan="1">Progression of HCC</td><td align="left" rowspan="1" colspan="1">Promotes eIF4A3 expression; disrupts cell cycle and mitosis regulation.</td><td align="left" rowspan="1" colspan="1">
<xref rid="ctm270239-bib-0092" ref-type="bibr">
<sup>92</sup>
</xref>, <xref rid="ctm270239-bib-0198" ref-type="bibr">
<sup>198</sup>
</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Progression of glioblastoma</td><td align="left" rowspan="1" colspan="1">Stabilises MYC mRNA; activates the Wnt/&#x003b2;&#x02010;catenin signalling pathway.</td><td align="left" rowspan="1" colspan="1">
<xref rid="ctm270239-bib-0163" ref-type="bibr">
<sup>163</sup>
</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Progression of glioma</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">
<xref rid="ctm270239-bib-0083" ref-type="bibr">
<sup>83</sup>
</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Progression of neuroblastoma</td><td align="left" rowspan="1" colspan="1">Forms a nuclear coactivator complex with MYCN to stimulate USP3 transcription.</td><td align="left" rowspan="1" colspan="1">
<xref rid="ctm270239-bib-0165" ref-type="bibr">
<sup>165</sup>
</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Progression of lung adenocarcinoma</td><td align="left" rowspan="1" colspan="1">Binds with 3&#x02032;&#x02010;UTR of YAP mRNA, increasing its stability and thus enhancing exosome secretion, tumour malignancy and drug resistance.</td><td align="left" rowspan="1" colspan="1">
<xref rid="ctm270239-bib-0199" ref-type="bibr">
<sup>199</sup>
</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Progression of HNSCC</td><td align="left" rowspan="1" colspan="1">Enhances mitochondrial activity and intracellular energy metabolism, ensuring continuous energy supplies.</td><td align="left" rowspan="1" colspan="1">
<xref rid="ctm270239-bib-0200" ref-type="bibr">
<sup>200</sup>
</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Progression of BCa</td><td align="left" rowspan="1" colspan="1">Binds and stabilises PKM2 mRNA, enhancing PKM2&#x02010;mediated glycolysis.</td><td align="left" rowspan="1" colspan="1">
<xref rid="ctm270239-bib-0201" ref-type="bibr">
<sup>201</sup>
</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Progression of BC</td><td align="left" rowspan="1" colspan="1">Binds with the NEAT1 lncRNA promoter region, enhancing its transcription.</td><td align="left" rowspan="1" colspan="1">
<xref rid="ctm270239-bib-0118" ref-type="bibr">
<sup>118</sup>
</xref>, <xref rid="ctm270239-bib-0150" ref-type="bibr">
<sup>150</sup>
</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Suppression of colon adenocarcinoma</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">
<xref rid="ctm270239-bib-0105" ref-type="bibr">
<sup>105</sup>
</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Inhibition of adipogenesis</td><td align="left" rowspan="1" colspan="1">Recognises and exports YBX2 and CDKN1A mRNAs into the cytoplasm, leading to increased YBX2 and CDKNIA protein expression levels which inhibit adipogenesis.</td><td align="left" rowspan="1" colspan="1">
<xref rid="ctm270239-bib-0202" ref-type="bibr">
<sup>202</sup>
</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Promotion of myogenesis</td><td align="left" rowspan="1" colspan="1">Recognises and exports SMO mRNA into the cytoplasm, leading to increased SMO protein expression levels which promote myogenesis.</td><td align="left" rowspan="1" colspan="1">
<xref rid="ctm270239-bib-0203" ref-type="bibr">
<sup>203</sup>
</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Promotion of retrovirus replication</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">
<xref rid="ctm270239-bib-0204" ref-type="bibr">
<sup>204</sup>
</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Promotion of abdominal aortic aneurysm and infiltration of CD45<sup>+</sup> leukocytes and CD3<sup>+</sup> T cells</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">
<xref rid="ctm270239-bib-0205" ref-type="bibr">
<sup>205</sup>
</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">YBX1</td><td align="left" rowspan="1" colspan="1">mRNA</td><td align="left" rowspan="1" colspan="1">m5C&#x02010;modified mRNAs</td><td align="left" rowspan="1" colspan="1">Progression of GC</td><td align="left" rowspan="1" colspan="1">Recognises and binds with NSUN2&#x02010;mediated m5C sites on FOXC2 mRNA to stabilise it.</td><td align="left" rowspan="1" colspan="1">
<xref rid="ctm270239-bib-0188" ref-type="bibr">
<sup>188</sup>
</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Progression of BCa</td><td align="left" rowspan="1" colspan="1">Stabilises oncogenic HDGF mRNA by targeting the m5C&#x02010;modified site on its 3&#x02032;&#x02010;UTR and recruiting ELAVL1.</td><td align="left" rowspan="1" colspan="1">
<xref rid="ctm270239-bib-0023" ref-type="bibr">
<sup>23</sup>
</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Progression of glioblastoma de</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">
<xref rid="ctm270239-bib-0206" ref-type="bibr">
<sup>206</sup>
</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Progression of CRC</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">
<xref rid="ctm270239-bib-0207" ref-type="bibr">
<sup>207</sup>
</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Progression of cholangiocarcinoma</td><td align="left" rowspan="1" colspan="1">Recognises and stabilises m5C&#x02010;modified NKILA.</td><td align="left" rowspan="1" colspan="1">
<xref rid="ctm270239-bib-0162" ref-type="bibr">
<sup>162</sup>
</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Suppresses the development of ccRCC</td><td align="left" rowspan="1" colspan="1">YBX1/ELAVL1 complex binds and stabilises PEBR1 mRNA, which negatively modulates ccRCC.</td><td align="left" rowspan="1" colspan="1">
<xref rid="ctm270239-bib-0208" ref-type="bibr">
<sup>208</sup>
</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Progression of PCa</td><td align="left" rowspan="1" colspan="1">Recognises and binds with NSUN2&#x02010;mediated m5C sites on AR mRNA to stabilise it.</td><td align="left" rowspan="1" colspan="1">
<xref rid="ctm270239-bib-0147" ref-type="bibr">
<sup>147</sup>
</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Progression of epithelial ovarian cancer</td><td align="left" rowspan="1" colspan="1">Modulates the expression of a variety of downstream targets, including CD44, thus enhancing chemoresistance.</td><td align="left" rowspan="1" colspan="1">
<xref rid="ctm270239-bib-0168" ref-type="bibr">
<sup>168</sup>
</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Progression of cervical cancer</td><td align="left" rowspan="1" colspan="1">Recognises and binds with NSUN2&#x02010;mediated m5C sites on KRT13 mRNA to stabilise it.</td><td align="left" rowspan="1" colspan="1">
<xref rid="ctm270239-bib-0167" ref-type="bibr">
<sup>167</sup>
</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Embryonic brain development</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">
<xref rid="ctm270239-bib-0206" ref-type="bibr">
<sup>206</sup>
</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Maternal&#x02010;to&#x02010;zygotic transition</td><td align="left" rowspan="1" colspan="1">Recognises and stabilises m5C&#x02010;modified mRNAs by recruiting Pabpc1a, preventing maternal mRNA decay.</td><td align="left" rowspan="1" colspan="1">
<xref rid="ctm270239-bib-0123" ref-type="bibr">
<sup>123</sup>
</xref>
</td></tr></tbody></table><table-wrap-foot><fn id="ctm270239-tbl2-note-0001"><p>Abbreviations: 5&#x02010;hmC, 5&#x02010;hydroxymethylcytosine; AR, androgen receptor; BC, breast cancer; BCa, bladder cancer; ccRCC, clear cell renal cell carcinoma; CRC, colorectal cancer; eRNA, enhancer RNA; ESCC, esophageal squamous cell carcinoma; GC, gastric cancer; HCC, hepatocellular carcinoma; HNSCC, head and neck squamous cell carcinoma; HPSCC, hypopharyngeal squamous cell carcinoma; lncRNA, long non&#x02010;coding RNA; NPC, nasopharyngeal carcinoma; PCa, prostate cancer; TME, tumour microenvironment; TNBC, triple&#x02010;negative breast cancer.</p></fn></table-wrap-foot><permissions><copyright-holder>John Wiley &#x00026; Sons, Ltd.</copyright-holder></permissions></table-wrap><p>Barriers persist in advancing research on RNA m5C modification, with the ultimate objective of comprehensively understanding the modification and facilitating clinical translation. In the realm of RNA m6A modification detection and research trends, homogeneous techniques are continually evolving to enhance resolution and sensitivity. However, the limitation and pivotal breakthrough lie in RNA methylation detection, where traditional high&#x02010;throughput methods for m5C site identification prove to be inefficient. Advancing this field will require integration of computational and experimental approaches, ensuring high sensitivity and specificity in detecting and mapping m5C modifications. These efforts will lay the foundation for applying m5C research to clinical diagnostics and therapeutic interventions.</p></sec><sec id="ctm270239-sec-0310"><title>AUTHOR CONTRIBUTIONS</title><p>Linhui Zhang and Yuelong Li wrote the original manuscript. Liqing Li and Fei Yao&#x000a0;reviewed and revised the manuscript. Maoping Cai, Dingwei Ye and Yuanyuan Qu designed, reviewed, edited and funded acquisition. All authors contributed to the writing and revision of the manuscript, and approved its submission.</p></sec><sec sec-type="COI-statement" id="ctm270239-sec-0330"><title>CONFLICT OF INTEREST STATEMENT</title><p>The authors declare they have no conflicts of interest.</p></sec><sec id="ctm270239-sec-0360"><title>ETHICS STATEMENT</title><p>The authors have nothing to report.</p></sec></body><back><ack id="ctm270239-sec-0320"><title>ACKNOWLEDGEMENTS</title><p>This work was supported by grants from the National Ten Thousand Plan Young Top Talents (Y.Y.Q.), Shanghai &#x02018;Rising Stars of Medical Talent&#x02019; Outstanding Youth Medical Talents (Y.Y.Q.), the National Natural Science Foundation of China (nos. 82172817 [Y.Y.Q.], 82172741 [W.D.Y.] and 82473192 [W.D.Y.]), Shanghai Rising&#x02010;Star Program (no. 23QA1408900 [Y.Y.Q.]), Shanghai &#x02018;Science and Technology Innovation Action Plan&#x02019; Medical Innovation Research Project (22Y11905100 [Y.Y.Q.]), Shanghai Municipal Health Bureau Project (no. 2020CXJQ03 [W.D.Y.]) and Fund of Fudan University and Cao'ejiang Basic Research (24FCA13 [Y.Y.Q.]).</p></ack><sec sec-type="data-availability" id="ctm270239-sec-0350"><title>DATA AVAILABILITY STATEMENT</title><p>No data are associated in the manuscript.</p></sec><ref-list id="ctm270239-bibl-0001"><title>REFERENCES</title><ref id="ctm270239-bib-0001"><label>1</label><mixed-citation publication-type="journal" id="ctm270239-cit-0001">
<string-name>
<surname>Roundtree</surname>
<given-names>IA</given-names>
</string-name>, <string-name>
<surname>Evans</surname>
<given-names>ME</given-names>
</string-name>, <string-name>
<surname>Pan</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>He</surname>
<given-names>C</given-names>
</string-name>. <article-title>Dynamic RNA modifications in gene expression regulation</article-title>. <source>Cell</source>. <year>2017</year>;<volume>169</volume>(<issue>7</issue>):<fpage>1187</fpage>&#x02010;<lpage>1200</lpage>.<pub-id pub-id-type="pmid">28622506</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0002"><label>2</label><mixed-citation publication-type="journal" id="ctm270239-cit-0002">
<string-name>
<surname>Cohn</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Volkin</surname>
<given-names>E</given-names>
</string-name>. <article-title>Nucleoside&#x02010;5&#x02032;&#x02010;phosphates from ribonucleic acid</article-title>. <source>Nature</source>. <year>1951</year>;<volume>167</volume>(<issue>4247</issue>):<fpage>483</fpage>&#x02010;<lpage>484</lpage>.</mixed-citation></ref><ref id="ctm270239-bib-0003"><label>3</label><mixed-citation publication-type="journal" id="ctm270239-cit-0003">
<string-name>
<surname>Boccaletto</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Stefaniak</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Ray</surname>
<given-names>A</given-names>
</string-name>, et&#x000a0;al. <article-title>MODOMICS: a database of RNA modification pathways. 2021 update</article-title>. <source>Nucleic Acids Res</source>. <year>2022</year>;<volume>50</volume>(<issue>D1</issue>):<fpage>D231</fpage>&#x02010;<lpage>D235</lpage>.<pub-id pub-id-type="pmid">34893873</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0004"><label>4</label><mixed-citation publication-type="journal" id="ctm270239-cit-0004">
<string-name>
<surname>Wiener</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Schwartz</surname>
</string-name>
<string-name>
<given-names>S</given-names>
</string-name>. <article-title>The epitranscriptome beyond m(6)A</article-title>. <source>Nat Rev Genet</source>. <year>2021</year>;<volume>22</volume>(<issue>2</issue>):<fpage>119</fpage>&#x02010;<lpage>131</lpage>.<pub-id pub-id-type="pmid">33188361</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0005"><label>5</label><mixed-citation publication-type="journal" id="ctm270239-cit-0005">
<string-name>
<surname>Frye</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Harada</surname>
<given-names>BT</given-names>
</string-name>, <string-name>
<surname>Behm</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>He</surname>
<given-names>C</given-names>
</string-name>. <article-title>RNA modifications modulate gene expression during development</article-title>. <source>Science</source>. <year>2018</year>;<volume>361</volume>(<issue>6409</issue>):<fpage>1346</fpage>&#x02010;<lpage>1349</lpage>.<pub-id pub-id-type="pmid">30262497</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0006"><label>6</label><mixed-citation publication-type="journal" id="ctm270239-cit-0006">
<string-name>
<surname>Yang</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Hsu</surname>
<given-names>PJ</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Yang</surname>
<given-names>Y</given-names>
</string-name>. <article-title>Dynamic transcriptomic m(6)A decoration: writers, erasers, readers and functions in RNA metabolism</article-title>. <source>Cell Res</source>. <year>2018</year>;<volume>28</volume>(<issue>6</issue>):<fpage>616</fpage>&#x02010;<lpage>624</lpage>.<pub-id pub-id-type="pmid">29789545</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0007"><label>7</label><mixed-citation publication-type="journal" id="ctm270239-cit-0007">
<string-name>
<surname>Hussain</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Sajini</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Blanco</surname>
<given-names>S</given-names>
</string-name>, et&#x000a0;al. <article-title>NSun2&#x02010;mediated cytosine&#x02010;5 methylation of vault noncoding RNA determines its processing into regulatory small RNAs</article-title>. <source>Cell Rep</source>. <year>2013</year>;<volume>4</volume>(<issue>2</issue>):<fpage>255</fpage>&#x02010;<lpage>261</lpage>.<pub-id pub-id-type="pmid">23871666</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0008"><label>8</label><mixed-citation publication-type="journal" id="ctm270239-cit-0008">
<string-name>
<surname>Yang</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Yang</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Sun</surname>
<given-names>B</given-names>
</string-name>, et&#x000a0;al. <article-title>5&#x02010;Methylcytosine promotes mRNA export&#x02014;NSUN2 as the methyltransferase and ALYREF as an m(5)C reader</article-title>. <source>Cell Res</source>. <year>2017</year>;<volume>27</volume>(<issue>5</issue>):<fpage>606</fpage>&#x02010;<lpage>625</lpage>.<pub-id pub-id-type="pmid">28418038</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0009"><label>9</label><mixed-citation publication-type="journal" id="ctm270239-cit-0009">
<string-name>
<surname>Liu</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Zuo</surname>
<given-names>Y</given-names>
</string-name>. <article-title>Function determinants of TET proteins: the arrangements of sequence motifs with specific codes</article-title>. <source>Brief Bioinform</source>. <year>2019</year>;<volume>20</volume>(<issue>5</issue>):<fpage>1826</fpage>&#x02010;<lpage>1835</lpage>.<pub-id pub-id-type="pmid">29947743</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0010"><label>10</label><mixed-citation publication-type="journal" id="ctm270239-cit-0010">
<string-name>
<surname>Frommer</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>McDonald</surname>
<given-names>LE</given-names>
</string-name>, <string-name>
<surname>Millar</surname>
<given-names>DS</given-names>
</string-name>, et&#x000a0;al. <article-title>A genomic sequencing protocol that yields a positive display of 5&#x02010;methylcytosine residues in individual DNA strands</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>1992</year>;<volume>89</volume>(<issue>5</issue>):<fpage>1827</fpage>&#x02010;<lpage>1831</lpage>.<pub-id pub-id-type="pmid">1542678</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0011"><label>11</label><mixed-citation publication-type="journal" id="ctm270239-cit-0011">
<string-name>
<surname>Fu</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Amato</surname>
<given-names>NJ</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>McGowan</surname>
<given-names>SJ</given-names>
</string-name>, <string-name>
<surname>Niedernhofer</surname>
<given-names>LJ</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>Y</given-names>
</string-name>. <article-title>Simultaneous quantification of methylated cytidine and adenosine in cellular and tissue RNA by nano&#x02010;flow liquid chromatography&#x02010;tandem mass spectrometry coupled with the stable isotope&#x02010;dilution method</article-title>. <source>Anal Chem</source>. <year>2015</year>;<volume>87</volume>(<issue>15</issue>):<fpage>7653</fpage>&#x02010;<lpage>7659</lpage>.<pub-id pub-id-type="pmid">26158405</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0012"><label>12</label><mixed-citation publication-type="journal" id="ctm270239-cit-0012">
<string-name>
<surname>Wang</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Lian</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Deng</surname>
<given-names>S</given-names>
</string-name>. <article-title>The role of RNA modification in HIV&#x02010;1 infection</article-title>. <source>Int J Mol Sci</source>. <year>2022</year>;<volume>23</volume>(<issue>14</issue>):<fpage>7571</fpage>.<pub-id pub-id-type="pmid">35886919</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0013"><label>13</label><mixed-citation publication-type="journal" id="ctm270239-cit-0013">
<string-name>
<surname>Zhang</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Song</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Yuan</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Sun</surname>
<given-names>Z</given-names>
</string-name>. <article-title>Roles of RNA methylation on tumor immunity and clinical implications</article-title>. <source>Front Immunol</source>. <year>2021</year>;<volume>12</volume>:<elocation-id>641507</elocation-id>.<pub-id pub-id-type="pmid">33777035</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0014"><label>14</label><mixed-citation publication-type="journal" id="ctm270239-cit-0014">
<string-name>
<surname>Huang</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>L</given-names>
</string-name>. <article-title>RNA N6&#x02010;methyladenosine modification in female reproductive biology and pathophysiology</article-title>. <source>Cell Commun Signal</source>. <year>2023</year>;<volume>21</volume>(<issue>1</issue>):<fpage>53</fpage>.<pub-id pub-id-type="pmid">36894952</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0015"><label>15</label><mixed-citation publication-type="journal" id="ctm270239-cit-0015">
<string-name>
<surname>Xu</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>Q</given-names>
</string-name>, et&#x000a0;al. <article-title>Role of main RNA methylation in hepatocellular carcinoma: N6&#x02010;methyladenosine, 5&#x02010;methylcytosine, and N1&#x02010;methyladenosine</article-title>. <source>Front Cell Dev Biol</source>. <year>2021</year>;<volume>9</volume>:<elocation-id>767668</elocation-id>.<pub-id pub-id-type="pmid">34917614</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0016"><label>16</label><mixed-citation publication-type="journal" id="ctm270239-cit-0016">
<string-name>
<surname>Yu</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Bao</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Zhan</surname>
<given-names>M</given-names>
</string-name>, et&#x000a0;al. <article-title>Comprehensive analysis of m5C methylation regulatory genes and tumor microenvironment in prostate cancer</article-title>. <source>Front Immunol</source>. <year>2022</year>;<volume>13</volume>:<elocation-id>914577</elocation-id>.<pub-id pub-id-type="pmid">35757739</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0017"><label>17</label><mixed-citation publication-type="journal" id="ctm270239-cit-0017">
<string-name>
<surname>Ponzetti</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Rucci</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Falone</surname>
<given-names>S</given-names>
</string-name>. <article-title>RNA methylation and cellular response to oxidative stress&#x02010;promoting anticancer agents</article-title>. <source>Cell Cycle</source>. <year>2023</year>;<volume>22</volume>(<issue>8</issue>):<fpage>870</fpage>&#x02010;<lpage>905</lpage>.<pub-id pub-id-type="pmid">36648057</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0018"><label>18</label><mixed-citation publication-type="journal" id="ctm270239-cit-0018">
<string-name>
<surname>Bohnsack</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>H&#x000f6;bartner</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Bohnsack</surname>
<given-names>M</given-names>
</string-name>. <article-title>Eukaryotic 5&#x02010;methylcytosine (m5C) RNA methyltransferases: mechanisms, cellular functions, and links to disease</article-title>. <source>Genes</source>. <year>2019</year>;<volume>10</volume>(<issue>2</issue>):<fpage>102</fpage>.<pub-id pub-id-type="pmid">30704115</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0019"><label>19</label><mixed-citation publication-type="journal" id="ctm270239-cit-0019">
<string-name>
<surname>Barbieri</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Kouzarides</surname>
<given-names>T</given-names>
</string-name>. <article-title>Role of RNA modifications in cancer</article-title>. <source>Nat Rev Cancer</source>. <year>2020</year>;<volume>20</volume>(<issue>6</issue>):<fpage>303</fpage>&#x02010;<lpage>322</lpage>.<pub-id pub-id-type="pmid">32300195</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0020"><label>20</label><mixed-citation publication-type="journal" id="ctm270239-cit-0020">
<string-name>
<surname>Delaunay</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Pascual</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Feng</surname>
<given-names>B</given-names>
</string-name>, et&#x000a0;al. <article-title>Mitochondrial RNA modifications shape metabolic plasticity in metastasis</article-title>. <source>Nature</source>. <year>2022</year>;<volume>607</volume>(<issue>7919</issue>):<fpage>593</fpage>&#x02010;<lpage>603</lpage>.<pub-id pub-id-type="pmid">35768510</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0021"><label>21</label><mixed-citation publication-type="journal" id="ctm270239-cit-0021">
<string-name>
<surname>Nishida</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Nagasaka</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Nishimura</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Ikai</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Boland</surname>
<given-names>RC</given-names>
</string-name>, <string-name>
<surname>Goel</surname>
<given-names>A</given-names>
</string-name>. <article-title>Aberrant methylation of multiple tumor suppressor genes in aging liver, chronic hepatitis, and hepatocellular carcinoma</article-title>. <source>Hepatology</source>. <year>2008</year>;<volume>47</volume>(<issue>3</issue>):<fpage>908</fpage>&#x02010;<lpage>918</lpage>.<pub-id pub-id-type="pmid">18161048</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0022"><label>22</label><mixed-citation publication-type="journal" id="ctm270239-cit-0022">
<string-name>
<surname>Zhang</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>An</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Ge</surname>
<given-names>X</given-names>
</string-name>, et&#x000a0;al. <article-title>NSUN2/YBX1 promotes the progression of breast cancer by enhancing HGH1 mRNA stability through m(5)C methylation</article-title>. <source>Breast Cancer Res</source>. <year>2024</year>;<volume>26</volume>(<issue>1</issue>):<fpage>94</fpage>.<pub-id pub-id-type="pmid">38844963</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0023"><label>23</label><mixed-citation publication-type="journal" id="ctm270239-cit-0023">
<string-name>
<surname>Chen</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Sun</surname>
<given-names>B</given-names>
</string-name>, et&#x000a0;al. <article-title>5&#x02010;Methylcytosine promotes pathogenesis of bladder cancer through stabilizing mRNAs</article-title>. <source>Nat Cell Biol</source>. <year>2019</year>;<volume>21</volume>(<issue>8</issue>):<fpage>978</fpage>&#x02010;<lpage>990</lpage>.<pub-id pub-id-type="pmid">31358969</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0024"><label>24</label><mixed-citation publication-type="journal" id="ctm270239-cit-0024">
<string-name>
<surname>Cui</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Ma</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Cai</surname>
<given-names>J</given-names>
</string-name>, et&#x000a0;al. <article-title>RNA modifications: importance in immune cell biology and related diseases</article-title>. <source>Signal Transduct Target Ther</source>. <year>2022</year>;<volume>7</volume>(<issue>1</issue>):<fpage>334</fpage>.<pub-id pub-id-type="pmid">36138023</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0025"><label>25</label><mixed-citation publication-type="journal" id="ctm270239-cit-0025">
<string-name>
<surname>Guo</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Pan</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Fang</surname>
<given-names>S</given-names>
</string-name>, et&#x000a0;al. <article-title>Advances in mRNA 5&#x02010;methylcytosine modifications: detection, effectors, biological functions, and clinical relevance</article-title>. <source>Mol Ther Nucleic Acids</source>. <year>2021</year>;<volume>26</volume>:<fpage>575</fpage>&#x02010;<lpage>593</lpage>.<pub-id pub-id-type="pmid">34631286</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0026"><label>26</label><mixed-citation publication-type="journal" id="ctm270239-cit-0026">
<string-name>
<surname>Buck</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Connick</surname>
</string-name>
<string-name>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Ames</surname>
</string-name>
<string-name>
<given-names>B</given-names>
</string-name>. <article-title>Complete analysis of tRNA&#x02010;modified nucleosides by high&#x02010;performance liquid chromatography: the 29 modified nucleosides of Salmonella typhimurium and <italic toggle="yes">Escherichia coli</italic> tRNA</article-title>. <source>Anal Biochem</source>. <year>1983</year>;<volume>129</volume>(<issue>1</issue>):<fpage>1</fpage>&#x02010;<lpage>13</lpage>.<pub-id pub-id-type="pmid">6190418</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0027"><label>27</label><mixed-citation publication-type="journal" id="ctm270239-cit-0027">
<string-name>
<surname>Mishima</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Jinno</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Akiyama</surname>
<given-names>Y</given-names>
</string-name>, et&#x000a0;al. <article-title>Immuno&#x02010;northern blotting: detection of RNA modifications by using antibodies against modified nucleosides</article-title>. <source>PLoS One</source>. <year>2015</year>;<volume>10</volume>(<issue>11</issue>):<elocation-id>e0143756</elocation-id>.<pub-id pub-id-type="pmid">26606401</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0028"><label>28</label><mixed-citation publication-type="journal" id="ctm270239-cit-0028">
<string-name>
<surname>Cui</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Liang</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Shen</surname>
<given-names>L</given-names>
</string-name>, et&#x000a0;al. <article-title>5&#x02010;Methylcytosine RNA methylation in <italic toggle="yes">Arabidopsis thaliana</italic>
</article-title>. <source>Mol Plant</source>. <year>2017</year>;<volume>10</volume>(<issue>11</issue>):<fpage>1387</fpage>&#x02010;<lpage>1399</lpage>.<pub-id pub-id-type="pmid">28965832</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0029"><label>29</label><mixed-citation publication-type="journal" id="ctm270239-cit-0029">
<string-name>
<surname>Wreczycka</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Gosdschan</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Yusuf</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Gr&#x000fc;ning</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Assenov</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Akalin</surname>
<given-names>A</given-names>
</string-name>. <article-title>Strategies for analyzing bisulfite sequencing data</article-title>. <source>J Biotechnol</source>. <year>2017</year>;<volume>261</volume>:<fpage>105</fpage>&#x02010;<lpage>115</lpage>.<pub-id pub-id-type="pmid">28822795</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0030"><label>30</label><mixed-citation publication-type="journal" id="ctm270239-cit-0030">
<string-name>
<surname>Yuan</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Bi</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Siejka&#x02010;Zielinska</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Zhou</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Song</surname>
<given-names>C</given-names>
</string-name>. <article-title>Bisulfite&#x02010;free and base&#x02010;resolution analysis of 5&#x02010;methylcytidine and 5&#x02010;hydroxymethylcytidine in RNA with peroxotungstate</article-title>. <source>Chem Commun (Camb)</source>. <year>2019</year>;<volume>55</volume>(<issue>16</issue>):<fpage>2328</fpage>&#x02010;<lpage>2331</lpage>.<pub-id pub-id-type="pmid">30723849</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0031"><label>31</label><mixed-citation publication-type="journal" id="ctm270239-cit-0031">
<string-name>
<surname>Dai</surname>
<given-names>Q</given-names>
</string-name>, <string-name>
<surname>Ye</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Irkliyenko</surname>
<given-names>I</given-names>
</string-name>, et&#x000a0;al. <article-title>Ultrafast bisulfite sequencing detection of 5&#x02010;methylcytosine in DNA and RNA</article-title>. <source>Nat Biotechnol</source>. <year>2024</year>;<volume>42</volume>:<fpage>1559</fpage>&#x02013;<lpage>1570</lpage>.<pub-id pub-id-type="pmid">38168991</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0032"><label>32</label><mixed-citation publication-type="journal" id="ctm270239-cit-0032">
<string-name>
<surname>Saplaoura</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Perrera</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Colot</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Kragler</surname>
<given-names>F</given-names>
</string-name>. <article-title>Methylated RNA immunoprecipitation assay to study m5C modification in arabidopsis</article-title>. <source>J Vis Exp</source>. <year>2020</year>;(<issue>159</issue>).</mixed-citation></ref><ref id="ctm270239-bib-0033"><label>33</label><mixed-citation publication-type="journal" id="ctm270239-cit-0033">
<string-name>
<surname>Khoddami</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Cairns</surname>
</string-name>
<string-name>
<given-names>B</given-names>
</string-name>. <article-title>Identification of direct targets and modified bases of RNA cytosine methyltransferases</article-title>. <source>Nat Biotechnol</source>. <year>2013</year>;<volume>31</volume>(<issue>5</issue>):<fpage>458</fpage>&#x02010;<lpage>464</lpage>.<pub-id pub-id-type="pmid">23604283</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0034"><label>34</label><mixed-citation publication-type="journal" id="ctm270239-cit-0034">
<string-name>
<surname>van Dijk</surname>
<given-names>EL</given-names>
</string-name>, <string-name>
<surname>Jaszczyszyn</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Naquin</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Thermes</surname>
<given-names>C</given-names>
</string-name>. <article-title>The third revolution in sequencing technology</article-title>. <source>Trends Genet</source>. <year>2018</year>;<volume>34</volume>(<issue>9</issue>):<fpage>666</fpage>&#x02010;<lpage>681</lpage>.<pub-id pub-id-type="pmid">29941292</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0035"><label>35</label><mixed-citation publication-type="journal" id="ctm270239-cit-0035">
<string-name>
<surname>Lv</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Tan</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Lin</surname>
<given-names>H</given-names>
</string-name>. <article-title>Evaluation of different computational methods on 5&#x02010;methylcytosine sites identification</article-title>. <source>Brief Bioinform</source>. <year>2020</year>;<volume>21</volume>(<issue>3</issue>):<fpage>982</fpage>&#x02010;<lpage>995</lpage>.<pub-id pub-id-type="pmid">31157855</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0036"><label>36</label><mixed-citation publication-type="journal" id="ctm270239-cit-0036">
<string-name>
<surname>Qiu</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Jiang</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Xu</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Xiao</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Chou</surname>
<given-names>K</given-names>
</string-name>. <article-title>iRNAm5C&#x02010;PseDNC: identifying RNA 5&#x02010;methylcytosine sites by incorporating physical&#x02010;chemical properties into pseudo dinucleotide composition</article-title>. <source>Oncotarget</source>. <year>2017</year>;<volume>8</volume>(<issue>25</issue>):<fpage>41178</fpage>&#x02010;<lpage>41188</lpage>.<pub-id pub-id-type="pmid">28476023</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0037"><label>37</label><mixed-citation publication-type="journal" id="ctm270239-cit-0037">
<string-name>
<surname>Zhang</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Xu</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Yang</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Yu</surname>
<given-names>D</given-names>
</string-name>. <article-title>Accurate RNA 5&#x02010;methylcytosine site prediction based on heuristic physical&#x02010;chemical properties reduction and classifier ensemble</article-title>. <source>Anal Biochem</source>. <year>2018</year>;<volume>550</volume>:<fpage>41</fpage>&#x02010;<lpage>48</lpage>.<pub-id pub-id-type="pmid">29649472</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0038"><label>38</label><mixed-citation publication-type="journal" id="ctm270239-cit-0038">
<string-name>
<surname>Ehrlich</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Gama&#x02010;Sosa</surname>
<given-names>MA</given-names>
</string-name>, <string-name>
<surname>Carreira</surname>
<given-names>LH</given-names>
</string-name>, <string-name>
<surname>Ljungdahl</surname>
<given-names>LG</given-names>
</string-name>, <string-name>
<surname>Kuo</surname>
<given-names>KC</given-names>
</string-name>, <string-name>
<surname>Gehrke</surname>
<given-names>CW</given-names>
</string-name>. <article-title>DNA methylation in thermophilic bacteria: n4&#x02010;methylcytosine, 5&#x02010;methylcytosine, and N6&#x02010;methyladenine</article-title>. <source>Nucleic Acids Res</source>. <year>1985</year>;<volume>13</volume>(<issue>4</issue>):<fpage>1399</fpage>&#x02010;<lpage>1412</lpage>.<pub-id pub-id-type="pmid">4000939</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0039"><label>39</label><mixed-citation publication-type="journal" id="ctm270239-cit-0039">
<string-name>
<surname>Thomas</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Akoulitchev</surname>
</string-name>
<string-name>
<given-names>A</given-names>
</string-name>. <article-title>Mass spectrometry of RNA</article-title>. <source>Trends Biochem Sci</source>. <year>2006</year>;<volume>31</volume>(<issue>3</issue>):<fpage>173</fpage>&#x02010;<lpage>181</lpage>.<pub-id pub-id-type="pmid">16483781</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0040"><label>40</label><mixed-citation publication-type="journal" id="ctm270239-cit-0040">
<string-name>
<surname>Th&#x000fc;ring</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Schmid</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Keller</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Helm</surname>
<given-names>M</given-names>
</string-name>. <article-title>Analysis of RNA modifications by liquid chromatography&#x02010;tandem mass spectrometry</article-title>. <source>Methods</source>. <year>2016</year>;<volume>107</volume>:<fpage>48</fpage>&#x02010;<lpage>56</lpage>.<pub-id pub-id-type="pmid">27020891</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0041"><label>41</label><mixed-citation publication-type="journal" id="ctm270239-cit-0041">
<string-name>
<surname>Th&#x000fc;ring</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Schmid</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Keller</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Helm</surname>
<given-names>M</given-names>
</string-name>. <article-title>LC&#x02010;MS analysis of methylated RNA</article-title>. <source>Methods Mol Biol</source>. <year>2017</year>;<volume>1562</volume>:<fpage>3</fpage>&#x02010;<lpage>18</lpage>.<pub-id pub-id-type="pmid">28349450</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0042"><label>42</label><mixed-citation publication-type="journal" id="ctm270239-cit-0042">
<string-name>
<surname>Zhang</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Shi</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Jia</surname>
<given-names>TZ</given-names>
</string-name>, et&#x000a0;al. <article-title>A general LC&#x02010;MS&#x02010;based RNA sequencing method for direct analysis of multiple&#x02010;base modifications in RNA mixtures</article-title>. <source>Nucleic Acids Res</source>. <year>2019</year>;<volume>47</volume>(<issue>20</issue>):<elocation-id>e125</elocation-id>.<pub-id pub-id-type="pmid">31504795</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0043"><label>43</label><mixed-citation publication-type="journal" id="ctm270239-cit-0043">
<string-name>
<surname>Wang</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Wei</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Feng</surname>
<given-names>L</given-names>
</string-name>, et&#x000a0;al. <article-title>Aberrant m5C hypermethylation mediates intrinsic resistance to gefitinib through NSUN2/YBX1/QSOX1 axis in EGFR&#x02010;mutant non&#x02010;small&#x02010;cell lung cancer</article-title>. <source>Mol Cancer</source>. <year>2023</year>;<volume>22</volume>(<issue>1</issue>):<fpage>81</fpage>.<pub-id pub-id-type="pmid">37161388</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0044"><label>44</label><mixed-citation publication-type="journal" id="ctm270239-cit-0044">
<string-name>
<surname>Yu</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Fan</surname>
<given-names>Q</given-names>
</string-name>, et&#x000a0;al. <article-title>mRNA 5&#x02010;methylcytosine in <italic toggle="yes">Eimeria tenella</italic> oocysts: an abundant post&#x02010;transcriptional modification associated with broad&#x02010;ranging biological processes</article-title>. <source>Int J Biol Macromol</source>. <year>2024</year>;<volume>280</volume>(<issue>pt 2</issue>):<elocation-id>135817</elocation-id>.<pub-id pub-id-type="pmid">39306157</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0045"><label>45</label><mixed-citation publication-type="journal" id="ctm270239-cit-0045">
<string-name>
<surname>Liao</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Gaur</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>McConie</surname>
<given-names>H</given-names>
</string-name>, et&#x000a0;al. <article-title>Human NOP2/NSUN1 regulates ribosome biogenesis through non&#x02010;catalytic complex formation with box C/D snoRNPs</article-title>. <source>Nucleic Acids Res</source>. <year>2022</year>;<volume>50</volume>(<issue>18</issue>):<fpage>10695</fpage>&#x02010;<lpage>10716</lpage>.<pub-id pub-id-type="pmid">36161484</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0046"><label>46</label><mixed-citation publication-type="journal" id="ctm270239-cit-0046">
<string-name>
<surname>Jenjaroenpun</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Wongsurawat</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Pereira</surname>
<given-names>R</given-names>
</string-name>, et&#x000a0;al. <article-title>Complete genomic and transcriptional landscape analysis using third&#x02010;generation sequencing: a case study of <italic toggle="yes">Saccharomyces cerevisiae</italic> CEN.PK113&#x02010;7D</article-title>. <source>Nucleic Acids Res</source>. <year>2018</year>;<volume>46</volume>(<issue>7</issue>):<elocation-id>e38</elocation-id>.<pub-id pub-id-type="pmid">29346625</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0047"><label>47</label><mixed-citation publication-type="journal" id="ctm270239-cit-0047">
<string-name>
<surname>Sun</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>B</given-names>
</string-name>, et&#x000a0;al. <article-title>DeepMRMP: a new predictor for multiple types of RNA modification sites using deep learning</article-title>. <source>Math Biosci Eng</source>. <year>2019</year>;<volume>16</volume>(<issue>6</issue>):<fpage>6231</fpage>&#x02010;<lpage>6241</lpage>.<pub-id pub-id-type="pmid">31698559</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0048"><label>48</label><mixed-citation publication-type="journal" id="ctm270239-cit-0048">
<string-name>
<surname>Li</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Huang</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Yang</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Zhou</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Zhou</surname>
<given-names>Y</given-names>
</string-name>. <article-title>RNAm5Cfinder: a web&#x02010;server for predicting RNA 5&#x02010;methylcytosine (m5C) sites based on random forest</article-title>. <source>Sci Rep</source>. <year>2018</year>;<volume>8</volume>(<issue>1</issue>):<elocation-id>17299</elocation-id>.<pub-id pub-id-type="pmid">30470762</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0049"><label>49</label><mixed-citation publication-type="journal" id="ctm270239-cit-0049">
<string-name>
<surname>Song</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Zhai</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Bian</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Song</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Yu</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Ma</surname>
<given-names>C</given-names>
</string-name>. <article-title>Transcriptome&#x02010;wide annotation of m(5)C RNA modifications using machine learning</article-title>. <source>Front Plant Sci</source>. <year>2018</year>;<volume>9</volume>:<fpage>519</fpage>.<pub-id pub-id-type="pmid">29720995</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0050"><label>50</label><mixed-citation publication-type="journal" id="ctm270239-cit-0050">
<string-name>
<surname>Chen</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Xiong</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Bi</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Zhu</surname>
<given-names>X</given-names>
</string-name>. <article-title>m5CPred&#x02010;SVM: a novel method for predicting m5C sites of RNA</article-title>. <source>BMC Bioinf</source>. <year>2020</year>;<volume>21</volume>(<issue>1</issue>):<fpage>489</fpage>.</mixed-citation></ref><ref id="ctm270239-bib-0051"><label>51</label><mixed-citation publication-type="journal" id="ctm270239-cit-0051">
<string-name>
<surname>Fang</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Sun</surname>
<given-names>R</given-names>
</string-name>, et&#x000a0;al. <article-title>RNAm5CPred: prediction of RNA 5&#x02010;methylcytosine sites based on three different kinds of nucleotide composition</article-title>. <source>Mol Ther Nucleic Acids</source>. <year>2019</year>;<volume>18</volume>:<fpage>739</fpage>&#x02010;<lpage>747</lpage>.<pub-id pub-id-type="pmid">31726390</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0052"><label>52</label><mixed-citation publication-type="journal" id="ctm270239-cit-0052">
<string-name>
<surname>Liu</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
</string-name>
<string-name>
<given-names>W</given-names>
</string-name>. <article-title>iMRM: a platform for simultaneously identifying multiple kinds of RNA modifications</article-title>. <source>Bioinformatics</source>. <year>2020</year>;<volume>36</volume>(<issue>11</issue>):<fpage>3336</fpage>&#x02010;<lpage>3342</lpage>.<pub-id pub-id-type="pmid">32134472</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0053"><label>53</label><mixed-citation publication-type="journal" id="ctm270239-cit-0053">
<string-name>
<surname>Xue</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Zhao</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>L</given-names>
</string-name>. <article-title>Advances in RNA cytosine&#x02010;5 methylation: detection, regulatory mechanisms, biological functions and links to cancer</article-title>. <source>Biomark Res</source>. <year>2020</year>;<volume>8</volume>(<issue>1</issue>):<fpage>43</fpage>.<pub-id pub-id-type="pmid">32944246</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0054"><label>54</label><mixed-citation publication-type="journal" id="ctm270239-cit-0054">
<string-name>
<surname>Zhang</surname>
<given-names>Q</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>W</given-names>
</string-name>, et&#x000a0;al. <article-title>The role of RNA m5C modification in cancer metastasis</article-title>. <source>Int J Biol Sci</source>. <year>2021</year>;<volume>17</volume>(<issue>13</issue>):<fpage>3369</fpage>&#x02010;<lpage>3380</lpage>.<pub-id pub-id-type="pmid">34512153</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0055"><label>55</label><mixed-citation publication-type="journal" id="ctm270239-cit-0055">
<string-name>
<surname>Gu</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Ma</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>C</given-names>
</string-name>, et&#x000a0;al. <article-title>Vital roles of m(5)C RNA modification in cancer and immune cell biology</article-title>. <source>Front Immunol</source>. <year>2023</year>;<volume>14</volume>:<elocation-id>1207371</elocation-id>.<pub-id pub-id-type="pmid">37325635</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0056"><label>56</label><mixed-citation publication-type="journal" id="ctm270239-cit-0056">
<string-name>
<surname>Han</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Zhao</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Yang</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Yang</surname>
<given-names>Y</given-names>
</string-name>. <article-title>RNA methylations in human cancers</article-title>. <source>Semin Cancer Biol</source>. <year>2021</year>;<volume>75</volume>:<fpage>97</fpage>&#x02010;<lpage>115</lpage>.<pub-id pub-id-type="pmid">33220459</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0057"><label>57</label><mixed-citation publication-type="journal" id="ctm270239-cit-0057">
<string-name>
<surname>Walbott</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Auxilien</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Grosjean</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Golinelli&#x02010;Pimpaneau</surname>
<given-names>B</given-names>
</string-name>. <article-title>The carboxyl&#x02010;terminal extension of yeast tRNA m5C methyltransferase enhances the catalytic efficiency of the amino&#x02010;terminal domain</article-title>. <source>J Biol Chem</source>. <year>2007</year>;<volume>282</volume>(<issue>32</issue>):<fpage>23663</fpage>&#x02010;<lpage>23671</lpage>.<pub-id pub-id-type="pmid">17567576</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0058"><label>58</label><mixed-citation publication-type="journal" id="ctm270239-cit-0058">
<string-name>
<surname>Govindaraju</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Jabeena</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Sethumadhavan</surname>
<given-names>DV</given-names>
</string-name>, <string-name>
<surname>Rajaram</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Rajavelu</surname>
<given-names>A</given-names>
</string-name>. <article-title>DNA methyltransferase homologue TRDMT1 in <italic toggle="yes">Plasmodium falciparum</italic> specifically methylates endogenous aspartic acid tRNA</article-title>. <source>Biochim Biophys Acta&#x02014;Gene Regulatory Mechanisms</source>. <year>2017</year>;<volume>1860</volume>(<issue>10</issue>):<fpage>1047</fpage>&#x02010;<lpage>1057</lpage>.</mixed-citation></ref><ref id="ctm270239-bib-0059"><label>59</label><mixed-citation publication-type="journal" id="ctm270239-cit-0059">
<string-name>
<surname>Schaefer</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Pollex</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Hanna</surname>
<given-names>K</given-names>
</string-name>, et&#x000a0;al. <article-title>RNA methylation by Dnmt2 protects transfer RNAs against stress&#x02010;induced cleavage</article-title>. <source>Genes Dev</source>. <year>2010</year>;<volume>24</volume>(<issue>15</issue>):<fpage>1590</fpage>&#x02010;<lpage>1595</lpage>.<pub-id pub-id-type="pmid">20679393</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0060"><label>60</label><mixed-citation publication-type="journal" id="ctm270239-cit-0060">
<string-name>
<surname>Goll</surname>
<given-names>MG</given-names>
</string-name>, <string-name>
<surname>Kirpekar</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Maggert</surname>
<given-names>KA</given-names>
</string-name>, et&#x000a0;al. <article-title>Methylation of tRNAAsp by the DNA methyltransferase homolog Dnmt2</article-title>. <source>Science</source>. <year>2006</year>;<volume>311</volume>(<issue>5759</issue>):<fpage>395</fpage>&#x02010;<lpage>398</lpage>.<pub-id pub-id-type="pmid">16424344</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0061"><label>61</label><mixed-citation publication-type="journal" id="ctm270239-cit-0061">
<string-name>
<surname>Tuorto</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Liebers</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Musch</surname>
<given-names>T</given-names>
</string-name>, et&#x000a0;al. <article-title>RNA cytosine methylation by Dnmt2 and NSun2 promotes tRNA stability and protein synthesis</article-title>. <source>Nat Struct Mol Biol</source>. <year>2012</year>;<volume>19</volume>(<issue>9</issue>):<fpage>900</fpage>&#x02010;<lpage>905</lpage>.<pub-id pub-id-type="pmid">22885326</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0062"><label>62</label><mixed-citation publication-type="journal" id="ctm270239-cit-0062">
<string-name>
<surname>Xue</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Xu</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Sun</surname>
<given-names>Z</given-names>
</string-name>, et&#x000a0;al. <article-title>Depletion of TRDMT1 affects 5&#x02010;methylcytosine modification of mRNA and inhibits HEK293 cell proliferation and migration</article-title>. <source>Biochem Biophys Res Commun</source>. <year>2019</year>;<volume>520</volume>(<issue>1</issue>):<fpage>60</fpage>&#x02010;<lpage>66</lpage>.<pub-id pub-id-type="pmid">31570165</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0063"><label>63</label><mixed-citation publication-type="journal" id="ctm270239-cit-0063">
<string-name>
<surname>Chellamuthu</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Gray</surname>
</string-name>
<string-name>
<given-names>S</given-names>
</string-name>. <article-title>The RNA methyltransferase NSUN2 and its potential roles in cancer</article-title>. <source>Cells</source>. <year>2020</year>;<volume>9</volume>(<issue>8</issue>):<fpage>1758</fpage>.<pub-id pub-id-type="pmid">32708015</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0064"><label>64</label><mixed-citation publication-type="journal" id="ctm270239-cit-0064">
<string-name>
<surname>Hussain</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Sajini</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Blanco</surname>
<given-names>S</given-names>
</string-name>, et&#x000a0;al. <article-title>NSun2&#x02010;mediated cytosine&#x02010;5 methylation of vault noncoding RNA determines its processing into regulatory small RNAs</article-title>. <source>Cell Rep</source>. <year>2013</year>;<volume>4</volume>(<issue>2</issue>):<fpage>255</fpage>&#x02010;<lpage>261</lpage>.<pub-id pub-id-type="pmid">23871666</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0065"><label>65</label><mixed-citation publication-type="journal" id="ctm270239-cit-0065">
<string-name>
<surname>Liu</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Santi</surname>
</string-name>
<string-name>
<given-names>D</given-names>
</string-name>. <article-title>m5C RNA and m5C DNA methyl transferases use different cysteine residues as catalysts</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>2000</year>;<volume>97</volume>(<issue>15</issue>):<fpage>8263</fpage>&#x02010;<lpage>8265</lpage>.<pub-id pub-id-type="pmid">10899996</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0066"><label>66</label><mixed-citation publication-type="journal" id="ctm270239-cit-0066">
<string-name>
<surname>Van Haute</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Lee</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>McCann</surname>
<given-names>BJ</given-names>
</string-name>, et&#x000a0;al. <article-title>NSUN2 introduces 5&#x02010;methylcytosines in mammalian mitochondrial tRNAs</article-title>. <source>Nucleic Acids Res</source>. <year>2019</year>;<volume>47</volume>(<issue>16</issue>):<fpage>8720</fpage>&#x02010;<lpage>8733</lpage>.<pub-id pub-id-type="pmid">31276587</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0067"><label>67</label><mixed-citation publication-type="journal" id="ctm270239-cit-0067">
<string-name>
<surname>Frye</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Watt</surname>
</string-name>
<string-name>
<given-names>F</given-names>
</string-name>. <article-title>The RNA methyltransferase misu (NSun2) mediates Myc&#x02010;induced proliferation and is upregulated in tumors</article-title>. <source>Curr Biol</source>. <year>2006</year>;<volume>16</volume>(<issue>10</issue>):<fpage>971</fpage>&#x02010;<lpage>981</lpage>.<pub-id pub-id-type="pmid">16713953</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0068"><label>68</label><mixed-citation publication-type="journal" id="ctm270239-cit-0068">
<string-name>
<surname>Sun</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Xue</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Xu</surname>
<given-names>H</given-names>
</string-name>, et&#x000a0;al. <article-title>Effects of NSUN2 deficiency on the mRNA 5&#x02010;methylcytosine modification and gene expression profile in HEK293 cells</article-title>. <source>Epigenomics</source>. <year>2019</year>;<volume>11</volume>(<issue>4</issue>):<fpage>439</fpage>&#x02010;<lpage>453</lpage>.<pub-id pub-id-type="pmid">30526041</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0069"><label>69</label><mixed-citation publication-type="journal" id="ctm270239-cit-0069">
<string-name>
<surname>Mei</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Shen</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Miao</surname>
<given-names>R</given-names>
</string-name>, et&#x000a0;al. <article-title>RNA methyltransferase NSUN2 promotes gastric cancer cell proliferation by repressing p57Kip2 by an m5C&#x02010;dependent manner</article-title>. <source>Cell Death Dis</source>. <year>2020</year>;<volume>11</volume>(<issue>4</issue>):<fpage>270</fpage>.<pub-id pub-id-type="pmid">32332707</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0070"><label>70</label><mixed-citation publication-type="journal" id="ctm270239-cit-0070">
<string-name>
<surname>Hu</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Tong</surname>
<given-names>X</given-names>
</string-name>, et&#x000a0;al. <article-title>NSUN2 modified by SUMO&#x02010;2/3 promotes gastric cancer progression and regulates mRNA m5C methylation</article-title>. <source>Cell Death Dis</source>. <year>2021</year>;<volume>12</volume>(<issue>9</issue>):<fpage>495</fpage>.<pub-id pub-id-type="pmid">33993198</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0071"><label>71</label><mixed-citation publication-type="journal" id="ctm270239-cit-0071">
<string-name>
<surname>Su</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Wu</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Ye</surname>
<given-names>Y</given-names>
</string-name>, et&#x000a0;al. <article-title>NSUN2&#x02010;mediated RNA 5&#x02010;methylcytosine promotes esophageal squamous cell carcinoma progression via LIN28B&#x02010;dependent GRB2 mRNA stabilization</article-title>. <source>Oncogene</source>. <year>2021</year>;<volume>40</volume>(<issue>39</issue>):<fpage>5814</fpage>&#x02010;<lpage>5828</lpage>.<pub-id pub-id-type="pmid">34345012</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0072"><label>72</label><mixed-citation publication-type="journal" id="ctm270239-cit-0072">
<string-name>
<surname>Sun</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Xue</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>M</given-names>
</string-name>, et&#x000a0;al. <article-title>Aberrant NSUN2&#x02010;mediated m5C modification of H19 lncRNA is associated with poor differentiation of hepatocellular carcinoma</article-title>. <source>Oncogene</source>. <year>2020</year>;<volume>39</volume>(<issue>45</issue>):<fpage>6906</fpage>&#x02010;<lpage>6919</lpage>.<pub-id pub-id-type="pmid">32978516</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0073"><label>73</label><mixed-citation publication-type="journal" id="ctm270239-cit-0073">
<string-name>
<surname>Chen</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Ding</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>B</given-names>
</string-name>, et&#x000a0;al. <article-title>RNA methyltransferase NSUN2 promotes hypopharyngeal squamous cell carcinoma proliferation and migration by enhancing TEAD1 expression in an m5C&#x02010;dependent manner</article-title>. <source>Exp Cell Res</source>. <year>2021</year>;<volume>404</volume>(<issue>2</issue>):<elocation-id>112664</elocation-id>.<pub-id pub-id-type="pmid">34048786</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0074"><label>74</label><mixed-citation publication-type="journal" id="ctm270239-cit-0074">
<string-name>
<surname>Zhu</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Wan</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Xu</surname>
<given-names>W</given-names>
</string-name>, et&#x000a0;al. <article-title>Positive epigenetic regulation loop between AR and NSUN2 promotes prostate cancer progression</article-title>. <source>Clin Transl Med</source>. <year>2022</year>;<volume>12</volume>(<issue>9</issue>):<elocation-id>e1028</elocation-id>.<pub-id pub-id-type="pmid">36169095</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0075"><label>75</label><mixed-citation publication-type="journal" id="ctm270239-cit-0075">
<string-name>
<surname>Wang</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Su</surname>
<given-names>Y</given-names>
</string-name>, et&#x000a0;al. <article-title>Distinct roles of m5C RNA methyltransferase NSUN2 in major gynecologic cancers</article-title>. <source>Front Oncol</source>. <year>2022</year>;<volume>12</volume>:<elocation-id>786266</elocation-id>.<pub-id pub-id-type="pmid">35280737</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0076"><label>76</label><mixed-citation publication-type="journal" id="ctm270239-cit-0076">
<string-name>
<surname>Tong</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Xiang</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Hu</surname>
<given-names>Y</given-names>
</string-name>, et&#x000a0;al. <article-title>NSUN2 promotes tumor progression and regulates immune infiltration in nasopharyngeal carcinoma</article-title>. <source>Front Oncol</source>. <year>2022</year>;<volume>12</volume>:<elocation-id>788801</elocation-id>.<pub-id pub-id-type="pmid">35574373</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0077"><label>77</label><mixed-citation publication-type="journal" id="ctm270239-cit-0077">
<string-name>
<surname>Luo</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Xu</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>X</given-names>
</string-name>, et&#x000a0;al. <article-title>NSUN2&#x02010;mediated RNA m5C modification modulates uveal melanoma cell proliferation and migration</article-title>. <source>Epigenetics</source>. <year>2022</year>;<volume>17</volume>(<issue>8</issue>):<fpage>922</fpage>&#x02010;<lpage>933</lpage>.<pub-id pub-id-type="pmid">35757999</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0078"><label>78</label><mixed-citation publication-type="journal" id="ctm270239-cit-0078">
<string-name>
<surname>Khan</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Rafiq</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Noor</surname>
<given-names>A</given-names>
</string-name>, et&#x000a0;al. <article-title>Mutation in NSUN2, which encodes an RNA methyltransferase, causes autosomal&#x02010;recessive intellectual disability</article-title>. <source>Am Hum Genet</source>. <year>2012</year>;<volume>90</volume>(<issue>5</issue>):<fpage>856</fpage>&#x02010;<lpage>863</lpage>.</mixed-citation></ref><ref id="ctm270239-bib-0079"><label>79</label><mixed-citation publication-type="journal" id="ctm270239-cit-0079">
<string-name>
<surname>Gkatza</surname>
<given-names>NA</given-names>
</string-name>, <string-name>
<surname>Castro</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Harvey</surname>
<given-names>RF</given-names>
</string-name>, et&#x000a0;al. <article-title>Cytosine&#x02010;5 RNA methylation links protein synthesis to cell metabolism</article-title>. <source>PLoS Biol</source>. <year>2019</year>;<volume>17</volume>(<issue>6</issue>):<elocation-id>e3000297</elocation-id>.<pub-id pub-id-type="pmid">31199786</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0080"><label>80</label><mixed-citation publication-type="journal" id="ctm270239-cit-0080">
<string-name>
<surname>Courtney</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Tsai</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Bogerd</surname>
<given-names>HP</given-names>
</string-name>, et&#x000a0;al. <article-title>Epitranscriptomic addition of m5C to HIV&#x02010;1 transcripts regulates viral gene expression</article-title>. <source>Cell Host Microbe</source>. <year>2019</year>;<volume>26</volume>(<issue>2</issue>):<fpage>217</fpage>&#x02010;<lpage>227.e6</lpage>.<pub-id pub-id-type="pmid">31415754</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0081"><label>81</label><mixed-citation publication-type="journal" id="ctm270239-cit-0081">
<string-name>
<surname>Cheng</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>Y</given-names>
</string-name>, et&#x000a0;al. <article-title>RNA cytosine methylation and methyltransferases mediate chromatin organization and 5&#x02010;azacytidine response and resistance in leukaemia</article-title>. <source>Nat Commun</source>. <year>2018</year>;<volume>9</volume>(<issue>1</issue>):<fpage>2286</fpage>.<pub-id pub-id-type="pmid">29875356</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0082"><label>82</label><mixed-citation publication-type="journal" id="ctm270239-cit-0082">
<string-name>
<surname>Henry</surname>
<given-names>BA</given-names>
</string-name>, <string-name>
<surname>Kanarek</surname>
<given-names>JP</given-names>
</string-name>, <string-name>
<surname>Kotter</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Helm</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Lee</surname>
<given-names>N</given-names>
</string-name>. <article-title>5&#x02010;methylcytosine modification of an Epstein&#x02012;Barr virus noncoding RNA decreases its stability</article-title>. <source>RNA</source>. <year>2020</year>;<volume>26</volume>(<issue>8</issue>):<fpage>1038</fpage>&#x02010;<lpage>1048</lpage>.<pub-id pub-id-type="pmid">32354721</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0083"><label>83</label><mixed-citation publication-type="journal" id="ctm270239-cit-0083">
<string-name>
<surname>Li</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Meng</surname>
<given-names>Y</given-names>
</string-name>. <article-title>Expression and prognostic characteristics of m(5) C regulators in low&#x02010;grade glioma</article-title>. <source>J Cell Mol Med</source>. <year>2021</year>;<volume>25</volume>(<issue>3</issue>):<fpage>1383</fpage>&#x02010;<lpage>1393</lpage>.<pub-id pub-id-type="pmid">33400376</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0084"><label>84</label><mixed-citation publication-type="journal" id="ctm270239-cit-0084">
<string-name>
<surname>Jin</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Shen</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Wu</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Ma</surname>
<given-names>H</given-names>
</string-name>. <article-title>RNA 5&#x02010;methylcytosine regulator NSUN3 promotes tumor progression through regulating immune infiltration in head and neck squamous cell carcinoma</article-title>. <source>Oral Dis</source>. <year>2022</year>;<volume>30</volume>(<issue>2</issue>):<fpage>313</fpage>&#x02010;<lpage>328</lpage>.<pub-id pub-id-type="pmid">35997137</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0085"><label>85</label><mixed-citation publication-type="journal" id="ctm270239-cit-0085">
<string-name>
<surname>Pan</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Huang</surname>
</string-name>
<string-name>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Xu</surname>
</string-name>
<string-name>
<given-names>Y</given-names>
</string-name>. <article-title>m5C RNA methylation regulators predict prognosis and regulate the immune microenvironment in lung squamous cell carcinoma</article-title>. <source>Front Oncol</source>. <year>2021</year>;<volume>11</volume>:<elocation-id>657466</elocation-id>.<pub-id pub-id-type="pmid">34195072</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0086"><label>86</label><mixed-citation publication-type="journal" id="ctm270239-cit-0086">
<string-name>
<surname>Paramasivam</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Meena</surname>
<given-names>AK</given-names>
</string-name>, <string-name>
<surname>Venkatapathi</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Pitceathly</surname>
<given-names>RD</given-names>
</string-name>, <string-name>
<surname>Thangaraj</surname>
<given-names>K</given-names>
</string-name>. <article-title>Novel biallelic NSUN3 variants cause early&#x02010;onset mitochondrial encephalomyopathy and seizures</article-title>. <source>J Mol Neurosci</source>. <year>2020</year>;<volume>70</volume>(<issue>12</issue>):<fpage>1962</fpage>&#x02010;<lpage>1965</lpage>.<pub-id pub-id-type="pmid">32488845</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0087"><label>87</label><mixed-citation publication-type="journal" id="ctm270239-cit-0087">
<string-name>
<surname>Van Haute</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Dietmann</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Kremer</surname>
<given-names>L</given-names>
</string-name>, et&#x000a0;al. <article-title>Deficient methylation and formylation of mt&#x02010;tRNA(Met) wobble cytosine in a patient carrying mutations in NSUN3</article-title>. <source>Nat Commun</source>. <year>2016</year>;<volume>7</volume>:<elocation-id>12039</elocation-id>.<pub-id pub-id-type="pmid">27356879</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0088"><label>88</label><mixed-citation publication-type="journal" id="ctm270239-cit-0088">
<string-name>
<surname>Nakano</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Suzuki</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Kawarada</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Iwata</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Asano</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Suzuki</surname>
<given-names>T</given-names>
</string-name>. <article-title>NSUN3 methylase initiates 5&#x02010;formylcytidine biogenesis in human mitochondrial tRNA(Met)</article-title>. <source>Nat Chem Biol</source>. <year>2016</year>;<volume>12</volume>(<issue>7</issue>):<fpage>546</fpage>&#x02010;<lpage>551</lpage>.<pub-id pub-id-type="pmid">27214402</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0089"><label>89</label><mixed-citation publication-type="journal" id="ctm270239-cit-0089">
<string-name>
<surname>Metodiev</surname>
<given-names>MD</given-names>
</string-name>, <string-name>
<surname>Sp&#x000e5;hr</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Loguercio Polosa</surname>
<given-names>P</given-names>
</string-name>, et&#x000a0;al. <article-title>NSUN4 is a dual function mitochondrial protein required for both methylation of 12S rRNA and coordination of mitoribosomal assembly</article-title>. <source>PLoS Genet</source>. <year>2014</year>;<volume>10</volume>(<issue>2</issue>):<elocation-id>e1004110</elocation-id>.<pub-id pub-id-type="pmid">24516400</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0090"><label>90</label><mixed-citation publication-type="journal" id="ctm270239-cit-0090">
<string-name>
<surname>Navarro</surname>
<given-names>IC</given-names>
</string-name>, <string-name>
<surname>Tuorto</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Jordan</surname>
<given-names>D</given-names>
</string-name>, et&#x000a0;al. <article-title>Translational adaptation to heat stress is mediated by RNA 5&#x02010;methylcytosine in <italic toggle="yes">Caenorhabditis elegans</italic>
</article-title>. <source>Embo J</source>. <year>2021</year>;<volume>40</volume>(<issue>6</issue>):<elocation-id>e105496</elocation-id>.<pub-id pub-id-type="pmid">33283887</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0091"><label>91</label><mixed-citation publication-type="journal" id="ctm270239-cit-0091">
<string-name>
<surname>Cui</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Qu</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>L</given-names>
</string-name>, et&#x000a0;al. <article-title>m5C RNA methyltransferase&#x02010;related gene NSUN4 stimulates malignant progression of hepatocellular carcinoma and can be a prognostic marker</article-title>. <source>Cancer Biomark</source>. <year>2022</year>;<volume>33</volume>(<issue>3</issue>):<fpage>389</fpage>&#x02010;<lpage>400</lpage>.<pub-id pub-id-type="pmid">34744073</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0092"><label>92</label><mixed-citation publication-type="journal" id="ctm270239-cit-0092">
<string-name>
<surname>He</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Yu</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>Q</given-names>
</string-name>, <string-name>
<surname>Zheng</surname>
<given-names>Q</given-names>
</string-name>, <string-name>
<surname>Guo</surname>
<given-names>W</given-names>
</string-name>. <article-title>Role of m(5)C&#x02010;related regulatory genes in the diagnosis and prognosis of hepatocellular carcinoma</article-title>. <source>Am J Transl Res</source>. <year>2020</year>;<volume>12</volume>(<issue>3</issue>):<fpage>912</fpage>&#x02010;<lpage>922</lpage>.<pub-id pub-id-type="pmid">32269723</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0093"><label>93</label><mixed-citation publication-type="journal" id="ctm270239-cit-0093">
<string-name>
<surname>Heissenberger</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Liendl</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Nagelreiter</surname>
<given-names>F</given-names>
</string-name>, et&#x000a0;al. <article-title>Loss of the ribosomal RNA methyltransferase NSUN5 impairs global protein synthesis and normal growth</article-title>. <source>Nucleic Acids Res</source>. <year>2019</year>;<volume>47</volume>(<issue>22</issue>):<fpage>11807</fpage>&#x02010;<lpage>11825</lpage>.<pub-id pub-id-type="pmid">31722427</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0094"><label>94</label><mixed-citation publication-type="journal" id="ctm270239-cit-0094">
<string-name>
<surname>Burgess</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>David</surname>
</string-name>
<string-name>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Searle</surname>
</string-name>
<string-name>
<given-names>I</given-names>
</string-name>. <article-title>Conservation of tRNA and rRNA 5&#x02010;methylcytosine in the kingdom Plantae</article-title>. <source>BMC Plant Biol</source>. <year>2015</year>;<volume>15</volume>:<fpage>199</fpage>.<pub-id pub-id-type="pmid">26268215</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0095"><label>95</label><mixed-citation publication-type="journal" id="ctm270239-cit-0095">
<string-name>
<surname>Zhang</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Wu</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>H</given-names>
</string-name>, et&#x000a0;al. <article-title>NSUN5 promotes progression and predicts poor prognosis in hepatocellular carcinoma</article-title>. <source>Oncol Lett</source>. <year>2022</year>;<volume>24</volume>(<issue>6</issue>):<fpage>439</fpage>.<pub-id pub-id-type="pmid">36420066</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0096"><label>96</label><mixed-citation publication-type="journal" id="ctm270239-cit-0096">
<string-name>
<surname>Yin</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Huang</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Niu</surname>
<given-names>S</given-names>
</string-name>, et&#x000a0;al. <article-title>5&#x02010;Methylcytosine (m(5)C) modification in peripheral blood immune cells is a novel non&#x02010;invasive biomarker for colorectal cancer diagnosis</article-title>. <source>Front Immunol</source>. <year>2022</year>;<volume>13</volume>:<elocation-id>967921</elocation-id>.<pub-id pub-id-type="pmid">36211353</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0097"><label>97</label><mixed-citation publication-type="journal" id="ctm270239-cit-0097">
<string-name>
<surname>Wang</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Jiang</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Xu</surname>
<given-names>J</given-names>
</string-name>, et&#x000a0;al. <article-title>Mutations in RNA methyltransferase gene NSUN5 confer high risk of outflow tract malformation</article-title>. <source>Front Cell Dev Biol</source>. <year>2021</year>;<volume>9</volume>:<elocation-id>623394</elocation-id>.<pub-id pub-id-type="pmid">33968922</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0098"><label>98</label><mixed-citation publication-type="journal" id="ctm270239-cit-0098">
<string-name>
<surname>Sharma</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Yang</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Watzinger</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>K&#x000f6;tter</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Entian</surname>
<given-names>K</given-names>
</string-name>. <article-title>Yeast Nop2 and Rcm1 methylate C2870 and C2278 of the 25S rRNA, respectively</article-title>. <source>Nucleic Acids Res</source>. <year>2013</year>;<volume>41</volume>(<issue>19</issue>):<fpage>9062</fpage>&#x02010;<lpage>9076</lpage>.<pub-id pub-id-type="pmid">23913415</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0099"><label>99</label><mixed-citation publication-type="journal" id="ctm270239-cit-0099">
<string-name>
<surname>Haag</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Warda</surname>
<given-names>AS</given-names>
</string-name>, <string-name>
<surname>Kretschmer</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>G&#x000fc;nnigmann</surname>
<given-names>MA</given-names>
</string-name>, <string-name>
<surname>H&#x000f6;bartner</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Bohnsack</surname>
<given-names>MT</given-names>
</string-name>. <article-title>NSUN6 is a human RNA methyltransferase that catalyzes formation of m5C72 in specific tRNAs</article-title>. <source>RNA</source>. <year>2015</year>;<volume>21</volume>(<issue>9</issue>):<fpage>1532</fpage>&#x02010;<lpage>1543</lpage>.<pub-id pub-id-type="pmid">26160102</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0100"><label>100</label><mixed-citation publication-type="journal" id="ctm270239-cit-0100">
<string-name>
<surname>Long</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>H</given-names>
</string-name>, et&#x000a0;al. <article-title>Sequence&#x02010;specific and shape&#x02010;selective RNA recognition by the human RNA 5&#x02010;methylcytosine methyltransferase NSun6</article-title>. <source>J Biol Chem</source>. <year>2016</year>;<volume>291</volume>(<issue>46</issue>):<fpage>24293</fpage>&#x02010;<lpage>24303</lpage>.<pub-id pub-id-type="pmid">27703015</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0101"><label>101</label><mixed-citation publication-type="journal" id="ctm270239-cit-0101">
<string-name>
<surname>Selmi</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Hussain</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Dietmann</surname>
<given-names>S</given-names>
</string-name>, et&#x000a0;al. <article-title>Sequence&#x02010; and structure&#x02010;specific cytosine&#x02010;5 mRNA methylation by NSUN6</article-title>. <source>Nucleic Acids Res</source>. <year>2021</year>;<volume>49</volume>(<issue>2</issue>):<fpage>1006</fpage>&#x02010;<lpage>1022</lpage>.<pub-id pub-id-type="pmid">33330931</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0102"><label>102</label><mixed-citation publication-type="journal" id="ctm270239-cit-0102">
<string-name>
<surname>Huang</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Pan</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>H</given-names>
</string-name>, et&#x000a0;al. <article-title>Prognostic significance and tumor immune microenvironment heterogenicity of m5C RNA methylation regulators in triple&#x02010;negative breast cancer</article-title>. <source>Front Cell Dev Biol</source>. <year>2021</year>;<volume>9</volume>:<elocation-id>657547</elocation-id>.<pub-id pub-id-type="pmid">33928086</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0103"><label>103</label><mixed-citation publication-type="journal" id="ctm270239-cit-0103">
<string-name>
<surname>Yang</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Liang</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>H</given-names>
</string-name>, et&#x000a0;al. <article-title>The RNA methyltransferase NSUN6 suppresses pancreatic cancer development by regulating cell proliferation</article-title>. <source>EBioMedicine</source>. <year>2021</year>;<volume>63</volume>:<elocation-id>103195</elocation-id>.<pub-id pub-id-type="pmid">33418496</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0104"><label>104</label><mixed-citation publication-type="journal" id="ctm270239-cit-0104">
<string-name>
<surname>Fang</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Miao</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Zeng</surname>
<given-names>T</given-names>
</string-name>, et&#x000a0;al. <article-title>Role of m(5) C RNA methylation regulators in colorectal cancer prognosis and immune microenvironment</article-title>. <source>J Clin Lab Anal</source>. <year>2022</year>;<volume>36</volume>(<issue>4</issue>):<elocation-id>e24303</elocation-id>.<pub-id pub-id-type="pmid">35212022</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0105"><label>105</label><mixed-citation publication-type="journal" id="ctm270239-cit-0105">
<string-name>
<surname>Huang</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Huang</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Jiang</surname>
<given-names>X</given-names>
</string-name>, et&#x000a0;al. <article-title>Exploration of potential roles of m5C&#x02010;related regulators in colon adenocarcinoma prognosis</article-title>. <source>Front Genet</source>. <year>2022</year>;<volume>13</volume>:<elocation-id>816173</elocation-id>.<pub-id pub-id-type="pmid">35281843</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0106"><label>106</label><mixed-citation publication-type="journal" id="ctm270239-cit-0106">
<string-name>
<surname>Wang</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Huang</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Jiang</surname>
<given-names>H</given-names>
</string-name>, et&#x000a0;al. <article-title>A cross&#x02010;tissue investigation of molecular targets and physiological functions of Nsun6 using knockout mice</article-title>. <source>Int J Mol Sci</source>. <year>2022</year>:<volume>23</volume>(<issue>12</issue>):<fpage>6584</fpage>.<pub-id pub-id-type="pmid">35743028</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0107"><label>107</label><mixed-citation publication-type="journal" id="ctm270239-cit-0107">
<string-name>
<surname>Aguilo</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Balasubramaniyan</surname>
<given-names>N</given-names>
</string-name>, et&#x000a0;al. <article-title>Deposition of 5&#x02010;methylcytosine on enhancer RNAs enables the coactivator function of PGC&#x02010;1&#x003b1;</article-title>. <source>Cell Rep</source>. <year>2016</year>;<volume>14</volume>(<issue>3</issue>):<fpage>479</fpage>&#x02010;<lpage>492</lpage>.<pub-id pub-id-type="pmid">26774474</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0108"><label>108</label><mixed-citation publication-type="journal" id="ctm270239-cit-0108">
<string-name>
<surname>Seethy</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Pethusamy</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Chattopadhyay</surname>
<given-names>I</given-names>
</string-name>, et&#x000a0;al. <article-title>TETology: epigenetic mastermind in action</article-title>. <source>Appl Biochem Biotechnol</source>. <year>2021</year>;<volume>193</volume>(<issue>6</issue>):<fpage>1701</fpage>&#x02010;<lpage>1726</lpage>.<pub-id pub-id-type="pmid">33694104</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0109"><label>109</label><mixed-citation publication-type="journal" id="ctm270239-cit-0109">
<string-name>
<surname>Yang</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Xiang</surname>
<given-names>Y</given-names>
</string-name>, et&#x000a0;al. <article-title>FMRP promotes transcription&#x02010;coupled homologous recombination via facilitating TET1&#x02010;mediated m5C RNA modification demethylation</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>2022</year>;<volume>119</volume>(<issue>12</issue>):<elocation-id>e2116251119</elocation-id>.<pub-id pub-id-type="pmid">35290126</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0110"><label>110</label><mixed-citation publication-type="journal" id="ctm270239-cit-0110">
<string-name>
<surname>Shen</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Ontiveros</surname>
<given-names>RJ</given-names>
</string-name>, <string-name>
<surname>Owens</surname>
<given-names>MC</given-names>
</string-name>, et&#x000a0;al. <article-title>TET&#x02010;mediated 5&#x02010;methylcytosine oxidation in tRNA promotes translation</article-title>. <source>J Biol Chem</source>. <year>2021</year>;<volume>296</volume>:<elocation-id>100087</elocation-id>.<pub-id pub-id-type="pmid">33199375</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0111"><label>111</label><mixed-citation publication-type="journal" id="ctm270239-cit-0111">
<string-name>
<surname>Arguello</surname>
<given-names>AE</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Sun</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Eggert</surname>
<given-names>TW</given-names>
</string-name>, <string-name>
<surname>Mairhofer</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Kleiner</surname>
<given-names>RE</given-names>
</string-name>. <article-title>Reactivity&#x02010;dependent profiling of RNA 5&#x02010;methylcytidine dioxygenases</article-title>. <source>Nat Commun</source>. <year>2022</year>;<volume>13</volume>(<issue>1</issue>):<fpage>4176</fpage>.<pub-id pub-id-type="pmid">35853884</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0112"><label>112</label><mixed-citation publication-type="journal" id="ctm270239-cit-0112">
<string-name>
<surname>Fu</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Guerrero</surname>
<given-names>CR</given-names>
</string-name>, <string-name>
<surname>Zhong</surname>
<given-names>N</given-names>
</string-name>, et&#x000a0;al. <article-title>Tet&#x02010;mediated formation of 5&#x02010;hydroxymethylcytosine in RNA</article-title>. <source>J Am Chem Soc</source>. <year>2014</year>;<volume>136</volume>(<issue>33</issue>):<fpage>11582</fpage>&#x02010;<lpage>11585</lpage>.<pub-id pub-id-type="pmid">25073028</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0113"><label>113</label><mixed-citation publication-type="journal" id="ctm270239-cit-0113">
<string-name>
<surname>Huang</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Liang</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Yang</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Cui</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>C</given-names>
</string-name>. <article-title>Loss of nuclear localization of TET2 in colorectal cancer</article-title>. <source>Clin Epigenetics</source>. <year>2016</year>;<volume>8</volume>:<fpage>9</fpage>.<pub-id pub-id-type="pmid">26816554</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0114"><label>114</label><mixed-citation publication-type="journal" id="ctm270239-cit-0114">
<string-name>
<surname>Chen</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Yang</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Zhao</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Yang</surname>
<given-names>Y</given-names>
</string-name>. <article-title>Dynamic transcriptomic m(5) C and its regulatory role in RNA processing</article-title>. <source>Wiley Interdiscip Rev RNA</source>. <year>2021</year>;<volume>12</volume>(<issue>4</issue>):<elocation-id>e1639</elocation-id>.<pub-id pub-id-type="pmid">33438329</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0115"><label>115</label><mixed-citation publication-type="journal" id="ctm270239-cit-0115">
<string-name>
<surname>Kawarada</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Suzuki</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Ohira</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Hirata</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Miyauchi</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Suzuki</surname>
<given-names>T</given-names>
</string-name>. <article-title>ALKBH1 is an RNA dioxygenase responsible for cytoplasmic and mitochondrial tRNA modifications</article-title>. <source>Nucleic Acids Res</source>. <year>2017</year>;<volume>45</volume>(<issue>12</issue>):<fpage>7401</fpage>&#x02010;<lpage>7415</lpage>.<pub-id pub-id-type="pmid">28472312</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0116"><label>116</label><mixed-citation publication-type="journal" id="ctm270239-cit-0116">
<string-name>
<surname>Ougland</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Jonson</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Moen</surname>
<given-names>MN</given-names>
</string-name>, et&#x000a0;al. <article-title>Role of ALKBH1 in the core transcriptional network of embryonic stem cells</article-title>. <source>Cell Physiol Biochem</source>. <year>2016</year>;<volume>38</volume>(<issue>1</issue>):<fpage>173</fpage>&#x02010;<lpage>184</lpage>.<pub-id pub-id-type="pmid">26765775</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0117"><label>117</label><mixed-citation publication-type="journal" id="ctm270239-cit-0117">
<string-name>
<surname>Liu</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Clark</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Luo</surname>
<given-names>G</given-names>
</string-name>, et&#x000a0;al. <article-title>ALKBH1&#x02010;mediated tRNA demethylation regulates translation</article-title>. <source>Cell</source>. <year>2016</year>;<volume>167</volume>(<issue>3</issue>):816&#x02010;828 e16.</mixed-citation></ref><ref id="ctm270239-bib-0118"><label>118</label><mixed-citation publication-type="journal" id="ctm270239-cit-0118">
<string-name>
<surname>Klec</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Knutsen</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Schwarzenbacher</surname>
<given-names>D</given-names>
</string-name>, et&#x000a0;al. <article-title>ALYREF, a novel factor involved in breast carcinogenesis, acts through transcriptional and post&#x02010;transcriptional mechanisms selectively regulating the short NEAT1 isoform</article-title>. <source>Cell Mol Life Sci</source>. <year>2022</year>;<volume>79</volume>(<issue>7</issue>):<fpage>391</fpage>.<pub-id pub-id-type="pmid">35776213</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0119"><label>119</label><mixed-citation publication-type="journal" id="ctm270239-cit-0119">
<string-name>
<surname>Fan</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Kuai</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Wu</surname>
<given-names>G</given-names>
</string-name>, et&#x000a0;al. <article-title>Exosome cofactor hMTR4 competes with export adaptor ALYREF to ensure balanced nuclear RNA pools for degradation and export</article-title>. <source>Embo J</source>. <year>2017</year>;<volume>36</volume>(<issue>19</issue>):<fpage>2870</fpage>&#x02010;<lpage>2886</lpage>.<pub-id pub-id-type="pmid">28801509</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0120"><label>120</label><mixed-citation publication-type="journal" id="ctm270239-cit-0120">
<string-name>
<surname>Cusenza</surname>
<given-names>VY</given-names>
</string-name>, <string-name>
<surname>Tameni</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Neri</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Frazzi</surname>
<given-names>R</given-names>
</string-name>. <article-title>The lncRNA epigenetics: the significance of m6A and m5C lncRNA modifications in cancer</article-title>. <source>Front Oncol</source>. <year>2023</year>;<volume>13</volume>:<elocation-id>1063636</elocation-id>.<pub-id pub-id-type="pmid">36969033</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0121"><label>121</label><mixed-citation publication-type="journal" id="ctm270239-cit-0121">
<string-name>
<surname>Song</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>B</given-names>
</string-name>, et&#x000a0;al. <article-title>Biological roles of RNA m5C modification and its implications in cancer immunotherapy</article-title>. <source>Biomark Res</source>. <year>2022</year>;<volume>10</volume>(<issue>1</issue>):<fpage>15</fpage>.<pub-id pub-id-type="pmid">35365216</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0122"><label>122</label><mixed-citation publication-type="journal" id="ctm270239-cit-0122">
<string-name>
<surname>Lyabin</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Eliseeva</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Ovchinnikov</surname>
<given-names>L</given-names>
</string-name>. <article-title>YB&#x02010;1 protein: functions and regulation</article-title>. <source>Wiley Interdiscip Rev RNA</source>. <year>2014</year>;<volume>5</volume>(<issue>1</issue>):<fpage>95</fpage>&#x02010;<lpage>110</lpage>.<pub-id pub-id-type="pmid">24217978</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0123"><label>123</label><mixed-citation publication-type="journal" id="ctm270239-cit-0123">
<string-name>
<surname>Yang</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Han</surname>
<given-names>X</given-names>
</string-name>, et&#x000a0;al. <article-title>RNA 5&#x02010;methylcytosine facilitates the maternal&#x02010;to&#x02010;zygotic transition by preventing maternal mRNA decay</article-title>. <source>Mol Cell</source>. <year>2019</year>;<volume>75</volume>(<issue>6</issue>):<fpage>1188</fpage>&#x02010;<lpage>1202.e11</lpage>.<pub-id pub-id-type="pmid">31399345</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0124"><label>124</label><mixed-citation publication-type="journal" id="ctm270239-cit-0124">
<string-name>
<surname>Mansfield</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Wilhelm</surname>
</string-name>
<string-name>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Hazelrigg</surname>
</string-name>
<string-name>
<given-names>T</given-names>
</string-name>. <article-title>Ypsilon Schachtel, a Drosophila Y&#x02010;box protein, acts antagonistically to Orb in the oskar mRNA localization and translation pathway</article-title>. <source>Development</source>. <year>2002</year>;<volume>129</volume>(<issue>1</issue>):<fpage>197</fpage>&#x02010;<lpage>209</lpage>.<pub-id pub-id-type="pmid">11782413</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0125"><label>125</label><mixed-citation publication-type="journal" id="ctm270239-cit-0125">
<string-name>
<surname>Tatomer</surname>
<given-names>DC</given-names>
</string-name>, <string-name>
<surname>Rizzardi</surname>
<given-names>LF</given-names>
</string-name>, <string-name>
<surname>Curry</surname>
<given-names>KP</given-names>
</string-name>, <string-name>
<surname>Witkowski</surname>
<given-names>AM</given-names>
</string-name>, <string-name>
<surname>Marzluff</surname>
<given-names>WF</given-names>
</string-name>, <string-name>
<surname>Duronio</surname>
<given-names>RJ</given-names>
</string-name>. <article-title>Drosophila Symplekin localizes dynamically to the histone locus body and tricellular junctions</article-title>. <source>Nucleus</source>. <year>2014</year>;<volume>5</volume>(<issue>6</issue>):<fpage>613</fpage>&#x02010;<lpage>625</lpage>.<pub-id pub-id-type="pmid">25493544</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0126"><label>126</label><mixed-citation publication-type="journal" id="ctm270239-cit-0126">
<string-name>
<surname>Chen</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Huang</surname>
</string-name>
<string-name>
<given-names>M</given-names>
</string-name>. <article-title>Oncometabolites in cancer: from cancer cells to the tumor microenvironment</article-title>. <source>Holistic Integrative Oncol</source>. <year>2024</year>;<volume>3</volume>(<issue>1</issue>):<fpage>26</fpage>.</mixed-citation></ref><ref id="ctm270239-bib-0127"><label>127</label><mixed-citation publication-type="journal" id="ctm270239-cit-0127">
<string-name>
<surname>Ren</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Tang</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Lee</surname>
<given-names>JJ</given-names>
</string-name>, et&#x000a0;al. <article-title>Expression of hepatoma&#x02010;derived growth factor is a strong prognostic predictor for patients with early&#x02010;stage non&#x02010;small&#x02010;cell lung cancer</article-title>. <source>J Clin Oncol</source>. <year>2004</year>;<volume>22</volume>(<issue>16</issue>):<fpage>3230</fpage>&#x02010;<lpage>3237</lpage>.<pub-id pub-id-type="pmid">15310766</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0128"><label>128</label><mixed-citation publication-type="journal" id="ctm270239-cit-0128">
<string-name>
<surname>Uyama</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Tomita</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Nakamura</surname>
<given-names>H</given-names>
</string-name>, et&#x000a0;al. <article-title>Hepatoma&#x02010;derived growth factor is a novel prognostic factor for patients with pancreatic cancer</article-title>. <source>Clin Cancer Res</source>. <year>2006</year>;<volume>12</volume>(<issue>20 pt 1</issue>):<fpage>6043</fpage>&#x02010;<lpage>6048</lpage>.<pub-id pub-id-type="pmid">17062679</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0129"><label>129</label><mixed-citation publication-type="journal" id="ctm270239-cit-0129">
<string-name>
<surname>Guo</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Pan</surname>
<given-names>WW</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>SB</given-names>
</string-name>, <string-name>
<surname>Shen</surname>
<given-names>ZF</given-names>
</string-name>, <string-name>
<surname>Xu</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Hu</surname>
<given-names>LL</given-names>
</string-name>. <article-title>ERK/MAPK signalling pathway and tumorigenesis</article-title>. <source>Exp Ther Med</source>. <year>2020</year>;<volume>19</volume>(<issue>3</issue>):<fpage>1997</fpage>&#x02010;<lpage>2007</lpage>.<pub-id pub-id-type="pmid">32104259</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0130"><label>130</label><mixed-citation publication-type="journal" id="ctm270239-cit-0130">
<string-name>
<surname>Li</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Tao</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Zhao</surname>
<given-names>Y</given-names>
</string-name>, et&#x000a0;al. <article-title>5&#x02010;Methylcytosine RNA methyltransferases and their potential roles in cancer</article-title>. <source>J Transl Med</source>. <year>2022</year>;<volume>20</volume>(<issue>1</issue>):<fpage>214</fpage>.<pub-id pub-id-type="pmid">35562754</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0131"><label>131</label><mixed-citation publication-type="journal" id="ctm270239-cit-0131">
<string-name>
<surname>Xue</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Zhao</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>L</given-names>
</string-name>. <article-title>Multi&#x02010;omic analyses of the m(5)C regulator ALYREF reveal its essential roles in hepatocellular carcinoma</article-title>. <source>Front Oncol</source>. <year>2021</year>;<volume>11</volume>:<elocation-id>633415</elocation-id>.<pub-id pub-id-type="pmid">34367948</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0132"><label>132</label><mixed-citation publication-type="journal" id="ctm270239-cit-0132">
<string-name>
<surname>Zhai</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Tian</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Tang</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Shao</surname>
<given-names>L</given-names>
</string-name>. <article-title>RNA methyltransferase NSUN2 promotes growth of hepatocellular carcinoma cells by regulating fizzy&#x02010;related&#x02010;1 in vitro and in vivo</article-title>. <source>Kaohsiung J Med Sci</source>. <year>2021</year>;<volume>37</volume>(<issue>11</issue>):<fpage>991</fpage>&#x02010;<lpage>999</lpage>.<pub-id pub-id-type="pmid">34370374</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0133"><label>133</label><mixed-citation publication-type="journal" id="ctm270239-cit-0133">
<string-name>
<surname>Zhang</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Qu</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Lian</surname>
<given-names>S</given-names>
</string-name>, et&#x000a0;al. <article-title>PRL&#x02010;3 promotes ubiquitination and degradation of AURKA and colorectal cancer progression via dephosphorylation of FZR1</article-title>. <source>Cancer Res</source>. <year>2019</year>;<volume>79</volume>(<issue>5</issue>):<fpage>928</fpage>&#x02010;<lpage>940</lpage>.<pub-id pub-id-type="pmid">30498084</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0134"><label>134</label><mixed-citation publication-type="journal" id="ctm270239-cit-0134">
<string-name>
<surname>He</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>Q</given-names>
</string-name>, <string-name>
<surname>Zheng</surname>
<given-names>Q</given-names>
</string-name>, <string-name>
<surname>Yu</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Guo</surname>
<given-names>W</given-names>
</string-name>. <article-title>Distinct 5&#x02010;methylcytosine profiles of circular RNA in human hepatocellular carcinoma</article-title>. <source>Am J Transl Res</source>. <year>2020</year>;<volume>12</volume>(<issue>9</issue>):<fpage>5719</fpage>&#x02010;<lpage>5729</lpage>.<pub-id pub-id-type="pmid">33042451</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0135"><label>135</label><mixed-citation publication-type="journal" id="ctm270239-cit-0135">
<string-name>
<surname>Gu</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Zhou</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Chu</surname>
<given-names>Q</given-names>
</string-name>, <string-name>
<surname>Zheng</surname>
<given-names>Q</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Zhu</surname>
<given-names>H</given-names>
</string-name>. <article-title>Uncovering the association between m(5)C regulator&#x02010;mediated methylation modification patterns and tumour microenvironment infiltration characteristics in hepatocellular carcinoma</article-title>. <source>Front Cell Dev Biol</source>. <year>2021</year>;<volume>9</volume>:<elocation-id>727935</elocation-id>.<pub-id pub-id-type="pmid">34589490</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0136"><label>136</label><mixed-citation publication-type="journal" id="ctm270239-cit-0136">
<string-name>
<surname>Yang</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Yang</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Lan</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Wen</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Sun</surname>
<given-names>X</given-names>
</string-name>. <article-title>Diagnostic and prognostic value of m5C regulatory genes in hepatocellular carcinoma</article-title>. <source>Front Genet</source>. <year>2022</year>;<volume>13</volume>:<elocation-id>972043</elocation-id>.<pub-id pub-id-type="pmid">36105093</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0137"><label>137</label><mixed-citation publication-type="journal" id="ctm270239-cit-0137">
<string-name>
<surname>Cheng</surname>
<given-names>JX</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>Y</given-names>
</string-name>, et&#x000a0;al. <article-title>RNA cytosine methylation and methyltransferases mediate chromatin organization and 5&#x02010;azacytidine response and resistance in leukaemia</article-title>. <source>Nat Commun</source>. <year>2018</year>;<volume>9</volume>(<issue>1</issue>):<fpage>1163</fpage>.<pub-id pub-id-type="pmid">29563491</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0138"><label>138</label><mixed-citation publication-type="journal" id="ctm270239-cit-0138">
<string-name>
<surname>Li</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Xue</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Deng</surname>
<given-names>X</given-names>
</string-name>, et&#x000a0;al. <article-title>TET2&#x02010;mediated mRNA demethylation regulates leukemia stem cell homing and self&#x02010;renewal</article-title>. <source>Cell Stem Cell</source>. <year>2023</year>;<volume>30</volume>(<issue>8</issue>):<fpage>1072</fpage>&#x02010;<lpage>1090</lpage>.<pub-id pub-id-type="pmid">37541212</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0139"><label>139</label><mixed-citation publication-type="journal" id="ctm270239-cit-0139">
<string-name>
<surname>Zou</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Dou</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>Y</given-names>
</string-name>, et&#x000a0;al. <article-title>RNA m(5)C oxidation by TET2 regulates chromatin state and leukaemogenesis</article-title>. <source>Nature</source>. <year>2024</year>;<volume>634</volume>(<issue>8035</issue>):<fpage>986</fpage>&#x02010;<lpage>994</lpage>.<pub-id pub-id-type="pmid">39358506</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0140"><label>140</label><mixed-citation publication-type="journal" id="ctm270239-cit-0140">
<string-name>
<surname>Zhang</surname>
<given-names>Q</given-names>
</string-name>, <string-name>
<surname>Sun</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Sun</surname>
<given-names>J</given-names>
</string-name>, et&#x000a0;al. <article-title>RNA m(5)C regulator&#x02010;mediated modification patterns and the cross&#x02010;talk between tumor microenvironment infiltration in gastric cancer</article-title>. <source>Front Immunol</source>. <year>2022</year>;<volume>13</volume>:<elocation-id>905057</elocation-id>.<pub-id pub-id-type="pmid">36389669</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0141"><label>141</label><mixed-citation publication-type="journal" id="ctm270239-cit-0141">
<string-name>
<surname>Hu</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Tong</surname>
<given-names>X</given-names>
</string-name>, et&#x000a0;al. <article-title>NSUN2 modified by SUMO&#x02010;2/3 promotes gastric cancer progression and regulates mRNA m5C methylation</article-title>. <source>Cell Death Dis</source>. <year>2021</year>;<volume>12</volume>(<issue>9</issue>):<fpage>842</fpage>.<pub-id pub-id-type="pmid">34504059</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0142"><label>142</label><mixed-citation publication-type="journal" id="ctm270239-cit-0142">
<string-name>
<surname>Ren</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>M</given-names>
</string-name>, et&#x000a0;al. <article-title>De&#x02010;SUMOylation of FOXC2 by SENP3 promotes the epithelial&#x02012;mesenchymal transition in gastric cancer cells</article-title>. <source>Oncotarget</source>. <year>2014</year>;<volume>5</volume>(<issue>16</issue>):<fpage>7093</fpage>&#x02010;<lpage>7104</lpage>.<pub-id pub-id-type="pmid">25216525</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0143"><label>143</label><mixed-citation publication-type="journal" id="ctm270239-cit-0143">
<string-name>
<surname>Zhang</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>He</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Yin</surname>
<given-names>D</given-names>
</string-name>, et&#x000a0;al. <article-title>Increased expression of long noncoding RNA TUG1 predicts a poor prognosis of gastric cancer and regulates cell proliferation by epigenetically silencing of p57</article-title>. <source>Cell Death Dis</source>. <year>2016</year>;<volume>7</volume>(<issue>2</issue>):<elocation-id>e2109</elocation-id>.</mixed-citation></ref><ref id="ctm270239-bib-0144"><label>144</label><mixed-citation publication-type="journal" id="ctm270239-cit-0144">
<string-name>
<surname>Li</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Xia</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Jiang</surname>
<given-names>T</given-names>
</string-name>, et&#x000a0;al. <article-title>Long noncoding RNA DIAPH2&#x02010;AS1 promotes neural invasion of gastric cancer via stabilizing NSUN2 to enhance the m5C modification of NTN1</article-title>. <source>Cell Death Dis</source>. <year>2023</year>;<volume>14</volume>(<issue>4</issue>):<fpage>260</fpage>.<pub-id pub-id-type="pmid">37037818</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0145"><label>145</label><mixed-citation publication-type="journal" id="ctm270239-cit-0145">
<string-name>
<surname>Mei</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Shen</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Miao</surname>
<given-names>R</given-names>
</string-name>, et&#x000a0;al. <article-title>RNA methyltransferase NSUN2 promotes gastric cancer cell proliferation by repressing p57(Kip2) by an m(5)C&#x02010;dependent manner</article-title>. <source>Cell Death Dis</source>. <year>2020</year>;<volume>11</volume>(<issue>4</issue>):<fpage>270</fpage>.<pub-id pub-id-type="pmid">32332707</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0146"><label>146</label><mixed-citation publication-type="journal" id="ctm270239-cit-0146">
<string-name>
<surname>Wang</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Zhong</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Long</surname>
<given-names>Z</given-names>
</string-name>, et&#x000a0;al. <article-title>5&#x02010;Methylcytosine RNA methyltransferases&#x02010;related long non&#x02010;coding RNA to develop and validate biochemical recurrence signature in prostate cancer</article-title>. <source>Front Mol Biosci</source>. <year>2021</year>;<volume>8</volume>:<elocation-id>775304</elocation-id>.<pub-id pub-id-type="pmid">34926580</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0147"><label>147</label><mixed-citation publication-type="journal" id="ctm270239-cit-0147">
<string-name>
<surname>Zhu</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Wan</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Xu</surname>
<given-names>W</given-names>
</string-name>, et&#x000a0;al. <article-title>Positive epigenetic regulation loop between AR and NSUN2 promotes prostate cancer progression</article-title>. <source>Clin Transl Med</source>. <year>2022</year>;<volume>12</volume>(<issue>9</issue>):<elocation-id>e1028</elocation-id>.<pub-id pub-id-type="pmid">36169095</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0148"><label>148</label><mixed-citation publication-type="journal" id="ctm270239-cit-0148">
<string-name>
<surname>Sun</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Ma</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Zheng</surname>
<given-names>Z</given-names>
</string-name>, et&#x000a0;al. <article-title>Multi&#x02010;omics analysis of expression and prognostic value of NSUN members in prostate cancer</article-title>. <source>Front Oncol</source>. <year>2022</year>;<volume>12</volume>:<elocation-id>965571</elocation-id>.<pub-id pub-id-type="pmid">35978830</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0149"><label>149</label><mixed-citation publication-type="journal" id="ctm270239-cit-0149">
<string-name>
<surname>Tan</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Cai</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>G</given-names>
</string-name>, et&#x000a0;al. <article-title>Identification and verification of an ALYREF&#x02010;involved 5&#x02010;methylcytosine based signature for stratification of prostate cancer patients and prediction of clinical outcome and response to therapies</article-title>. <source>Discov Oncol</source>. <year>2023</year>;<volume>14</volume>(<issue>1</issue>):<fpage>62</fpage>.<pub-id pub-id-type="pmid">37155024</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0150"><label>150</label><mixed-citation publication-type="journal" id="ctm270239-cit-0150">
<string-name>
<surname>Liu</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Xiao</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Lou</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>X</given-names>
</string-name>. <article-title>A comprehensive analysis for expression, diagnosis, and prognosis of m(5)C regulator in breast cancer and its ncRNA&#x02010;mRNA regulatory mechanism</article-title>. <source>Front Genet</source>. <year>2022</year>;<volume>13</volume>:<elocation-id>822721</elocation-id>.<pub-id pub-id-type="pmid">35812757</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0151"><label>151</label><mixed-citation publication-type="journal" id="ctm270239-cit-0151">
<string-name>
<surname>Huang</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>D</given-names>
</string-name>. <article-title>Construction of prognostic risk model of 5&#x02010;methylcytosine&#x02010;related long non&#x02010;coding RNAs and evaluation of the characteristics of tumor&#x02010;infiltrating immune cells in breast cancer</article-title>. <source>Front Genet</source>. <year>2021</year>;<volume>12</volume>:<elocation-id>748279</elocation-id>.<pub-id pub-id-type="pmid">34777473</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0152"><label>152</label><mixed-citation publication-type="journal" id="ctm270239-cit-0152">
<string-name>
<surname>Li</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Xing</surname>
<given-names>Z</given-names>
</string-name>, et&#x000a0;al. <article-title>A ROR1&#x02010;HER3&#x02010;lncRNA signalling axis modulates the Hippo&#x02010;YAP pathway to regulate bone metastasis</article-title>. <source>Nat Cell Biol</source>. <year>2017</year>;<volume>19</volume>(<issue>2</issue>):<fpage>106</fpage>&#x02010;<lpage>119</lpage>.<pub-id pub-id-type="pmid">28114269</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0153"><label>153</label><mixed-citation publication-type="journal" id="ctm270239-cit-0153">
<string-name>
<surname>Huang</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Qi</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Lv</surname>
<given-names>S</given-names>
</string-name>, et&#x000a0;al. <article-title>Determination of DNA and RNA methylation in circulating tumor cells by mass spectrometry</article-title>. <source>Anal Chem</source>. <year>2016</year>;<volume>88</volume>(<issue>2</issue>):<fpage>1378</fpage>&#x02010;<lpage>1384</lpage>.<pub-id pub-id-type="pmid">26707930</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0154"><label>154</label><mixed-citation publication-type="journal" id="ctm270239-cit-0154">
<string-name>
<surname>Zhang</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Sun</surname>
<given-names>F</given-names>
</string-name>, et&#x000a0;al. <article-title>RNA methyltransferase NSUN2&#x02010;mediated m5C methylation promotes Cr(VI)&#x02010;induced malignant transformation and lung cancer by accelerating metabolism reprogramming</article-title>. <source>Environ Int</source>. <year>2024</year>;<volume>192</volume>:<elocation-id>109055</elocation-id>.<pub-id pub-id-type="pmid">39395236</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0155"><label>155</label><mixed-citation publication-type="journal" id="ctm270239-cit-0155">
<string-name>
<surname>Elhardt</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Shanmugam</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Jurkowski</surname>
<given-names>TP</given-names>
</string-name>, <string-name>
<surname>Jeltsch</surname>
<given-names>A</given-names>
</string-name>. <article-title>Somatic cancer mutations in the DNMT2 tRNA methyltransferase alter its catalytic properties</article-title>. <source>Biochimie</source>. <year>2015</year>;<volume>112</volume>:<fpage>66</fpage>&#x02010;<lpage>72</lpage>.<pub-id pub-id-type="pmid">25747896</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0156"><label>156</label><mixed-citation publication-type="journal" id="ctm270239-cit-0156">
<string-name>
<surname>Frye</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Watt</surname>
</string-name>
<string-name>
<given-names>F</given-names>
</string-name>. <article-title>The RNA methyltransferase Misu (NSun2) mediates Myc&#x02010;induced proliferation and is upregulated in tumors</article-title>. <source>Curr Biol</source>. <year>2006</year>;<volume>16</volume>(<issue>10</issue>):<fpage>971</fpage>&#x02010;<lpage>981</lpage>.<pub-id pub-id-type="pmid">16713953</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0157"><label>157</label><mixed-citation publication-type="journal" id="ctm270239-cit-0157">
<string-name>
<surname>Yang</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Risch</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Huang</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Huang</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Lu</surname>
<given-names>L</given-names>
</string-name>. <article-title>Association of tRNA methyltransferase NSUN2/IGF&#x02010;II molecular signature with ovarian cancer survival</article-title>. <source>Future Oncol</source>. <year>2017</year>;<volume>13</volume>(<issue>22</issue>):<fpage>1981</fpage>&#x02010;<lpage>1990</lpage>.<pub-id pub-id-type="pmid">28829218</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0158"><label>158</label><mixed-citation publication-type="journal" id="ctm270239-cit-0158">
<string-name>
<surname>Yi</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Gao</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>Y</given-names>
</string-name>, et&#x000a0;al. <article-title>Overexpression of NSUN2 by DNA hypomethylation is associated with metastatic progression in human breast cancer</article-title>. <source>Oncotarget</source>. <year>2017</year>;<volume>8</volume>(<issue>13</issue>):<fpage>20751</fpage>&#x02010;<lpage>20765</lpage>.<pub-id pub-id-type="pmid">27447970</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0159"><label>159</label><mixed-citation publication-type="journal" id="ctm270239-cit-0159">
<string-name>
<surname>Chen</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Ding</surname>
<given-names>L</given-names>
</string-name>, et&#x000a0;al. <article-title>RNA bisulfite sequencing reveals NSUN2&#x02010;mediated suppression of epithelial differentiation in pancreatic cancer</article-title>. <source>Oncogene</source>. <year>2022</year>;<volume>41</volume>(<issue>22</issue>):<fpage>3162</fpage>&#x02010;<lpage>3176</lpage>.<pub-id pub-id-type="pmid">35501460</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0160"><label>160</label><mixed-citation publication-type="journal" id="ctm270239-cit-0160">
<string-name>
<surname>Yu</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>Q</given-names>
</string-name>, <string-name>
<surname>Gao</surname>
<given-names>F</given-names>
</string-name>, et&#x000a0;al. <article-title>Predictive value of m5C regulatory gene expression in pancreatic adenocarcinoma</article-title>. <source>Sci Rep</source>. <year>2021</year>;<volume>11</volume>(<issue>1</issue>):<elocation-id>17529</elocation-id>.<pub-id pub-id-type="pmid">34471186</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0161"><label>161</label><mixed-citation publication-type="journal" id="ctm270239-cit-0161">
<string-name>
<surname>Geng</surname>
<given-names>Q</given-names>
</string-name>, <string-name>
<surname>Wei</surname>
<given-names>Q</given-names>
</string-name>, <string-name>
<surname>Shen</surname>
<given-names>Z</given-names>
</string-name>, et&#x000a0;al. <article-title>Comprehensive analysis of the prognostic value and immune infiltrates of the three&#x02010;m5C signature in colon carcinoma</article-title>. <source>Cancer Manag Res</source>. <year>2021</year>;<volume>13</volume>:<fpage>7989</fpage>&#x02010;<lpage>8002</lpage>.<pub-id pub-id-type="pmid">34707405</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0162"><label>162</label><mixed-citation publication-type="journal" id="ctm270239-cit-0162">
<string-name>
<surname>Zheng</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Zhu</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Zhou</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Wan</surname>
<given-names>X</given-names>
</string-name>. <article-title>m(5) C and m(6) A modification of long noncoding NKILA accelerates cholangiocarcinoma progression via the miR&#x02010;582&#x02010;3p&#x02010;YAP1 axis</article-title>. <source>Liver Int</source>. <year>2022</year>;<volume>42</volume>(<issue>5</issue>):<fpage>1144</fpage>&#x02010;<lpage>1157</lpage>.<pub-id pub-id-type="pmid">35274813</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0163"><label>163</label><mixed-citation publication-type="journal" id="ctm270239-cit-0163">
<string-name>
<surname>Wang</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Xu</surname>
<given-names>B</given-names>
</string-name>, et&#x000a0;al. <article-title>ALYREF drives cancer cell proliferation through an ALYREF&#x02010;MYC positive feedback loop in glioblastoma</article-title>. <source>Onco Targets Ther</source>. <year>2021</year>;<volume>14</volume>:<fpage>145</fpage>&#x02010;<lpage>155</lpage>.<pub-id pub-id-type="pmid">33447056</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0164"><label>164</label><mixed-citation publication-type="journal" id="ctm270239-cit-0164">
<string-name>
<surname>Zottel</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Jov&#x0010d;evska</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>&#x00160;amec</surname>
<given-names>N</given-names>
</string-name>, et&#x000a0;al. <article-title>Anti&#x02010;vimentin, anti&#x02010;TUFM, anti&#x02010;NAP1L1 and anti&#x02010;DPYSL2 nanobodies display cytotoxic effect and reduce glioblastoma cell migration</article-title>. <source>Ther Adv Med Oncol</source>. <year>2020</year>;<volume>12</volume>:<elocation-id>1758835920915302</elocation-id>.<pub-id pub-id-type="pmid">32426045</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0165"><label>165</label><mixed-citation publication-type="journal" id="ctm270239-cit-0165">
<string-name>
<surname>Nagy</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Seneviratne</surname>
<given-names>JA</given-names>
</string-name>, <string-name>
<surname>Kanikevich</surname>
<given-names>M</given-names>
</string-name>, et&#x000a0;al. <article-title>An ALYREF&#x02010;MYCN coactivator complex drives neuroblastoma tumorigenesis through effects on USP3 and MYCN stability</article-title>. <source>Nat Commun</source>. <year>2021</year>;<volume>12</volume>(<issue>1</issue>):<fpage>1881</fpage>.<pub-id pub-id-type="pmid">33767157</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0166"><label>166</label><mixed-citation publication-type="journal" id="ctm270239-cit-0166">
<string-name>
<surname>Niu</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Peng</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>W</given-names>
</string-name>, et&#x000a0;al. <article-title>A cis&#x02010;eQTL in NSUN2 promotes esophageal squamous&#x02010;cell carcinoma progression and radiochemotherapy resistance by mRNA&#x02010;m(5)C methylation</article-title>. <source>Signal Transduct Target Ther</source>. <year>2022</year>;<volume>7</volume>(<issue>1</issue>):<fpage>267</fpage>.<pub-id pub-id-type="pmid">35934711</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0167"><label>167</label><mixed-citation publication-type="journal" id="ctm270239-cit-0167">
<string-name>
<surname>Wang</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Su</surname>
<given-names>Y</given-names>
</string-name>, et&#x000a0;al. <article-title>Distinct roles of m(5)C RNA methyltransferase NSUN2 in major gynecologic cancers</article-title>. <source>Front Oncol</source>. <year>2022</year>;<volume>12</volume>:<elocation-id>786266</elocation-id>.<pub-id pub-id-type="pmid">35280737</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0168"><label>168</label><mixed-citation publication-type="journal" id="ctm270239-cit-0168">
<string-name>
<surname>Kang</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Hu</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Ivan</surname>
<given-names>C</given-names>
</string-name>, et&#x000a0;al. <article-title>Role of focal adhesion kinase in regulating YB&#x02010;1&#x02010;mediated paclitaxel resistance in ovarian cancer</article-title>. <source>J Natl Cancer Inst</source>. <year>2013</year>;<volume>105</volume>(<issue>19</issue>):<fpage>1485</fpage>&#x02010;<lpage>1495</lpage>.<pub-id pub-id-type="pmid">24062525</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0169"><label>169</label><mixed-citation publication-type="journal" id="ctm270239-cit-0169">
<string-name>
<surname>Chen</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Xu</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Luo</surname>
<given-names>J</given-names>
</string-name>, et&#x000a0;al. <article-title>NSUN2 is a glucose sensor suppressing cGAS/STING to maintain tumorigenesis and immunotherapy resistance</article-title>. <source>Cell Metab</source>. <year>2023</year>;<volume>35</volume>(<issue>10</issue>):1782&#x02010;1798 e8.</mixed-citation></ref><ref id="ctm270239-bib-0170"><label>170</label><mixed-citation publication-type="journal" id="ctm270239-cit-0170">
<string-name>
<surname>Sato</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Tahata</surname>
</string-name>
<string-name>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Akimoto</surname>
</string-name>
<string-name>
<given-names>K</given-names>
</string-name>. <article-title>Five genes associated with survival in patients with lower&#x02010;grade gliomas were identified by information&#x02010;theoretical analysis</article-title>. <source>Anticancer Res</source>. <year>2020</year>;<volume>40</volume>(<issue>5</issue>):<fpage>2777</fpage>&#x02010;<lpage>2785</lpage>.<pub-id pub-id-type="pmid">32366424</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0171"><label>171</label><mixed-citation publication-type="journal" id="ctm270239-cit-0171">
<string-name>
<surname>Dai</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Gonzalez</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>L</given-names>
</string-name>, et&#x000a0;al. <article-title>YTHDF2 binds to 5&#x02010;methylcytosine in RNA and modulates the maturation of ribosomal RNA</article-title>. <source>Anal Chem</source>. <year>2020</year>;<volume>92</volume>(<issue>1</issue>):<fpage>1346</fpage>&#x02010;<lpage>1354</lpage>.<pub-id pub-id-type="pmid">31815440</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0172"><label>172</label><mixed-citation publication-type="journal" id="ctm270239-cit-0172">
<string-name>
<surname>Li</surname>
<given-names>Q</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Tang</surname>
<given-names>H</given-names>
</string-name>, et&#x000a0;al. <article-title>NSUN2&#x02010;mediated m5C methylation and METTL3/METTL14&#x02010;mediated m6A methylation cooperatively enhance p21 translation</article-title>. <source>J Cell Biochem</source>. <year>2017</year>;<volume>118</volume>(<issue>9</issue>):<fpage>2587</fpage>&#x02010;<lpage>2598</lpage>.<pub-id pub-id-type="pmid">28247949</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0173"><label>173</label><mixed-citation publication-type="journal" id="ctm270239-cit-0173">
<string-name>
<surname>Wu</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Zhao</surname>
<given-names>Q</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>S</given-names>
</string-name>, et&#x000a0;al. <article-title>NSUN4&#x02010;mediated m5C modification of circERI3 promotes lung cancer development by altering mitochondrial energy metabolism</article-title>. <source>Cancer Lett</source>. <year>2024</year>;<volume>605</volume>:<elocation-id>217266</elocation-id>.<pub-id pub-id-type="pmid">39332589</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0174"><label>174</label><mixed-citation publication-type="journal" id="ctm270239-cit-0174">
<string-name>
<surname>Wang</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Feng</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Fu</surname>
<given-names>Z</given-names>
</string-name>, et&#x000a0;al. <article-title>Epitranscriptomic m(5)C methylation of SARS&#x02010;CoV&#x02010;2 RNA regulates viral replication and the virulence of progeny viruses in the new infection</article-title>. <source>Sci Adv</source>. <year>2024</year>;<volume>10</volume>(<issue>32</issue>):<elocation-id>eadn9519</elocation-id>.<pub-id pub-id-type="pmid">39110796</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0175"><label>175</label><mixed-citation publication-type="journal" id="ctm270239-cit-0175">
<string-name>
<surname>Yankova</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Blackaby</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Albertella</surname>
<given-names>M</given-names>
</string-name>, et&#x000a0;al. <article-title>Small&#x02010;molecule inhibition of METTL3 as a strategy against myeloid leukaemia</article-title>. <source>Nature</source>. <year>2021</year>;<volume>593</volume>(<issue>7860</issue>):<fpage>597</fpage>&#x02010;<lpage>601</lpage>.<pub-id pub-id-type="pmid">33902106</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0176"><label>176</label><mixed-citation publication-type="journal" id="ctm270239-cit-0176">
<string-name>
<surname>Sakita&#x02010;Suto</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Kanda</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Suzuki</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Sato</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Takata</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Tatsuka</surname>
<given-names>M</given-names>
</string-name>. <article-title>Aurora&#x02010;B regulates RNA methyltransferase NSUN2</article-title>. <source>Mol Biol Cell</source>. <year>2007</year>;<volume>18</volume>(<issue>3</issue>):<fpage>1107</fpage>&#x02010;<lpage>1117</lpage>.<pub-id pub-id-type="pmid">17215513</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0177"><label>177</label><mixed-citation publication-type="journal" id="ctm270239-cit-0177">
<string-name>
<surname>Glasner</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Riml</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Micura</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Breuker</surname>
<given-names>K</given-names>
</string-name>. <article-title>Label&#x02010;free, direct localization and relative quantitation of the RNA nucleobase methylations m6A, m5C, m3U, and m5U by top&#x02010;down mass spectrometry</article-title>. <source>Nucleic Acids Res</source>. <year>2017</year>;<volume>45</volume>(<issue>13</issue>):<fpage>8014</fpage>&#x02010;<lpage>8025</lpage>.<pub-id pub-id-type="pmid">28549193</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0178"><label>178</label><mixed-citation publication-type="journal" id="ctm270239-cit-0178">
<string-name>
<surname>Heiss</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Reichle</surname>
</string-name>
<string-name>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Kellner</surname>
</string-name>
<string-name>
<given-names>S</given-names>
</string-name>. <article-title>Observing the fate of tRNA and its modifications by nucleic acid isotope labeling mass spectrometry: NAIL&#x02010;MS</article-title>. <source>RNA Biol</source>. <year>2017</year>;<volume>14</volume>(<issue>9</issue>):<fpage>1260</fpage>&#x02010;<lpage>1268</lpage>.<pub-id pub-id-type="pmid">28488916</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0179"><label>179</label><mixed-citation publication-type="journal" id="ctm270239-cit-0179">
<string-name>
<surname>Zhang</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Shi</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Yoo</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Yuan</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>S</given-names>
</string-name>. <article-title>2D&#x02010;HELS MS Seq: a general LC&#x02010;MS&#x02010;based method for direct and de novo sequencing of RNA mixtures with different nucleotide modifications</article-title>. <source>J Vis Exp</source>. <year>2020;</year>(<issue>161</issue>).</mixed-citation></ref><ref id="ctm270239-bib-0180"><label>180</label><mixed-citation publication-type="journal" id="ctm270239-cit-0180">
<string-name>
<surname>Khoddami</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Cairns</surname>
</string-name>
<string-name>
<given-names>B</given-names>
</string-name>. <article-title>Transcriptome&#x02010;wide target profiling of RNA cytosine methyltransferases using the mechanism&#x02010;based enrichment procedure Aza&#x02010;IP</article-title>. <source>Nat Protoc</source>. <year>2014</year>;<volume>9</volume>(<issue>2</issue>):<fpage>337</fpage>&#x02010;<lpage>361</lpage>.<pub-id pub-id-type="pmid">24434802</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0181"><label>181</label><mixed-citation publication-type="journal" id="ctm270239-cit-0181">
<string-name>
<surname>Lu</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Giordano</surname>
</string-name>
<string-name>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Ning</surname>
</string-name>
<string-name>
<given-names>Z</given-names>
</string-name>. <article-title>Oxford nanopore MinION sequencing and GenomeAssembly</article-title>. <source>Genomics Proteomics Bioinform</source>. <year>2016</year>;<volume>14</volume>(<issue>5</issue>):<fpage>265</fpage>&#x02010;<lpage>279</lpage>.</mixed-citation></ref><ref id="ctm270239-bib-0182"><label>182</label><mixed-citation publication-type="journal" id="ctm270239-cit-0182">
<string-name>
<surname>Sabooh</surname>
<given-names>MF</given-names>
</string-name>, <string-name>
<surname>Iqbal</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Khan</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Khan</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Maqbool</surname>
<given-names>H</given-names>
</string-name>. <article-title>Identifying 5&#x02010;methylcytosine sites in RNA sequence using composite encoding feature into Chou's PseKNC</article-title>. <source>J Theor Biol</source>. <year>2018</year>;<volume>452</volume>:<fpage>1</fpage>&#x02010;<lpage>9</lpage>.<pub-id pub-id-type="pmid">29727634</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0183"><label>183</label><mixed-citation publication-type="journal" id="ctm270239-cit-0183">
<string-name>
<surname>Feng</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Ding</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Yang</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Lin</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Chou</surname>
<given-names>K</given-names>
</string-name>. <article-title>iRNA&#x02010;PseColl: identifying the occurrence sites of different RNA modifications by incorporating collective effects of nucleotides into PseKNC</article-title>. <source>Mol Ther Nucleic Acids</source>. <year>2017</year>;<volume>7</volume>:<fpage>155</fpage>&#x02010;<lpage>163</lpage>.<pub-id pub-id-type="pmid">28624191</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0184"><label>184</label><mixed-citation publication-type="journal" id="ctm270239-cit-0184">
<string-name>
<surname>Xue</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Xu</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Sun</surname>
<given-names>Z</given-names>
</string-name>, et&#x000a0;al. <article-title>Depletion of TRDMT1 affects 5&#x02010;methylcytosine modification of mRNA and inhibits HEK293 cell proliferation and migration</article-title>. <source>Biochem Biophys Res Commun</source>. <year>2019</year>;<volume>520</volume>(<issue>1</issue>):<fpage>60</fpage>&#x02010;<lpage>66</lpage>.<pub-id pub-id-type="pmid">31570165</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0185"><label>185</label><mixed-citation publication-type="journal" id="ctm270239-cit-0185">
<string-name>
<surname>Kong</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Biswas</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Zhou</surname>
<given-names>D</given-names>
</string-name>, et&#x000a0;al. <article-title>Nucleolar protein NOP2/NSUN1 suppresses HIV&#x02010;1 transcription and promotes viral latency by competing with Tat for TAR binding and methylation</article-title>. <source>PLoS Pathog</source>. <year>2020</year>;<volume>16</volume>(<issue>3</issue>):<elocation-id>e1008430</elocation-id>.<pub-id pub-id-type="pmid">32176734</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0186"><label>186</label><mixed-citation publication-type="journal" id="ctm270239-cit-0186">
<string-name>
<surname>Kosi</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Ali&#x00107;</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Kola&#x0010d;evi&#x00107;</surname>
<given-names>M</given-names>
</string-name>, et&#x000a0;al. <article-title>Nop2 is expressed during proliferation of neural stem cells and in adult mouse and human brain</article-title>. <source>Brain Res</source>. <year>2015</year>;<volume>1597</volume>:<fpage>65</fpage>&#x02010;<lpage>76</lpage>.<pub-id pub-id-type="pmid">25481415</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0187"><label>187</label><mixed-citation publication-type="journal" id="ctm270239-cit-0187">
<string-name>
<surname>Blaze</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Navickas</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Phillips</surname>
<given-names>HL</given-names>
</string-name>, et&#x000a0;al. <article-title>Neuronal Nsun2 deficiency produces tRNA epitranscriptomic alterations and proteomic shifts impacting synaptic signaling and behavior</article-title>. <source>Nat Commun</source>. <year>2021</year>;<volume>12</volume>(<issue>1</issue>):<fpage>4913</fpage>.<pub-id pub-id-type="pmid">34389722</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0188"><label>188</label><mixed-citation publication-type="journal" id="ctm270239-cit-0188">
<string-name>
<surname>Yan</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Huang</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Huang</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Lv</surname>
<given-names>J</given-names>
</string-name>. <article-title>FOXC2&#x02010;AS1 stabilizes FOXC2 mRNA via association with NSUN2 in gastric cancer cells</article-title>. <source>Hum Cell</source>. <year>2021</year>;<volume>34</volume>(<issue>6</issue>):<fpage>1755</fpage>&#x02010;<lpage>1764</lpage>.<pub-id pub-id-type="pmid">34324140</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0189"><label>189</label><mixed-citation publication-type="journal" id="ctm270239-cit-0189">
<string-name>
<surname>Song</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>An</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Zhai</surname>
<given-names>W</given-names>
</string-name>, et&#x000a0;al. <article-title>NSUN2&#x02010;mediated mRNA m(5)C modification regulates the progression of hepatocellular carcinoma</article-title>. <source>Genomics Proteomics Bioinform</source>. <year>2023</year>;<volume>21</volume>(<issue>4</issue>):<fpage>823</fpage>&#x02010;<lpage>833</lpage>.</mixed-citation></ref><ref id="ctm270239-bib-0190"><label>190</label><mixed-citation publication-type="journal" id="ctm270239-cit-0190">
<string-name>
<surname>Chen</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Ding</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>B</given-names>
</string-name>, et&#x000a0;al. <article-title>RNA methyltransferase NSUN2 promotes hypopharyngeal squamous cell carcinoma proliferation and migration by enhancing TEAD1 expression in an m(5)C&#x02010;dependent manner</article-title>. <source>Exp Cell Res</source>. <year>2021</year>;<volume>404</volume>(<issue>2</issue>):<elocation-id>112664</elocation-id>.<pub-id pub-id-type="pmid">34048786</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0191"><label>191</label><mixed-citation publication-type="journal" id="ctm270239-cit-0191">
<string-name>
<surname>Tong</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Xiang</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Hu</surname>
<given-names>Y</given-names>
</string-name>, et&#x000a0;al. <article-title>NSUN2 promotes tumor progression and regulates immune infiltration in nasopharyngeal carcinoma</article-title>. <source>Front Oncol</source>. <year>2022</year>;<volume>12</volume>:<elocation-id>788801</elocation-id>.<pub-id pub-id-type="pmid">35574373</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0192"><label>192</label><mixed-citation publication-type="journal" id="ctm270239-cit-0192">
<string-name>
<surname>Wang</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Tang</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Feng</surname>
<given-names>J</given-names>
</string-name>. <article-title>Homocysteine upregulates interleukin&#x02010;17A expression via NSun2&#x02010;mediated RNA methylation in T lymphocytes</article-title>. <source>Biochem Biophys Res Commun</source>. <year>2017</year>;<volume>493</volume>(<issue>1</issue>):<fpage>94</fpage>&#x02010;<lpage>99</lpage>.<pub-id pub-id-type="pmid">28919411</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0193"><label>193</label><mixed-citation publication-type="journal" id="ctm270239-cit-0193">
<string-name>
<surname>Yang</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Ren</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Yan</surname>
<given-names>S</given-names>
</string-name>, et&#x000a0;al. <article-title>Nsun4 and Mettl3 mediated translational reprogramming of Sox9 promotes BMSC chondrogenic differentiation</article-title>. <source>Commun Biol</source>. <year>2022</year>;<volume>5</volume>(<issue>1</issue>):<fpage>495</fpage>.<pub-id pub-id-type="pmid">35614315</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0194"><label>194</label><mixed-citation publication-type="journal" id="ctm270239-cit-0194">
<string-name>
<surname>Liu</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Huang</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>W</given-names>
</string-name>, et&#x000a0;al. <article-title>Developmental mRNA m(5)C landscape and regulatory innovations of massive m(5)C modification of maternal mRNAs in animals</article-title>. <source>Nat Commun</source>. <year>2022</year>;<volume>13</volume>(<issue>1</issue>):<fpage>2484</fpage>.<pub-id pub-id-type="pmid">35513466</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0195"><label>195</label><mixed-citation publication-type="journal" id="ctm270239-cit-0195">
<string-name>
<surname>Li</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Jiang</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Huang</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>N</given-names>
</string-name>. <article-title>Prognostic value of an m(5)C RNA methylation regulator&#x02010;related signature for clear cell renal cell carcinoma</article-title>. <source>Cancer Manag Res</source>. <year>2021</year>;<volume>13</volume>:<fpage>6673</fpage>&#x02010;<lpage>6687</lpage>.<pub-id pub-id-type="pmid">34471382</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0196"><label>196</label><mixed-citation publication-type="journal" id="ctm270239-cit-0196">
<string-name>
<surname>Xu</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Yi</surname>
<given-names>P</given-names>
</string-name>. <article-title>RNA 5&#x02010;methylcytosine regulators contribute to metabolism heterogeneity and predict prognosis in ovarian cancer</article-title>. <source>Front Cell Dev Biol</source>. <year>2022</year>;<volume>10</volume>:<elocation-id>807786</elocation-id>.<pub-id pub-id-type="pmid">35372362</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0197"><label>197</label><mixed-citation publication-type="journal" id="ctm270239-cit-0197">
<string-name>
<surname>Xu</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>M</given-names>
</string-name>. <article-title>Roles of m5C RNA modification patterns in biochemical recurrence and tumor microenvironment characterization of prostate adenocarcinoma</article-title>. <source>Front Immunol</source>. <year>2022</year>;<volume>13</volume>:<elocation-id>869759</elocation-id>.<pub-id pub-id-type="pmid">35603206</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0198"><label>198</label><mixed-citation publication-type="journal" id="ctm270239-cit-0198">
<string-name>
<surname>Li</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Yang</surname>
</string-name>
<string-name>
<given-names>X</given-names>
</string-name>. <article-title>Correlation between the RNA methylation genes and immune infiltration and prognosis of patients with hepatocellular carcinoma: a pan&#x02010;cancer analysis</article-title>. <source>J Inflamm Res</source>. <year>2022</year>;<volume>15</volume>:<fpage>3941</fpage>&#x02010;<lpage>3956</lpage>.<pub-id pub-id-type="pmid">35860228</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0199"><label>199</label><mixed-citation publication-type="journal" id="ctm270239-cit-0199">
<string-name>
<surname>Liu</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Hu</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Lin</surname>
<given-names>C</given-names>
</string-name>, et&#x000a0;al. <article-title>5&#x02010;Methylcytosine RNA methylation regulators affect prognosis and tumor microenvironment in lung adenocarcinoma</article-title>. <source>Ann Transl Med</source>. <year>2022</year>;<volume>10</volume>(<issue>5</issue>):<fpage>259</fpage>.<pub-id pub-id-type="pmid">35402591</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0200"><label>200</label><mixed-citation publication-type="journal" id="ctm270239-cit-0200">
<string-name>
<surname>Xue</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Shi</surname>
<given-names>Q</given-names>
</string-name>, <string-name>
<surname>Zheng</surname>
<given-names>L</given-names>
</string-name>, et&#x000a0;al. <article-title>Gene signatures of m5C regulators may predict prognoses of patients with head and neck squamous cell carcinoma</article-title>. <source>Am J Transl Res</source>. <year>2020</year>;<volume>12</volume>(<issue>10</issue>):<fpage>6841</fpage>&#x02010;<lpage>6852</lpage>.<pub-id pub-id-type="pmid">33194076</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0201"><label>201</label><mixed-citation publication-type="journal" id="ctm270239-cit-0201">
<string-name>
<surname>Wang</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Zhu</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Han</surname>
<given-names>J</given-names>
</string-name>, et&#x000a0;al. <article-title>The role of the HIF&#x02010;1&#x003b1;/ALYREF/PKM2 axis in glycolysis and tumorigenesis of bladder cancer</article-title>. <source>Cancer Commun</source>. <year>2021</year>;<volume>41</volume>(<issue>7</issue>):<fpage>560</fpage>&#x02010;<lpage>575</lpage>.</mixed-citation></ref><ref id="ctm270239-bib-0202"><label>202</label><mixed-citation publication-type="journal" id="ctm270239-cit-0202">
<string-name>
<surname>Liu</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Zhao</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Wu</surname>
<given-names>R</given-names>
</string-name>, et&#x000a0;al. <article-title>mRNA m5C controls adipogenesis by promoting CDKN1A mRNA export and translation</article-title>. <source>RNA Biol</source>. <year>2021</year>;<volume>18</volume>(<issue>sup2</issue>):<fpage>711</fpage>&#x02010;<lpage>721</lpage>.<pub-id pub-id-type="pmid">34570675</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0203"><label>203</label><mixed-citation publication-type="journal" id="ctm270239-cit-0203">
<string-name>
<surname>Liu</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Yang</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Wu</surname>
<given-names>R</given-names>
</string-name>, et&#x000a0;al. <article-title>mRNA m(5)C inhibits adipogenesis and promotes myogenesis by respectively facilitating YBX2 and SMO mRNA export in ALYREF&#x02010;m(5)C manner</article-title>. <source>Cell Mol Life Sci</source>. <year>2022</year>;<volume>79</volume>(<issue>9</issue>):<fpage>481</fpage>.<pub-id pub-id-type="pmid">35962235</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0204"><label>204</label><mixed-citation publication-type="journal" id="ctm270239-cit-0204">
<string-name>
<surname>Eckwahl</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Xu</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Michalkiewicz</surname>
<given-names>J</given-names>
</string-name>, et&#x000a0;al. <article-title>5&#x02010;Methylcytosine RNA modifications promote retrovirus replication in an ALYREF reader protein&#x02010;dependent manner</article-title>. <source>J Virol</source>. <year>2020</year>;<volume>94</volume>(<issue>13</issue>):<fpage>e00544</fpage>&#x02010;<lpage>20</lpage>.<pub-id pub-id-type="pmid">32321818</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0205"><label>205</label><mixed-citation publication-type="journal" id="ctm270239-cit-0205">
<string-name>
<surname>He</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Yin</surname>
<given-names>F</given-names>
</string-name>, et&#x000a0;al. <article-title>Novel insights into the role of 5&#x02010;Methylcytosine RNA methylation in human abdominal aortic aneurysm</article-title>. <source>Front Biosci (Landmark Ed)</source>. <year>2021</year>;<volume>26</volume>(<issue>11</issue>):<fpage>1147</fpage>&#x02010;<lpage>1165</lpage>.<pub-id pub-id-type="pmid">34856760</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0206"><label>206</label><mixed-citation publication-type="journal" id="ctm270239-cit-0206">
<string-name>
<surname>Fotovati</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Abu&#x02010;Ali</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>P</given-names>
</string-name>, et&#x000a0;al. <article-title>YB&#x02010;1 bridges neural stem cells and brain tumor&#x02010;initiating cells via its roles in differentiation and cell growth</article-title>. <source>Cancer Res</source>. <year>2011</year>;<volume>71</volume>(<issue>16</issue>):<fpage>5569</fpage>&#x02010;<lpage>5578</lpage>.<pub-id pub-id-type="pmid">21730024</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0207"><label>207</label><mixed-citation publication-type="journal" id="ctm270239-cit-0207">
<string-name>
<surname>Chen</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Cao</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Ben</surname>
<given-names>S</given-names>
</string-name>, et&#x000a0;al. <article-title>Genetic variants in RNA m(5) C modification genes associated with survival and chemotherapy efficacy of colorectal cancer</article-title>. <source>Cancer Med</source>. <year>2023</year>;<volume>12</volume>(<issue>2</issue>):<fpage>1376</fpage>&#x02010;<lpage>1388</lpage>.<pub-id pub-id-type="pmid">35861369</pub-id>
</mixed-citation></ref><ref id="ctm270239-bib-0208"><label>208</label><mixed-citation publication-type="journal" id="ctm270239-cit-0208">
<string-name>
<surname>Yang</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Yin</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>Y</given-names>
</string-name>, et&#x000a0;al. <article-title>Low expression of PEBP1P2 promotes metastasis of clear cell renal cell carcinoma by post&#x02010;transcriptional regulation of PEBP1 and KLF13 mRNA</article-title>. <source>Exp Hematol Oncol</source>. <year>2022</year>;<volume>11</volume>(<issue>1</issue>):<fpage>87</fpage>.<pub-id pub-id-type="pmid">36348434</pub-id>
</mixed-citation></ref></ref-list></back></article>